Publications

Publications published since 2010 from OUS - Department of Oncology

1886 publications found (only first 1000 shown)

Publications 2021

  1. Aamdal E, Inderberg EM, Ellingsen EB, Rasch W, Brunsvig PF, Aamdal S, Heintz KM, Vodák D, Nakken S, Hovig E, Nyakas M, Guren TK, Gaudernack G (2021)
    Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial
    Front Immunol, 12, 663865
    DOI 10.3389/fimmu.2021.663865, PubMed 34046035
  2. Aas K, Berge V, Myklebust TA, Fossa SD (2021)
    Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
    Eur. Urol. Open Sci., 26, 55-63
  3. Abrahamsen CS, Lang-Ree HM, Halvorsen K, Stenbakken CM (2021)
    Patients with COPD: Exploring patients' coping ability during an interdisciplinary pulmonary rehabilitation programme: A qualitative focus group study
    J Clin Nurs, 30 (9-10), 1479-1488
    DOI 10.1111/jocn.15700, PubMed 33555629
  4. Aljabri B, Lilleby W, Switlyk MD, Tafjord G (2021)
    Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up
    Urol Case Rep, 37, 101648
    DOI 10.1016/j.eucr.2021.101648, PubMed 33868933
  5. ArdeshirRouhaniFard S, Dinh PC, Monahan PO, Fossa SD, Huddart R, Fung C, Song Y, Feldman DR, Hamilton RJ, Vaughn DJ, Martin NE, Kollmannsberger C, Einhorn L, Kroenke K, Travis LB (2021)
    Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study
    Cancer Epidemiol Biomarkers Prev, 30 (6), 1129-1138
    DOI 10.1158/1055-9965.EPI-20-1762, PubMed 33849970
  6. Autio M, Leivonen SK, Brück O, Mustjoki S, Mészáros Jørgensen J, Karjalainen-Lindsberg ML, Beiske K, Holte H, Pellinen T, Leppä S (2021)
    Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
    Haematologica, 106 (3), 718-729
    DOI 10.3324/haematol.2019.243626, PubMed 32079690
  7. Bahadoer RR, Bastiaannet E, Claassen YHM, van der Mark M, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT (2021)
    One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison
    Eur J Surg Oncol, 47 (7), 1651-1660
    DOI 10.1016/j.ejso.2021.01.011, PubMed 33518367
  8. Balstad TR, Brunelli C, Pettersen CH, Schønberg SA, Skorpen F, Fallon M, Kaasa S, Bye A, Laird BJA, Stene GB, Solheim TS (2021)
    Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial
    Front Nutr, 7, 602775
    DOI 10.3389/fnut.2020.602775, PubMed 33585533
  9. Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M et al. (2021)
    Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study
    Cancers (Basel), 13 (7)
    DOI 10.3390/cancers13071565, PubMed 33805367
  10. Barkovskaya A, Goodwin CM, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, Engebraaten O, Briem E, Der CJ, Moestue SA, Gudjonsson T, Maelandsmo GM, Prasmickaite L (2021)
    Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen
    Mol Oncol
    DOI 10.1002/1878-0261.12951, PubMed 33759347
  11. Berg J, Ramberg C, Haugstvedt JOS, Bengtson MB, Gabrielsen AM, Brustugun OT, Halvorsen AR, Helland Å (2021)
    Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
    Front Oncol, 11, 674731
    DOI 10.3389/fonc.2021.674731, PubMed 34109123
  12. Beyer J, Collette L, Sauve N, Daugaard G, Feldman DR, Tandstad T, Tryakin A, Stahl O, Gonzalez-Billalabeitia E, De Giorgi U, Culine S, de Wit R, Hansen AR, Bebek M, Terbuch A, Albany C, Hentrich M, Gietema JA, Negaard H, Huddart RA, Lorch A, Cafferty FH, Heng DYC, Sweeney CJ, Winquist E et al. (2021)
    Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
    J. Clin. Oncol., 39 (14), 1553-+
  13. Bjerring AW, Fosså SD, Haugnes HS, Nome R, Stokke TM, Haugaa KH, Kiserud CE, Edvardsen T, Sarvari SI (2021)
    The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
    Eur Heart J Cardiovasc Imaging, 22 (4), 443-450
    DOI 10.1093/ehjci/jeaa289, PubMed 33152065
  14. Blindheim AJ, Fosså SD, Babigumira R, Andreassen BK (2021)
    The use of reTURB in T1 bladder cancer: a Norwegian population-based study
    Scand J Urol
    DOI 10.1080/21681805.2021.1917652, PubMed 33998957
  15. Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
    Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
    TH Open, 5 (1), e14-e23
    DOI 10.1055/s-0040-1721782, PubMed 33564742
  16. Bong WK, Gaustadnes LM, Bergland A, Chen W, Bye A (2021)
    Community-living older people's interpretation of the Norwegian version of older people's quality of life (OPQOL) questionnaire
    Health Soc Care Community
    DOI 10.1111/hsc.13273, PubMed 33440057
  17. Bonsaksen T, Skogstad L, Grimholt TK, Heir T, Ekeberg O, Lerdal A, Schou-Bredal I (2021)
    Substance use in the Norwegian general population: prevalence and associations with disease
    J. Subst. Use, 26 (2), 144-150
  18. Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E (2021)
    Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
    Cancer Immunol Immunother
    DOI 10.1007/s00262-021-02876-w, PubMed 33580363
  19. Brustugun OT (2021)
    Cancer and coronavirus risk
    Tidsskr Nor Laegeforen, 141 (2)
    DOI 10.4045/tidsskr.20.1044, PubMed 33528129
  20. Brustugun OT, Heggelund L (2021)
    COVID-19 vaccination of cancer patients
    Tidsskr Nor Laegeforen, 141 (3)
    DOI 10.4045/tidsskr.21.0026, PubMed 33624982
  21. Caulier B, Enserink JM, Wälchli S (2021)
    Pharmacologic Control of CAR T Cells
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094320, PubMed 33919245
  22. Choudhury A, Theophanous S, Lønne PI, Samuel R, Guren MG, Berbee M, Brown P, Lilley J, van Soest J, Dekker A, Gilbert A, Malinen E, Wee L, Appelt AL (2021)
    Predicting outcomes in anal cancer patients using multi-centre data and distributed learning - A proof-of-concept study
    Radiother Oncol, 159, 183-189
    DOI 10.1016/j.radonc.2021.03.013, PubMed 33753156
  23. Dahle DO, Skauby M, Langberg CW, Brabrand K, Wessel N, Midtvedt K (2021)
    Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
    Transplantation (in press)
    DOI 10.1097/TP.0000000000003762, PubMed 33741842
  24. Damhuis RAM, Senan S, Khakwani A, Harden S, Helland Ȧ, Strand TE (2021)
    Age-related treatment patterns for stage I NSCLC in three European countries
    J Geriatr Oncol (in press)
    DOI 10.1016/j.jgo.2021.05.005, PubMed 33994330
  25. Eikeland SA, Smeland KB, Mols F, Fagerli UM, Bersvendsen HS, Kiserud CE, Fosså A (2021)
    Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life
    Acta Oncol, 1-10 (in press)
    DOI 10.1080/0284186X.2021.1917776, PubMed 33905285
  26. Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K (2021)
    Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour
    Pathology (in press)
    DOI 10.1016/j.pathol.2020.11.010, PubMed 33745702
  27. Gerdtsson A, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Sagstuen Haugnes H, Engen Andreassen K, Melsen Larsen S, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2021)
    Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
    Eur Urol Oncol (in press)
    DOI 10.1016/j.euo.2021.02.002, PubMed 33750683
  28. Gillessen S, Sauvé N, Collette L, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A et al. (2021)
    Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
    J Clin Oncol, 39 (14), 1563-1574
    DOI 10.1200/JCO.20.03296, PubMed 33822655
  29. Gjersvik P, Heikkila R, Johansen TEB (2021)
    Rescue treatment for cancer
    Tidsskr. Nor. Laegeforen., 141 (5), 487
  30. Groendahl AR, Skjei Knudtsen I, Huynh BN, Mulstad M, Moe YM, Knuth F, Tomic O, Indahl UG, Torheim T, Dale E, Malinen E, Futsaether CM (2021)
    A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers
    Phys Med Biol, 66 (6), 065012
    DOI 10.1088/1361-6560/abe553, PubMed 33666176
  31. Grønberg BH, Killingberg KT, Fløtten Ø, Brustugun OT, Hornslien K, Madebo T, Langer SW, Schytte T, Nyman J, Risum S, Tsakonas G, Engleson J, Halvorsen TO (2021)
    High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial
    Lancet Oncol, 22 (3), 321-331
    DOI 10.1016/S1470-2045(20)30742-7, PubMed 33662285
  32. Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
    Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
    NPJ Digit Med, 4 (1), 33
    DOI 10.1038/s41746-021-00398-4, PubMed 33619361
  33. Gullhaug A, Hjermstad MJ, Yri O, Svestad JG, Aass N, Johansen S (2021)
    Use of radiotherapy in breast cancer patients with brain metastases- a retrospective 11-year single center study
    J Med Imaging Radiat Sci (in press)
    DOI 10.1016/j.jmir.2021.01.002, PubMed 33549504
  34. Haakensen VD, Nowak AK, Ellingsen EB, Farooqi SJ, Bjaanæs MM, Horndalsveen H, Mcculloch T, Grundberg O, Cedres SM, Helland Å (2021)
    NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
    J Transl Med, 19 (1), 232
    DOI 10.1186/s12967-021-02905-3, PubMed 34059094
  35. Habberstad R, Frøseth TCS, Aass N, Bjerkeset E, Abramova T, Garcia-Alonso E, Caputo M, Rossi R, Boland JW, Brunelli C, Lund JÅ, Kaasa S, Klepstad P (2021)
    Clinical Predictors for Analgesic Response to Radiotherapy in Patients with Painful Bone Metastases
    J Pain Symptom Manage (in press)
    DOI 10.1016/j.jpainsymman.2021.03.022, PubMed 33794301
  36. Hamfjord J, Guren TK, Glimelius B, Sorbye H, Pfeiffer P, Dajani O, Lingjaerde OC, Tveit KM, Pallisgaard N, Spindler KG, Kure EH (2021)
    Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer
    Int J Cancer
    DOI 10.1002/ijc.33672, PubMed 33961700
  37. Haugen MH, Lingjærde OC, Hedenfalk I, Garred Ø, Borgen E, Loman N, Hatschek T, Børresen-Dale AL, Naume B, Mills GB, Mælandsmo GM, Engebraaten O (2021)
    Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
    JCO Precis Oncol, 5
    DOI 10.1200/PO.20.00086, PubMed 34036235
  38. Heck A, Winge-Main AK (2021)
    Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors
    BMJ Case Rep, 14 (5)
    DOI 10.1136/bcr-2021-241981, PubMed 34045201
  39. Hernæs KH, Smeland KB, Fagerli UM, Kiserud CE (2021)
    Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation
    BMC Cancer, 21 (1), 143
    DOI 10.1186/s12885-021-07836-2, PubMed 33557789
  40. Hernes E, Revheim ME, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Seierstad T (2021)
    Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
    PET Clin, 16 (2), 147-165
    DOI 10.1016/j.cpet.2020.12.001, PubMed 33648661
  41. Hjermstad MJ, Hamfjord J, Aass N, Dajani O, Lundeby T, Wester T, Kaasa S (2021)
    Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway-Results from a Cluster Randomized Trial
    Cancers (Basel), 13 (9)
    DOI 10.3390/cancers13092194, PubMed 34063594
  42. Høghaug G, Skår R, Tran TN, Diep LM, Bredal IS (2021)
    Three-month follow-up effects of a medication management program on nurses' knowledge
    Nurse Educ Pract, 51, 102979
    DOI 10.1016/j.nepr.2021.102979, PubMed 33588183
  43. Holmebakk T, Boye K (2021)
    ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Patients with Localized Gastrointestinal Stromal Tumor of the Stomach?
    Ann. Surg. Oncol.
  44. Hølmebakk T, Boye K (2021)
    Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
    Ann Surg Oncol
    DOI 10.1245/s10434-021-09939-3, PubMed 33829360
  45. Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
    Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
    Ann Surg Oncol
    DOI 10.1245/s10434-021-09605-8, PubMed 33651216
  46. Hompland I, Ferrari S, Bielack S, Palmerini E, Hall KS, Picci P, Hecker-Nolting S, Donati DM, Blattmann C, Bjerkehagen B, Staals E, Kager L, Gambarotti M, Kühne T, Eriksson M, Ferraresi V, Kevric M, Biagini R, Baumhoer D, Brosjø O, Comandone A, Schwarz R, Bertulli R, Kessler T, Hansson L et al. (2021)
    Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
    Eur J Cancer, 151, 150-158
    DOI 10.1016/j.ejca.2021.04.017, PubMed 33990016
  47. Hugenschmidt H, Labori KJ, Borgen E, Brunborg C, Schirmer CB, Seeberg LT, Naume B, Wiedswang G (2021)
    Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
    Cancers (Basel), 13 (3)
    DOI 10.3390/cancers13030485, PubMed 33513877
  48. Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2021)
    Bilateral calcification of the optic nerve sheath: A diagnostic dilemma
    Am J Ophthalmol Case Rep, 22, 101106
    DOI 10.1016/j.ajoc.2021.101106, PubMed 33997471
  49. Ito J, Minemura T, Wälchli S, Niimi T, Fujihara Y, Kuroda S, Takimoto K, Maturana AD (2021)
    Id2 Represses Aldosterone-Stimulated Cardiac T-Type Calcium Channels Expression
    Int J Mol Sci, 22 (7)
    DOI 10.3390/ijms22073561, PubMed 33808082
  50. Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, Helland Å (2021)
    COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
    Front Oncol, 11, 652535
    DOI 10.3389/fonc.2021.652535, PubMed 33842366
  51. Johansson ALV, Trewin CB, Fredriksson I, Reinertsen KV, Russnes H, Ursin G (2021)
    In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study
    Breast Cancer Res, 23 (1), 17
    DOI 10.1186/s13058-021-01393-z, PubMed 33526044
  52. Johnson ML, Zvirbule Z, Laktionov K, Helland A, Cho BC, Gutierrez V, Colinet B, Lena H, Wolf M, Gottfried M, Okamoto I, van der Leest C, Rich P, Hung JY, Appenzeller C, Sun Z, Maag D, Luo Y, Nickner C, Vajikova A, Komarnitsky P, Bar J (2021)
    Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study
    J Thorac Oncol (in press)
    DOI 10.1016/j.jtho.2021.03.012, PubMed 33823285
  53. Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
    Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
    Cancers (Basel), 13 (4)
    DOI 10.3390/cancers13040779, PubMed 33668474
  54. Karlsson AT, Hjermstad MJ, Omdahl T, Aass N, Skovlund E, Hellebust TP, Johansen S, Kaasa S, Yri OE (2021)
    Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer
    Acta Oncol
    DOI 10.1080/0284186X.2021.1924399, PubMed 34032536
  55. Krüger K, Silwal-Pandit L, Wik E, Straume O, Stefansson IM, Borgen E, Garred Ø, Naume B, Engebraaten O, Akslen LA (2021)
    Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
    Sci Rep, 11 (1), 3388
    DOI 10.1038/s41598-021-81914-0, PubMed 33564016
  56. Kurch L, Mauz-Körholz C, Fosså A, Georgi TW, Kluge R, Bartelt JM, Kunze C, Wohlgemuth WA, Pelz T, Vordermark D, Plößl S, Hasenclever D, Sabri O, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Løndalen AM, Steiner D, Krombach G, Attarbaschi A, Hoffmann M, Ceppi F et al. (2021)
    Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial
    Pediatr Blood Cancer, 68 (4), e28903
    DOI 10.1002/pbc.28903, PubMed 33538093
  57. Lærum-Onsager E, Molin M, Olsen CF, Bye A, Debesay J, Hestevik CH, Bjerk M, Pripp AH (2021)
    Effect of nutritional and physical exercise intervention on hospital readmission for patients aged 65 or older: a systematic review and meta-analysis of randomized controlled trials
    Int J Behav Nutr Phys Act, 18 (1), 62
    DOI 10.1186/s12966-021-01123-w, PubMed 33971901
  58. Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL (2021)
    Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial
    JAMA Oncol, 7 (1), e205865
    DOI 10.1001/jamaoncol.2020.5865, PubMed 33180100
  59. Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S (2021)
    Calcium Carbonate Microparticles as Carriers of 224Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
    Curr Radiopharm, 14 (2), 145-153
    DOI 10.2174/1874471013666201201102056, PubMed 33261548
  60. Lilleheie I, Debesay J, Bye A, Bergland A (2021)
    The tension between carrying a burden and feeling like a burden: a qualitative study of informal caregivers' and care recipients' experiences after patient discharge from hospital
    Int J Qual Stud Health Well-being, 16 (1), 1855751
    DOI 10.1080/17482631.2020.1855751, PubMed 33345749
  61. Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lödén B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R (2021)
    The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
    J Thorac Oncol, 16 (7), 1200-1210
    DOI 10.1016/j.jtho.2021.03.019, PubMed 33823286
  62. Lindemann K, Smogeli E, Småstuen MC, Bruheim K, Trovik J, Nordberg T, Kristensen GB, Werner HMJ, Nakken E (2021)
    Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
    Cancers (Basel), 13 (6)
    DOI 10.3390/cancers13061367, PubMed 33803531
  63. Liposits G, Orrevall Y, Kaasa S, Österlund P, Cederholm T (2021)
    Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice
    JCO Oncol Pract, OP2000704 (in press)
    DOI 10.1200/OP.20.00704, PubMed 33444111
  64. Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
    Outcome After Treatment of Spinal Ependymoma in Children and Adolescents: Long-Term Follow-up of a Single Consecutive Institutional Series of 33 Patients Treated Over Eight Decades
    World Neurosurg, 150, e228-e235
    DOI 10.1016/j.wneu.2021.02.131, PubMed 33684583
  65. Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
    Outcome after treatment of pediatric supratentorial ependymoma: long-term follow-up of a single consecutive institutional series of 26 patients
    Br J Neurosurg
    DOI 10.1080/02688697.2021.1914821, PubMed 34096810
  66. Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG (2021)
    Metastases in locally advanced rectal cancer undergoing curatively intended treatment
    Eur J Surg Oncol (in press)
    DOI 10.1016/j.ejso.2021.04.023, PubMed 34049768
  67. Meltzer S, Torgunrud A, Abrahamsson H, Solbakken AM, Flatmark K, Dueland S, Bakke KM, Bousquet PA, Negård A, Johansen C, Lyckander LG, Larsen FO, Schou JV, Redalen KR, Ree AH (2021)
    The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
    Br J Cancer
    DOI 10.1038/s41416-021-01377-y, PubMed 33837301
  68. Moe YM, Groendahl AR, Tomic O, Dale E, Malinen E, Futsaether CM (2021)
    Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET/CT images of head and neck cancer patients
    Eur J Nucl Med Mol Imaging
    DOI 10.1007/s00259-020-05125-x, PubMed 33559711
  69. Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO (2021)
    Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
    Clin Transl Radiat Oncol, 28, 39-47
    DOI 10.1016/j.ctro.2021.03.001, PubMed 33796796
  70. Nakken S, Lilleby W, Switlyk MD, Knudsen KE, Lilleby O, Zhao S, Kaveh F, Ekstrøm PO, Urbanucci A, Hovig E (2021)
    The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology
    J Pers Med, 11 (5)
    DOI 10.3390/jpm11050330, PubMed 33922147
  71. Napoli E, Bønsdorff TB, Jorstad IS, Bruland ØS, Larsen RH, Westrøm S (2021)
    Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
    PLoS One, 16 (3), e0248133
    DOI 10.1371/journal.pone.0248133, PubMed 33662039
  72. Nobre AR, Risson E, Singh DK, Di Martino JS, Cheung JF, Wang JP, Johnson J, Russnes HG, Bravo-Cordero JJ, Birbrair A, Naume B, Azhar M, Frenette PS, Aguirre-Ghiso JA (2021)
    Bone marrow NG2(+)/Nestin(+) mesenchymal stem cells drive DTC dormancy via TGF-beta 2
    Nat. Cancer, 2 (3), 327-+
  73. Olsen CF, Bergland A, Bye A, Debesay J, Langaas AG (2021)
    Crossing knowledge boundaries: health care providers' perceptions and experiences of what is important to achieve more person-centered patient pathways for older people
    BMC Health Serv Res, 21 (1), 310
    DOI 10.1186/s12913-021-06312-8, PubMed 33827714
  74. Olsen SU, Hesseberg K, Aas AM, Pripp AH, Ranhoff AH, Bye A (2021)
    A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial
    Eur Geriatr Med
    DOI 10.1007/s41999-021-00520-5, PubMed 34086194
  75. Olszewski AJ, Jakobsen LH, Collins GP, Cwynarski K, Bachanova V, Blum KA, Boughan KM, Bower M, Dalla Pria A, Danilov A, David KA, Diefenbach C, Ellin F, Epperla N, Farooq U, Feldman TA, Gerrie AS, Jagadeesh D, Kamdar M, Karmali R, Kassam S, Kenkre VP, Khan N, Kim SH, Klein AK et al. (2021)
    Burkitt Lymphoma International Prognostic Index
    J Clin Oncol, 39 (10), 1129-1138
    DOI 10.1200/JCO.20.03288, PubMed 33502927
  76. Pandya AD, Iversen TG, Moestue S, Grinde MT, Mørch Ý, Snipstad S, Åslund AKO, Øy GF, Kildal W, Engebråten O, Sandvig K, Skotland T, Mælandsmo GM (2021)
    Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
    Nanomaterials (Basel), 11 (5)
    DOI 10.3390/nano11051140, PubMed 33924869
  77. Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, Noh DY, Ahn SH, Lee JW, Kim MK, Jee SH, Wen W, Bolla MK, Wang Q, Dennis J, Michailidou K, Shah M, Conroy DM, Harrington PA, Mayes R, Czene K, Hall P, Teras LR, Patel AV et al. (2021)
    Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
    Cancers (Basel), 13 (10)
    DOI 10.3390/cancers13102370, PubMed 34069208
  78. Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ et al. (2021)
    Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
    Nat Commun, 12 (1), 3230
    DOI 10.1038/s41467-021-23445-w, PubMed 34050156
  79. Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR et al. (2021)
    Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
    Eur Urol (in press)
    DOI 10.1016/j.eururo.2021.04.035, PubMed 33985797
  80. Pommergaard HC, Nielsen K, Sorbye H, Federspiel B, Tabaksblat EM, Vestermark LW, Janson ET, Hansen CP, Ladekarl M, Garresori H, Hjortland GO, Sundlöv A, Galleberg R, Knigge P, Kjaer A, Langer SW, Knigge U (2021)
    Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms
    J Neuroendocrinol, 33 (5), e12967
    DOI 10.1111/jne.12967, PubMed 33769624
  81. Popat S, Brustugun OT, Cadranel J, Felip E, Garassino MC, Griesinger F, Helland Å, Hochmair M, Pérol M, Bent-Ennakhil N, Kruhl C, Novello S (2021)
    Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer
    Lung Cancer, 157, 9-16
    DOI 10.1016/j.lungcan.2021.05.017, PubMed 34051652
  82. Popperud TH, Gul KA, Brunborg C, Olaussen RW, Abrahamsen TG, Osnes LT, Kerty E (2021)
    Thymectomy in Juvenile Myasthenia Gravis Is Safe Regarding Long Term Immunological Effects
    Front. Neurol., 12, 596859
  83. Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C et al. (2021)
    MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
    Lancet Oncol, 22 (4), 538-547
    DOI 10.1016/S1470-2045(20)30753-1, PubMed 33794207
  84. Riis ML (2021)
    Management of patients with BRCA mutation from the point of view of a breast surgeon
    Ann Med Surg (Lond), 65, 102311
    DOI 10.1016/j.amsu.2021.102311, PubMed 33996049
  85. Rodrigues AM, Romeu JC, Canas da Silva J, Tavares-Costa J, Faustino A, Vaz C, Pereira da Silva JA, Canhão H (2021)
    Osteoporosis management during the COVID-19 pandemic - Position paper
    Acta Reumatol Port, 46 (1), 55-57
    PubMed 33820898
  86. Rodrigues JM, Nikkarinen A, Hollander P, Weibull CE, Raty R, Kolstad A, Amini RM, Porwit A, Jerkeman M, Ek S, Glimelius I (2021)
    Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
    Br. J. Haematol., 193 (3), 520-531
  87. Røen I, Brenne AT, Brunelli C, Stifoss-Hanssen H, Grande G, Solheim TS, Kaasa S, Knudsen AK (2021)
    Spiritual quality of life in family carers of patients with advanced cancer-a cross-sectional study
    Support Care Cancer
    DOI 10.1007/s00520-021-06080-5, PubMed 33661369
  88. Schou-Bredal I, Grimholt T, Bonsaksen T, Skogstad L, Heir T, Ekeberg O (2021)
    Optimists' and pessimists' self-reported mental and global health during the COVID-19 pandemic in Norway
    HEALTH PSYCHOL. REP., 9 (2), 160-168
  89. Seierstad T, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Revheim ME, Hernes E (2021)
    18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
    PET Clin, 16 (2), 167-176
    DOI 10.1016/j.cpet.2020.12.012, PubMed 33648662
  90. Shkodra M, Brunelli C, Zecca E, Formaglio F, Bracchi P, Lo Dico S, Caputo M, Kaasa S, Caraceni A (2021)
    Neuropathic pain: clinical classification and assessment in patients with pain due to cancer
    Pain, 162 (3), 866-874
    DOI 10.1097/j.pain.0000000000002076, PubMed 32947548
  91. Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
    Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
    Sci Rep, 11 (1), 11593
    DOI 10.1038/s41598-021-90976-z, PubMed 34078971
  92. Skaga E, Skretteberg MA, Johannesen TB, Brandal P, Vik-Mo EO, Helseth E, Langmoen IA (2021)
    Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
    Neurooncol Adv, 3 (1), vdab008
    DOI 10.1093/noajnl/vdab008, PubMed 33665615
  93. Skalleberg J, Myhrum M, Småstuen MC, Osnes TA, Fosså SD, Bunne M (2021)
    Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity?
    Acta Oncol, 60 (4), 426-433
    DOI 10.1080/0284186X.2021.1887514, PubMed 33617403
  94. Slørdahl KS, Klotz D, Olsen JÅ, Skovlund E, Undseth C, Abildgaard HL, Brændengen M, Nesbakken A, Larsen SG, Hanekamp BA, Holmboe L, Tvedt R, Sveen A, Lothe RA, Malinen E, Kaasa S, Guren MG (2021)
    Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
    Acta Oncol
    DOI 10.1080/0284186X.2021.1918763, PubMed 33966592
  95. Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2021)
    Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis
    Radiother Oncol, 158, 312-320
    DOI 10.1016/j.radonc.2021.01.019, PubMed 33545254
  96. Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2021)
    Response to Yuce Sari et al
    Radiother Oncol, 158, 323-324
    DOI 10.1016/j.radonc.2021.02.022, PubMed 33647355
  97. Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jøssang DE, Awada A, Kristeleit R, Loirat D, Lazaridis G, Jungels C, Brunsvig P, Nicolaisen B, Saunders A, Patel H, Galon J, Hermitte F, Camilio KA, Mauseth B, Sundvold V, Sveinbjørnsson B, Rekdal Ø (2021)
    Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors
    Clin Cancer Res, 27 (10), 2755-2763
    DOI 10.1158/1078-0432.CCR-20-3435, PubMed 33542073
  98. Stacchiotti S, Frezza AM, Blay JY, Baldini EH, Bonvalot S, Bovée JVMG, Callegaro D, Casali PG, Chiang RC, Demetri GD, Demicco EG, Desai J, Eriksson M, Gelderblom H, George S, Gounder MM, Gronchi A, Gupta A, Haas RL, Hayes-Jardon A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A et al. (2021)
    Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
    Cancer
    DOI 10.1002/cncr.33618, PubMed 33910263
  99. Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, Antonescu CR, Bajpai J, Baldini E, Bauer S, Biagini R, Bielack S, Blay JY, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Callegaro D, De Alava E, Deoras-Sutliff M, Dufresne A, Eriksson M, Errani C, Fedenko A et al. (2021)
    Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
    ESMO Open, 6 (3), 100170
    DOI 10.1016/j.esmoop.2021.100170, PubMed 34090171
  100. Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
    Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094815, PubMed 34062920
  101. Tabernero J, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, Desai J, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Elez E, Gollerkeri A, Maharry K, Christy-Bittel J, Kopetz S (2021)
    Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
    J Clin Oncol, 39 (4), 273-284
    DOI 10.1200/JCO.20.02088, PubMed 33503393
  102. Thorgersen EB, Asvall J, Frøysnes IS, Schjalm C, Larsen SG, Dueland S, Andersson Y, Fodstad Ø, Mollnes TE, Flatmark K (2021)
    Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Ann Surg Oncol
    DOI 10.1245/s10434-021-10022-0, PubMed 34019185
  103. Vajavaara H, Ekeblad F, Holte H, Jorgensen J, Leivonen SK, Berglund M, Kamper P, Moller HJ, D'Amore F, Molin D, Enblad G, Ludvigsen M, Glimelius I, Leppa S (2021)
    Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma
    Haematologica (in press)
    DOI 10.3324/haematol.2020.278182, PubMed 33764002
  104. Vajavaara H, Mortensen JB, Leivonen SK, Hansen IM, Ludvigsen M, Holte H, Jørgensen J, Bjerre M, d'Amore F, Leppä S (2021)
    Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
    Cancers (Basel), 13 (3)
    DOI 10.3390/cancers13030398, PubMed 33499013
  105. van den Berg MH, van Dijk M, Byrne J, Berger C, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, Haupt R, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, van der Kooi ALF, Kremer LCM, Kruseova J, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Spix C, Twisk JWR, Ronckers CM, Kaatsch P, van Dulmen-den Broeder E et al. (2021)
    Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)
    Hum Reprod, 36 (6), 1561-1573
    DOI 10.1093/humrep/deab035, PubMed 33744927
  106. van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, Laven JSE, van Leeuwen FE, Lambalk CB, Overbeek A, Loonen JJ, van der Pal HJ, Tissing WJ, Versluys B, Bresters D, Beerendonk CCM, Ronckers CR, van der Heiden-van der Loo M, Kaspers GL, de Vries ACH, Robison LL, Hudson MM, Chemaitilly W, Byrne J, Berger C, Clemens E, Dirksen U et al. (2021)
    Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function
    Hum Reprod, 36 (4), 1120-1133
    DOI 10.1093/humrep/deaa342, PubMed 33582778
  107. Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS (2021)
    HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease
    J Clin Endocrinol Metab, 106 (4), e1763-e1774
    DOI 10.1210/clinem/dgaa958, PubMed 33367784
  108. Westgaard KL, Hynne H, Amdal CD, Young A, Singh PB, Chen X, Rykke M, Hove LH, Aqrawi LA, Utheim TP, Herlofson BB, Jensen JL (2021)
    Oral and ocular late effects in head and neck cancer patients treated with radiotherapy
    Sci Rep, 11 (1), 4026
    DOI 10.1038/s41598-021-83635-w, PubMed 33597629
  109. Winther RR, Vik-Mo EO, Yri OE, Aass N, Kaasa S, Skovlund E, Helseth E, Hjermstad MJ (2021)
    Surgery for brain metastases - real-world prognostic factors' association with survival
    Acta Oncol
    DOI 10.1080/0284186X.2021.1930150, PubMed 34032547
  110. Yap TA, Nakagawa K, Fujimoto N, Kuribayashi K, Guren TK, Calabrò L, Shapira-Frommer R, Gao B, Kao S, Matos I, Planchard D, Chatterjee A, Jin F, Norwood K, Kindler HL (2021)
    Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
    Lancet Respir Med, 9 (6), 613-621
    DOI 10.1016/S2213-2600(20)30515-4, PubMed 33836153

Publications 2020

  1. Aas K, Dorothea Fosså S, Åge Myklebust T, Møller B, Kvåle R, Vlatkovic L, Berge V (2020)
    Increased curative treatment is associated with decreased prostate cancer-specific and overall mortality in senior adults with high-risk prostate cancer; results from a national registry-based cohort study
    Cancer Med, 9 (18), 6646-6657
    DOI 10.1002/cam4.3297, PubMed 32750229
  2. Abravan A, Eide HA, Helland Å, Malinen E (2020)
    Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
    Clin Transl Radiat Oncol, 22, 15-21
    DOI 10.1016/j.ctro.2020.02.005, PubMed 32181373
  3. Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ (2020)
    In Reply to Sari et al
    Int J Radiat Oncol Biol Phys, 107 (2), 388-389
    DOI 10.1016/j.ijrobp.2020.02.027, PubMed 32112877
  4. Al-Haidari G, Skovlund E, Undseth C, Rekstad BL, Larsen SG, Åsli LM, Dueland S, Malinen E, Guren MG (2020)
    Re-irradiation for recurrent rectal cancer - a single-center experience
    Acta Oncol, 59 (5), 534-540
    DOI 10.1080/0284186X.2020.1725111, PubMed 32056476
  5. Aqrawi LA, Chen X, Hynne H, Amdal C, Reppe S, Aass HCD, Rykke M, Hove LH, Young A, Herlofson BB, Westgaard KL, Utheim TP, Galtung HK, Jensen JL (2020)
    Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways
    Cells, 9 (9)
    DOI 10.3390/cells9092050, PubMed 32911805
  6. Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, Ferlay J, Tervonen H, Shack L, Woods RR, Saint-Jacques N, De P, McClure C, Engholm G, Gavin AT, Morgan E, Walsh PM, Jackson C, Porter G, Møller B, Bucher O, Eden M, O'Connell DL, Bray F, Soerjomataram I (2020)
    Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)
    Gut, 70 (1), 114-126
    DOI 10.1136/gutjnl-2020-320625, PubMed 32482683
  7. Ascierto PA, Del Vecchio M, Mackiewicz A, Robert C, Chiarion-Sileni V, Arance A, Lebbé C, Svane IM, McNeil C, Rutkowski P, Loquai C, Mortier L, Hamid O, Bastholt L, Dreno B, Schadendorf D, Garbe C, Nyakas M, Grob JJ, Thomas L, Liszkay G, Smylie M, Hoeller C, Ferraresi V, Grange F et al. (2020)
    Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
    J Immunother Cancer, 8 (1)
    DOI 10.1136/jitc-2019-000391, PubMed 32503946
  8. Astrup GL, Hofsø K, Bjordal K, Rustøen T (2020)
    Cancer patients' diagnosis and symptoms and their family caregivers' self-efficacy and social support are associated with different caregiver reactions
    Eur J Cancer Care (Engl), 29 (6), e13311
    DOI 10.1111/ecc.13311, PubMed 32885524
  9. Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP, RAPIDO collaborative investigators (2020)
    Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
    Lancet Oncol, 22 (1), 29-42
    DOI 10.1016/S1470-2045(20)30555-6, PubMed 33301740
  10. Bai B, Myklebust JH, Wälchli S (2020)
    Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology
    Methods Mol Biol, 2115, 445-454
    DOI 10.1007/978-1-0716-0290-4_25, PubMed 32006416
  11. Beisland E, Hauge EM, Aarstad AKH, Hjermstad MJ, Aarstad HJ, Beisland C (2020)
    Personality and educational level determine self-reported health-related quality-of-life and distress in patients with renal tumors awaiting radical surgery
    Scand J Urol, 54 (4), 304-312
    DOI 10.1080/21681805.2020.1773528, PubMed 32500779
  12. Bell L, Holloway L, Bruheim K, Petrič P, Kirisits C, Tanderup K, Pötter R, Vinod S, Lim K, Pogson E, Metcalfe P, Hellebust TP (2020)
    Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer
    Brachytherapy, 19 (2), 146-153
    DOI 10.1016/j.brachy.2020.01.002, PubMed 32067884
  13. Benard E, Casey NP, Inderberg EM, Wälchli S (2020)
    SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy
    Scand J Immunol, 92 (4), e12917
    DOI 10.1111/sji.12917, PubMed 32557659
  14. Bergsland CH, Bruun J, Guren MG, Svindland A, Bjørnslett M, Smeby J, Hektoen M, Kolberg M, Domingo E, Pellinen T, Tomlinson I, Kerr D, Church DN, Nesbakken A, Sveen A, Lothe RA (2020)
    Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
    ESMO Open, 5 (6), e001040
    DOI 10.1136/esmoopen-2020-001040, PubMed 33219056
  15. Bersvendsen HS, Haugnes HS, Dahl AA, Fagerli UM, Fluge Ø, Holte H, Wilsgaard T, Smeland KB, Kiserud CE (2020)
    Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress
    Bone Marrow Transplant, 56 (4), 968-970
    DOI 10.1038/s41409-020-01098-5, PubMed 33139869
  16. Bhave P, Pallan L, Long GV, Menzies AM, Atkinson V, Cohen JV, Sullivan RJ, Chiarion-Sileni V, Nyakas M, Kahler K, Hauschild A, Plummer R, Trojaniello C, Ascierto PA, Zimmer L, Schadendorf D, Allayous C, Lebbe C, Maurichi A, Santinami M, Roy S, Robert C, Lesimple T, Patel S, Versluis JM et al. (2020)
    Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis
    Br J Cancer, 124 (3), 574-580
    DOI 10.1038/s41416-020-01121-y, PubMed 33087895
  17. Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewski KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A, EORTC Quality of Life Group and Breast Cancer Group (2020)
    Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288
    Ann Oncol, 31 (4), 552
    DOI 10.1016/j.annonc.2020.02.001, PubMed 32089397
  18. Bjerkeset E, Röhrl K, Schou-Bredal I (2020)
    Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics
    Breast Cancer Res Treat, 180 (1), 63-71
    DOI 10.1007/s10549-020-05522-8, PubMed 31938939
  19. Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK (2020)
    T1 bladder cancer in Norway: treatment and survival
    Scand J Urol, 54 (5), 370-375
    DOI 10.1080/21681805.2020.1803401, PubMed 32783590
  20. Bøhn SH, Lie HC, Reinertsen KV, Fosså SD, Haugnes HS, Kiserud CE, Loge JH, Wisløff T, Thorsen L (2020)
    Lifestyle among long-term survivors of cancers in young adulthood
    Support Care Cancer, 29 (1), 289-300
    DOI 10.1007/s00520-020-05445-6, PubMed 32358776
  21. Bonsaksen T, Heir T, Skogstad L, Grimholt TK, Ekeberg O, Lerdal A, Schou-Bredal I (2020)
    Daily use of alcohol in the Norwegian general population: Prevalence and associated factors
    Drugs Alcohol Today, 20 (2), 109-121
  22. Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Bäckström G, Kerna I, Gubanski M, Björnlinger K, Evensen ME, Kuddu M, Pettersson E, Brydøy M, Hellebust TP, Dale E, Valdman A, Weber L, Høyer M (2020)
    A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
    Acta Oncol, 59 (10), 1157-1163
    DOI 10.1080/0284186X.2020.1817977, PubMed 32902341
  23. Brenne AT, Knudsen AK, Raj SX, Skjelvan L, Lund JÅ, Thronæs M, Løhre ET, Hågensen LÅ, Brunelli C, Kaasa S (2020)
    Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model
    Pain Ther, 9 (1), 297-318
    DOI 10.1007/s40122-020-00163-7, PubMed 32274655
  24. Breugom AJ, Bastiaannet E, Guren MG, Kørner H, Boelens PG, Dekker FW, Kapiteijn E, Gelderblom H, Larsen IK, Liefers GJ, van de Velde CJH (2020)
    Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway
    Eur J Surg Oncol, 46 (6), 1167-1173
    DOI 10.1016/j.ejso.2020.02.005, PubMed 32151531
  25. Brunelli C, Borreani C, Caraceni A, Roli A, Bellazzi M, Lombi L, Zito E, Pellegrini C, Spada P, Kaasa S, Foschi AM, Apolone G, PATIENT VOICES study group (2020)
    PATIENT VOICES, a project for the integration of the systematic assessment of patient reported outcomes and experiences within a comprehensive cancer center: a protocol for a mixed method feasibility study
    Health Qual Life Outcomes, 18 (1), 252
    DOI 10.1186/s12955-020-01501-1, PubMed 32723341
  26. Brunsvig PF, Guren TK, Nyakas M, Steinfeldt-Reisse CH, Rasch W, Kyte JA, Juul HV, Aamdal S, Gaudernack G, Inderberg EM (2020)
    Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
    Front Immunol, 11, 572172
    DOI 10.3389/fimmu.2020.572172, PubMed 33324397
  27. Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lømo J, Fagerland MW, McTiernan A, Schlichting E, Hjartåker A (2020)
    Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
    Br J Nutr, 125 (2), 172-182
    DOI 10.1017/S0007114520002627, PubMed 32811572
  28. Brustugun OT, Sorhaug S, Gronberg BH, Aanerud M, Al-Zubayidy MMZ, Fjellbirkeland L, Helland A, Berg J, Andreassen B, Paulsen EE, Haram PM, Ashraf H, Wahl SGF (2020)
    Lung cancer: Improved prognosis presents capacity challenges
    Tidsskr. Nor. Laegeforen., 140 (5), 432-434
  29. Bruun J, Kryeziu K, Eide PW, Moosavi SH, Eilertsen IA, Langerud J, Røsok B, Totland MZ, Brunsell TH, Pellinen T, Saarela J, Bergsland CH, Palmer HG, Brudvik KW, Guren T, Dienstmann R, Guren MG, Nesbakken A, Bjørnbeth BA, Sveen A, Lothe RA (2020)
    Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
    Clin Cancer Res, 26 (15), 4107-4119
    DOI 10.1158/1078-0432.CCR-19-3637, PubMed 32299813
  30. Bye A, Sandmael JA, Stene GB, Thorsen L, Balstad TR, Solheim TS, Pripp AH, Oldervoll LM (2020)
    Exercise and Nutrition Interventions in Patients with Head and Neck Cancer during Curative Treatment: A Systematic Review and Meta-Analysis
    Nutrients, 12 (11)
    DOI 10.3390/nu12113233, PubMed 33105699
  31. Clarke M, Mackay A, Ismer B, Pickles JC, Tatevossian RG, Newman S, Bale TA, Stoler I, Izquierdo E, Temelso S, Carvalho DM, Molinari V, Burford A, Howell L, Virasami A, Fairchild AR, Avery A, Chalker J, Kristiansen M, Haupfear K, Dalton JD, Orisme W, Wen J, Hubank M, Kurian KM et al. (2020)
    Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
    Cancer Discov, 10 (7), 942-963
    DOI 10.1158/2159-8290.CD-19-1030, PubMed 32238360
  32. Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, Oudard S, Bruland Ø, Flamen P, Kurth A, Van Poznak C, Aapro M, Jordan K, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2020)
    Bone health in cancer: ESMO Clinical Practice Guidelines
    Ann Oncol, 31 (12), 1650-1663
    DOI 10.1016/j.annonc.2020.07.019, PubMed 32801018
  33. Dagenborg VJ, Marshall SE, Yaqub S, Grzyb K, Boye K, Lund-Iversen M, Høye E, Berstad AE, Fretland ÅA, Edwin B, Ree AH, Flatmark K (2020)
    Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases
    Cancer Biol Ther, 21 (5), 432-440
    DOI 10.1080/15384047.2020.1721252, PubMed 32098573
  34. Dahl AA, Bentzen AG, Fosså SD, Hess SL, Steen R, Kiserud CE (2020)
    Long-term cervical cancer survivors on disability pension: a subgroup in need of attention from health care providers
    J Cancer Surviv, 14 (4), 578-585
    DOI 10.1007/s11764-020-00877-9, PubMed 32279150
  35. Dahl AA, Bentzen AG, Fosså SD, Hess SL, Steen R, Vistad I, Kiserud CE (2020)
    Sexual Inactivity During the Last 4 Weeks in Long-Term Cervical Cancer Survivors: Prevalence and Associated Factors
    J Sex Med, 17 (7), 1359-1369
    DOI 10.1016/j.jsxm.2020.03.010, PubMed 32336554
  36. Dahl AA, Brennhovd B, Fosså SD, Axcrona K (2020)
    A cross-sectional study of current work ability after radical prostatectomy
    BMC Urol, 20 (1), 9
    DOI 10.1186/s12894-020-0579-9, PubMed 32005115
  37. Dahl AA, Fosså SD, Brennhovd B, Axcrona K (2020)
    The EPIC-26 domain scores after radical prostatectomy are associated with the personality trait of neuroticism
    Int Urol Nephrol, 53 (4), 691-698
    DOI 10.1007/s11255-020-02688-4, PubMed 33118115
  38. Dahl AA, Grotmol KS, Hjermstad MJ, Kiserud CE, Loge JH (2020)
    Norwegian reference data on the Fatigue Questionnaire and the Patient Health Questionnaire-9 and their interrelationship
    Ann Gen Psychiatry, 19, 60
    DOI 10.1186/s12991-020-00311-5, PubMed 33062033
  39. Dahl O, Myklebust MP, Dale JE, Leon O, Serup-Hansen E, Jakobsen A, Pfeiffer P, Løes IM, Pfeffer F, Spindler KG, Guren MG, Glimelius B, Johnsson A (2020)
    Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version
    Acta Oncol, 59 (9), 1016-1023
    DOI 10.1080/0284186X.2020.1778180, PubMed 32574087
  40. De Bruycker A, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, Gomez-Iturriaga A, Everaerts W, Otte F, Papachristofilou A, Scorsetti M, Shelan M, Siva S, Ameye F, Guckenberger M, Heikkilä R, Putora PM, Zapatero A, Conde-Moreno A, Couñago F, Vanhoutte F, Goetghebeur E, Reynders D, Zilli T, Ost P (2020)
    PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
    BMC Cancer, 20 (1), 406
    DOI 10.1186/s12885-020-06911-4, PubMed 32398040
  41. Deek M, Lilleby W, Vaage V, Hole KH, DeWeese T, Stensvold A, Tran P, Seierstad T (2020)
    Impact of radiation dose on recurrence in high-risk prostate cancer patients
    Prostate, 80 (15), 1322-1327
    DOI 10.1002/pros.24059, PubMed 33258482
  42. Demetri GD, Antonescu CR, Bjerkehagen B, Bovée JVMG, Boye K, Chacón M, Dei Tos AP, Desai J, Fletcher JA, Gelderblom H, George S, Gronchi A, Haas RL, Hindi N, Hohenberger P, Joensuu H, Jones RL, Judson I, Kang YK, Kawai A, Lazar AJ, Le Cesne A, Maestro R, Maki RG, Martín J et al. (2020)
    Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
    Ann Oncol, 31 (11), 1506-1517
    DOI 10.1016/j.annonc.2020.08.2232, PubMed 32891793
  43. Digernes I, Nilsen LB, Grøvik E, Bjørnerud A, Løvland G, Vik-Mo E, Meling TR, Saxhaug C, Helland Å, Jacobsen KD, Geier O, Emblem KE (2020)
    Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI
    Phys Med Biol, 65 (22), 225020
    DOI 10.1088/1361-6560/abb71a, PubMed 33200748
  44. Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2020)
    Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
    Mol Ther, 29 (3), 1199-1213
    DOI 10.1016/j.ymthe.2020.11.019, PubMed 33212301
  45. Dillard P, Lie M, Baken E, Lobert VH, Benard E, Köksal H, Inderberg EM, Wälchli S (2020)
    Colorectal cysts as a validating tool for CAR therapy
    BMC Biotechnol, 20 (1), 30
    DOI 10.1186/s12896-020-00623-0, PubMed 32487146
  46. Dueland S, Line PD (2020)
    Response to the Comment on"Survival Following Liver Transplantation for Patients With Non-resectable Liver Only Colorectal Metastases": What if those Lesions Are Gone?
    Ann Surg, 271 (5), e124
    DOI 10.1097/SLA.0000000000003604, PubMed 32301798
  47. Dueland S, Line PD (2020)
    Liver segment 2+3 living donation in liver transplantation for colorectal liver metastases
    Hepatobiliary Surg Nutr, 9 (3), 382-384
    DOI 10.21037/hbsn.2019.11.15, PubMed 32509836
  48. Dummer R, Hauschild A, Santinami M, Atkinson V, Mandalà M, Kirkwood JM, Chiarion Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Gasal E, Tan M, Long GV, Schadendorf D (2020)
    Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
    N Engl J Med, 383 (12), 1139-1148
    DOI 10.1056/NEJMoa2005493, PubMed 32877599
  49. Dybvik E, Furnes O, Havelin LI, Fosså SD, Trovik C, Lie SA (2020)
    A prospective study on cancer risk after total hip replacements for 41,402 patients linked to the Cancer registry of Norway
    BMC Musculoskelet Disord, 21 (1), 599
    DOI 10.1186/s12891-020-03605-7, PubMed 32900364
  50. Eide IJZ, Helland Å, Ekman S, Mellemgaard A, Hansen KH, Cicenas S, Koivunen J, Grønberg BH, Brustugun OT (2020)
    Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)
    Lung Cancer, 143, 27-35
    DOI 10.1016/j.lungcan.2020.03.009, PubMed 32200138
  51. Ekström MP, Palmqvist S, Currow DC, Sjøgren P, Kurita GP, Jakobsen G, Kaasa S, Hjermstad M (2020)
    Mild to Moderate Cognitive Impairment Does Not Affect the Ability to Self-Report Important Symptoms in Patients With Cancer: A Prospective Longitudinal Multinational Study (EPCCS)
    J Pain Symptom Manage, 60 (2), 346-354.e2
    DOI 10.1016/j.jpainsymman.2020.03.007, PubMed 32179133
  52. Elvebakken H, Perren A, Scoazec JY, Tang LH, Federspiel B, Klimstra DS, Vestermark LW, Ali AS, Zlobec I, Myklebust TÅ, Hjortland GO, Langer SW, Gronbæk H, Knigge U, Tiensuu Janson E, Sorbye H (2020)
    A consensus developed morphological re-evaluation of 196 high-grade gastroenteropancreatic neuroendocrine neoplasms and its clinical correlations
    Neuroendocrinology (in press)
    DOI 10.1159/000511905, PubMed 33002892
  53. Eskelund CW, Dimopoulos K, Kolstad A, Glimelius I, Räty R, Gjerdrum LMR, Sonnevi K, Josefsson P, Nilsson-Ehle H, Bentzen HHN, Fagerli UM, Kuittinen O, Haaber J, Niemann CU, Pedersen LB, Larsen MT, Geisler CH, Hutchings M, Jerkeman M, Grønbæk K (2020)
    Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3
    Hemasphere, 5 (1), e510
    DOI 10.1097/HS9.0000000000000510, PubMed 33364550
  54. Eskelund CW, Husby S, Favero F, Klausen TW, Rodriguez-Gonzalez FG, Kolstad A, Pedersen LB, Räty RK, Geisler CH, Jerkeman M, Weischenfeldt J, Grønbæk K (2020)
    Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
    Blood, 135 (22), 2000-2004
    DOI 10.1182/blood.2019003539, PubMed 32181815
  55. Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffmann C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F, Castleman Disease Collaborative Network Scientific Advisory Board diagnostic criteria international working group and treatment guidelines international working group (2020)
    Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
    Am J Hematol, 95 (12), 1553-1561
    DOI 10.1002/ajh.25992, PubMed 32894785
  56. Falstie-Jensen AM, Esen BÖ, Kjærsgaard A, Lorenzen EL, Jensen JD, Reinertsen KV, Dekkers OM, Ewertz M, Cronin-Fenton DP (2020)
    Incidence of hypothyroidism after treatment for breast cancer-a Danish matched cohort study
    Breast Cancer Res, 22 (1), 106
    DOI 10.1186/s13058-020-01337-z, PubMed 33050919
  57. Fauske L, Hompland I, Lorem G, Hall KS, Bondevik H (2020)
    Striving towards Normality in Daily Life: A Qualitative Study of Patients Living with Metastatic Gastrointestinal Stromal Tumour in Long-Term Clinical Remission
    Sarcoma, 2020, 1814394
    DOI 10.1155/2020/1814394, PubMed 33082706
  58. Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM (2020)
    Soluble AXL as a marker of disease progression and survival in melanoma
    PLoS One, 15 (1), e0227187
    DOI 10.1371/journal.pone.0227187, PubMed 31917795
  59. Fleten KG, Lund-Andersen C, Waagene S, Abrahamsen TW, Mørch Y, Boye K, Torgunrud A, Flatmark K (2020)
    Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models
    Transl Oncol, 13 (8), 100793
    DOI 10.1016/j.tranon.2020.100793, PubMed 32447231
  60. Fosså A, Smeland KH, Fluge Ø, Tronstad KJ, Loge JH, Midttun Ø, Ueland PM, Kiserud CE (2020)
    Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue
    PLoS One, 15 (1), e0227384
    DOI 10.1371/journal.pone.0227384, PubMed 31923274
  61. Fosså SD, Aas K, Müller C, Jerm MB, Tandstad T, Lilleby W, Kvåle R, Gulbrandsen J, Haug E, Myklebust TA (2020)
    Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
    Radiother Oncol, 155, 33-41
    DOI 10.1016/j.radonc.2020.10.022, PubMed 33096165
  62. Fosså SD, Dahl AA, Myklebust TÅ, Kiserud CE, Nome R, Klepp OH, Brydøy M, Haugnes HS (2020)
    Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
    Cancer Epidemiol, 67, 101744
    DOI 10.1016/j.canep.2020.101744, PubMed 32652337
  63. Frafjord A, Skarshaug R, Hammarström C, Stankovic B, Dorg LT, Aamodt H, Woldbaek PR, Helland Å, Brustugun OT, Øynebråten I, Corthay A (2020)
    Antibody combinations for optimized staining of macrophages in human lung tumours
    Scand J Immunol, 92 (1), e12889
    DOI 10.1111/sji.12889, PubMed 32299134
  64. Fredheim OM, Skurtveit S, Loge JH, Sjøgren P, Handal M, Hjellvik V (2020)
    Prescription of analgesics to long-term survivors of cancer in early adulthood, adolescence, and childhood in Norway: a national cohort study
    Pain, 161 (5), 1083-1091
    DOI 10.1097/j.pain.0000000000001800, PubMed 31923046
  65. Frič R, Due-Tønnessen BJ, Lundar T, Egge A, Kronen Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2020)
    Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood
    Sci Rep, 10 (1), 9371
    DOI 10.1038/s41598-020-66328-8, PubMed 32523021
  66. Frydenberg H, Harsem NK, Ofigsbø Å, Skoglund H, Brændengen M, Kaasa S, Guren MG (2020)
    Chemotherapy During Pregnancy for Advanced Colon Cancer: A Case Report
    Clin Colorectal Cancer, 19 (2), 141-144
    DOI 10.1016/j.clcc.2020.02.013, PubMed 32222353
  67. Georgiesh T, Boye K, Bjerkehagen B (2020)
    A novel risk score to predict early and late recurrence in solitary fibrous tumour
    Histopathology, 77 (1), 123-132
    DOI 10.1111/his.14078, PubMed 31991494
  68. Grindedal EM, Jørgensen K, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Vamre T, Wangensteen T, Heramb C, Mæhle L (2020)
    Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
    Fam Cancer, 19 (2), 133-142
    DOI 10.1007/s10689-020-00160-x, PubMed 32002722
  69. Grov EK, Dahl AA (2020)
    Is neuroticism relevant for old cancer survivors? A controlled, population-based study (the Norwegian HUNT-3 survey)
    Support Care Cancer, 29 (7), 3623-3632
    DOI 10.1007/s00520-020-05870-7, PubMed 33174077
  70. Grut H, Stern NM, Dueland S, Labori KJ, Dormagen JB, Schulz A (2020)
    Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases
    Nucl Med Commun, 41 (9), 916-923
    DOI 10.1097/MNM.0000000000001235, PubMed 32796480
  71. Guldvik IJ, Zuber V, Braadland PR, Grytli HH, Ramberg H, Lilleby W, Thiede B, Zucknick M, Saatcioglu F, Gislefoss R, Kvale R, George A, Gronberg H, Wiklund F, Neal DE, Gnanapragasam VJ, Tasken KA, Mills IG (2020)
    Identification and Validation of Leucine-rich alpha-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
    Eur. Urol. Open Sci., 21, 51-60
  72. Gullestad HP, Haugen G, Fosså SD (2020)
    Late arm and shoulder problems after axillary therapeutic lymph node dissection in patients with melanoma
    J Plast Surg Hand Surg, 55 (2), 127-131
    DOI 10.1080/2000656X.2020.1842746, PubMed 33176535
  73. Haakensen VD, Khadse A, Sandhu V, Halvorsen AR, Solberg SK, Jørgensen LH, Brustugun OT, Kure EH, Helland Å (2020)
    Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
    Int J Cancer, 147 (10), 2957-2966
    DOI 10.1002/ijc.33121, PubMed 32468587
  74. Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M (2020)
    Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study
    Clin Sarcoma Res, 10 (1), 22
    DOI 10.1186/s13569-020-00145-5, PubMed 33292545
  75. Halvorsen AR, Haugen MH, Öjlert ÅK, Lund-Iversen M, Jørgensen L, Solberg S, Mælandsmo GM, Brustugun OT, Helland Å (2020)
    Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients
    Front Oncol, 10, 590755
    DOI 10.3389/fonc.2020.590755, PubMed 33324562
  76. Halvorsen TO, Stokke K, Killingberg KT, Raj SX, Sørhaug S, Brustugun OT, Fløtten Ø, Helbekkmo N, Hornslien K, Madebo T, Fluge S, Grønberg BH (2020)
    Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC
    Acta Oncol, 59 (9), 1051-1057
    DOI 10.1080/0284186X.2020.1778179, PubMed 32543258
  77. Halvorsrud L, Bye A, Brekke LA, Bergland A (2020)
    Being a trained volunteer Peer Supporter for carers of people living with dementia in Norway: Reciprocal benefits and challenges
    Health Soc Care Community, 28 (6), 2150-2159
    DOI 10.1111/hsc.13026, PubMed 32490553
  78. Hamre CFB, Kvammen EMH, Vinge LE, Skeie AT, Hompland I (2020)
    Sarcoma of the heart
    Tidsskr. Nor. Laegeforen., 140 (6), 582-583
  79. Hannevik TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2020)
    Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
    Thromb Res, 196, 238-244
    DOI 10.1016/j.thromres.2020.08.042, PubMed 32919178
  80. Harneshaug M, Benth JS, Kirkhus L, Gronberg BH, Bergh S, Rostoft S, Slaaen M (2020)
    CT Derived Muscle Measures, Inflammation, and Frailty in a Cohort of Older Cancer Patients
    In Vivo, 34 (6), 3565-3572
    DOI 10.21873/invivo.12200, PubMed 33144469
  81. Hauge T, Amdal CD, Falk RS, Johannessen HO, Johnson E (2020)
    Long-term outcome in patients operated with hybrid esophagectomy for esophageal cancer - a cohort study
    Acta Oncol, 59 (7), 859-865
    DOI 10.1080/0284186X.2020.1750694, PubMed 32324079
  82. Helland T, Naume B, Hustad S, Bifulco E, Kvaløy JT, Saetersdal AB, Synnestvedt M, Lende TH, Gilje B, Mjaaland I, Weyde K, Blix ES, Wiedswang G, Borgen E, Hertz DL, Janssen EAM, Mellgren G, Søiland H (2020)
    Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
    Mol Oncol, 15 (4), 957-967
    DOI 10.1002/1878-0261.12865, PubMed 33252186
  83. Hellesnes R, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Kvammen Ø, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS (2020)
    Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
    J Clin Oncol, 39 (4), 308-318
    DOI 10.1200/JCO.20.02713, PubMed 33356420
  84. Hestevik CH, Molin M, Debesay J, Bergland A, Bye A (2020)
    Older patients' and their family caregivers' perceptions of food, meals and nutritional care in the transition between hospital and home care: a qualitative study
    BMC Nutr, 6, 11
    DOI 10.1186/s40795-020-00335-w, PubMed 32206325
  85. Hjermstad MJ, Aass N, Andersen S, Brunelli C, Dajani O, Garresori H, Hamre H, Haukland EC, Holmberg M, Jordal F, Krogstad H, Lundeby T, Løhre ET, Mjåland S, Nordbø A, Paulsen Ø, Schistad Staff E, Wester T, Kaasa S, Loge JH (2020)
    PALLiON - PALLiative care Integrated in ONcology: study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care
    Trials, 21 (1), 303
    DOI 10.1186/s13063-020-4224-4, PubMed 32241299
  86. Hompland I, Fauske L, Lorem GF, Bruland ØS (2020)
    Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
    Clin Sarcoma Res, 10, 2
    DOI 10.1186/s13569-019-0124-3, PubMed 31969978
  87. Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Bendigtsen Schirmer C, Renolen A, Borgen E, Naume B, Wiedswang G (2020)
    Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information
    BMC Cancer, 20 (1), 1107
    DOI 10.1186/s12885-020-07510-z, PubMed 33198661
  88. Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Schirmer CB, Renolen A, Borgen EF, Naume B, Wiedswang G (2020)
    Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma
    Ann Surg, 271 (3), 549-558
    DOI 10.1097/SLA.0000000000003035, PubMed 30216219
  89. Inderberg EM, Wälchli S (2020)
    Long-term surviving cancer patients as a source of therapeutic TCR
    Cancer Immunol Immunother, 69 (5), 859-865
    DOI 10.1007/s00262-019-02468-9, PubMed 31915853
  90. Inderberg EM, Wälchli S (2020)
    Sympathetic improvement of cancer vaccine efficacy
    Hum Vaccin Immunother, 16 (8), 1888-1890
    DOI 10.1080/21645515.2019.1703456, PubMed 31977269
  91. Jakobsen G, Engstrøm M, Hjermstad MJ, Rosland JH, Aass N, Albert E, Kaasa S, Fayers P, Klepstad P, Paulsen Ø (2020)
    The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
    Support Care Cancer, 29 (4), 2047-2055
    DOI 10.1007/s00520-020-05693-6, PubMed 32856209
  92. Jakobsen LH, Ellin F, Smeland KB, Wästerlid T, Christensen JH, Jørgensen JM, Josefsson PL, Øvlisen AK, Holte H, Blaker YN, Grauslund JH, Bjørn J, Molin D, Lagerlöf I, Smedby KE, Colvin K, Thanarajasingam G, Maurer MJ, Habermann TM, Song KW, Zhu KY, Gerrie AS, Cheah CY, El-Galaly TC (2020)
    Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients
    Br J Haematol, 189 (4), 661-671
    DOI 10.1111/bjh.16425, PubMed 32017050
  93. Janssens GO, Melchior P, Mul J, Saunders D, Bolle S, Cameron AL, Claude L, Gurtner K, van de Ven KP, van Grotel M, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Muracciole X, Boterberg T, Mandeville H, Godzinski J, Graf N, van den Heuvel-Eibrink MM, Rübe C (2020)
    The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy
    Lancet Child Adolesc Health, 4 (11), 846-852
    DOI 10.1016/S2352-4642(20)30183-8, PubMed 33068550
  94. Jeanmougin M, Håvik AB, Cekaite L, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE (2020)
    Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
    Mol Oncol, 14 (5), 1016-1027
    DOI 10.1002/1878-0261.12668, PubMed 32171051
  95. Joensuu H, Eriksson M, Sundby Hall K, Reichardt A, Hermes B, Schütte J, Cameron S, Hohenberger P, Jost PJ, Al-Batran SE, Lindner LH, Bauer S, Wardelmann E, Nilsson B, Kallio R, Jaakkola P, Junnila J, Alvegård T, Reichardt P (2020)
    Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up
    JAMA Oncol, 6 (8), 1241-1246
    DOI 10.1001/jamaoncol.2020.2091, PubMed 32469385
  96. K Jensen NB, Pötter R, Spampinato S, Fokdal LU, Chargari C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Wiebe E, Cooper R, Van der Steen-Banasik E, Van Limbergen E, Sundset M, Pieters BR, Nout RA, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2020)
    Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study
    Int J Radiat Oncol Biol Phys, 109 (3), 688-700
    DOI 10.1016/j.ijrobp.2020.10.006, PubMed 33068689
  97. Kerns SL, Fung C, Fossa SD, Dinh PC, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB (2020)
    Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors
    JNCI Cancer Spectr, 4 (4), pkaa022
    DOI 10.1093/jncics/pkaa022, PubMed 32704617
  98. Kierulf-Vieira KS, Sandberg CJ, Waaler J, Lund K, Skaga E, Saberniak BM, Panagopoulos I, Brandal P, Krauss S, Langmoen IA, Vik-Mo EO (2020)
    A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
    Cancers (Basel), 12 (6)
    DOI 10.3390/cancers12061630, PubMed 32575464
  99. Kimby E, Lockmer S, Holte H, Hagberg H, Wahlin BE, Brown P, Østenstad B (2020)
    The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy
    Br J Haematol, 191 (5), 738-747
    DOI 10.1111/bjh.16692, PubMed 32410260
  100. Kluge R, Wittig T, Georgi TW, Kurch L, Sabri O, Wallace WH, Klekawka T, Fernández-Teijeiro A, Ceppi F, Karlén J, Pears J, Cepelová M, Fosså A, Beishuizen A, Hjalgrim LL, Körholz D, Mauz-Körholz C, Hasenclever D (2020)
    Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease
    J Nucl Med, 62 (3), 338-341
    DOI 10.2967/jnumed.120.247924, PubMed 32764122
  101. Knoth J, Pötter R, Jürgenliemk-Schulz IM, Haie-Meder C, Fokdal L, Sturdza A, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Wiebe E, Rai B, Cooper R, van der Steen-Banasik E, van Limbergen E, Pieters BR, Sundset M, Tan LT, Nout RA, Tanderup K, Kirisits C, Nesvacil N, Lindegaard JC, Schmid MP (2020)
    Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study
    Gynecol Oncol, 159 (1), 136-141
    DOI 10.1016/j.ygyno.2020.07.007, PubMed 32798000
  102. Knutsen E, Lellahi SM, Aure MR, Nord S, Fismen S, Larsen KB, Gabriel MT, Hedberg A, Bjørklund SS, Oslo Breast Cancer Research Consortium (OSBREAC), Bofin AM, Mælandsmo GM, Sørlie T, Mortensen ES, Perander M (2020)
    The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers
    Sci Rep, 10 (1), 1277
    DOI 10.1038/s41598-020-57759-4, PubMed 31992741
  103. Koch M, Hjermstad MJ, Tomaszewski K, Tomaszewska I, Hornslien K, Harle A, Arraras J, Morag O, Pompili C, Ioannidis G, Navarra C, Chie W, Johnson C, Bohrer T, Janssens A, Kulis D, Bottomley A, Schulz C, Zeman F, Koller M (2020)
    Gender effects on quality of life and symptom burden in patients with lung cancer: results from a prospective, cross-cultural, multi-center study
    J Thorac Dis, 12 (8), 4253-4261
    DOI 10.21037/jtd-20-1054, PubMed 32944337
  104. Köksal H, Dillard P, Juzeniene A, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2020)
    Combinatorial CAR design improves target restriction
    J Biol Chem, 296, 100116 (in press)
    DOI 10.1074/jbc.RA120.016234, PubMed 33234592
  105. Koller M, Shamieh O, Hjermstad MJ, Hornslien K, Young T, Chalk T, Ioannidis G, Harle A, Johnson CD, Tomaszewski KA, Serpentini S, Pinto M, van der Weijst L, Janssens A, Morag O, Chie WC, Arraras JI, Pompili C, Jungraithmayr W, Hechtner M, Katsochi D, Müller K, Gräfenstein L, Schulz C, Bottomley A et al. (2020)
    Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study
    Lancet Oncol, 21 (5), 723-732
    DOI 10.1016/S1470-2045(20)30093-0, PubMed 32213338
  106. Kolstad A, Illidge T, Bolstad N, Spetalen S, Madsbu U, Stokke C, Blakkisrud J, Løndalen A, O'Rourke N, Beasley M, Jurczak W, Fagerli UM, Kaščák M, Bayne M, Obr A, Dahle J, Rojkjaer L, Pascal V, Holte H (2020)
    Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
    Blood Adv, 4 (17), 4091-4101
    DOI 10.1182/bloodadvances.2020002583, PubMed 32877524
  107. König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR (2020)
    The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review
    Front Oncol, 10, 1402
    DOI 10.3389/fonc.2020.01402, PubMed 32850452
  108. Kramer I, Hooning MJ, Mavaddat N, Hauptmann M, Keeman R, Steyerberg EW, Giardiello D, Antoniou AC, Pharoah PDP, Canisius S, Abu-Ful Z, Andrulis IL, Anton-Culver H, Aronson KJ, Augustinsson A, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Brauch H et al. (2020)
    Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
    Am J Hum Genet, 107 (5), 837-848
    DOI 10.1016/j.ajhg.2020.09.001, PubMed 33022221
  109. Krause R, Nyakabau A, Gwyther LG, Luyirika E, Kaasa S (2020)
    Calling for advocacy, education and public policy actions on pain control for patients with cancer in Africa
    ESMO Open, 5 (4)
    DOI 10.1136/esmoopen-2020-000757, PubMed 32826300
  110. Krogstad H, Loge JH, Grotmol KS, Kaasa S, Kiserud CE, Salvesen Ø, Hjermstad MJ (2020)
    Symptoms in the general Norwegian adult population - prevalence and associated factors
    BMC Public Health, 20 (1), 988
    DOI 10.1186/s12889-020-09109-2, PubMed 32576168
  111. Kummen M, Thingholm LB, Rühlemann MC, Holm K, Hansen SH, Moitinho-Silva L, Liwinski T, Zenouzi R, Storm-Larsen C, Midttun Ø, McCann A, Ueland PM, Høivik ML, Vesterhus M, Trøseid M, Laudes M, Lieb W, Karlsen TH, Bang C, Schramm C, Franke A, Hov JR (2020)
    Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis
    Gastroenterology, 160 (5), 1784-1798.e0
    DOI 10.1053/j.gastro.2020.12.058, PubMed 33387530
  112. Kværner AS, Harnæs H, Alavi DH, Bärebring L, Henriksen HB, Guren MG, Lauritzen PM, Eggesbø HB, Wiedswang G, Smeland S, Blomhoff R (2020)
    Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
    Tidsskr Nor Laegeforen, 140 (8)
    DOI 10.4045/tidsskr.19.0769, PubMed 32463187
  113. Kyte JA, Andresen NK, Russnes HG, Fretland SØ, Falk RS, Lingjærde OC, Naume B (2020)
    ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
    J Transl Med, 18 (1), 269
    DOI 10.1186/s12967-020-02421-w, PubMed 32620163
  114. Kyte JA, Røssevold A, Falk RS, Naume B (2020)
    ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
    J Transl Med, 18 (1), 252
    DOI 10.1186/s12967-020-02424-7, PubMed 32576225
  115. Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ (2020)
    Prospects for NK Cell Therapy of Sarcoma
    Cancers (Basel), 12 (12)
    DOI 10.3390/cancers12123719, PubMed 33322371
  116. Lærum-Onsager E, Brovold T, Bergland A, Pripp AH, Bye A (2020)
    Associations between health-related quality of life, body mass index, health status and sociodemographic variables in geriatric patients and non-hospitalized older people: A comparative cross-sectional study
    Nutr Health, 26 (2), 141-150
    DOI 10.1177/0260106020909047, PubMed 32297563
  117. Larsson C, Groote I, Vardal J, Kleppestø M, Odland A, Brandal P, Due-Tønnessen P, Holme SS, Hope TR, Meling TR, Fosse E, Emblem KE, Bjørnerud A (2020)
    Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy
    Magn Reson Imaging, 68, 106-112
    DOI 10.1016/j.mri.2020.01.012, PubMed 32004711
  118. Leppä S, Jørgensen J, Tierens A, Meriranta L, Østlie I, de Nully Brown P, Fagerli UM, Larsen TS, Mannisto S, Munksgaard L, Maisenhölder M, Vasala K, Meyer P, Jerkeman M, Björkholm M, Fluge Ø, Jyrkkiö S, Liestøl K, Ralfkiaer E, Spetalen S, Beiske K, Karjalainen-Lindsberg ML, Holte H (2020)
    Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
    Blood Adv, 4 (9), 1906-1915
    DOI 10.1182/bloodadvances.2020001518, PubMed 32380536
  119. Lichtenegger FS, Schnorfeil FM, Rothe M, Deiser K, Altmann T, Bücklein VL, Köhnke T, Augsberger C, Konstandin NP, Spiekermann K, Moosmann A, Boehm S, Boxberg M, Heemskerk MH, Goerlich D, Wittmann G, Wagner B, Hiddemann W, Schendel DJ, Kvalheim G, Bigalke I, Subklewe M (2020)
    Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
    Clin Transl Immunology, 9 (3), e1117
    DOI 10.1002/cti2.1117, PubMed 32153780
  120. Lilleheie I, Debesay J, Bye A, Bergland A (2020)
    A qualitative study of old patients' experiences of the quality of the health services in hospital and 30 days after hospitalization
    BMC Health Serv Res, 20 (1), 446
    DOI 10.1186/s12913-020-05303-5, PubMed 32434506
  121. Lilleheie I, Debesay J, Bye A, Bergland A (2020)
    Informal caregivers' views on the quality of healthcare services provided to older patients aged 80 or more in the hospital and 30 days after discharge
    BMC Geriatr, 20 (1), 97
    DOI 10.1186/s12877-020-1488-1, PubMed 32164569
  122. Lindemann K, Martinsson L, Kaasa S, Lindquist D (2020)
    Elderly gynaecological cancer patients at risk for poor end of life care: a population-based study from the Swedish Register of Palliative Care
    Acta Oncol, 59 (6), 636-643
    DOI 10.1080/0284186X.2020.1744717, PubMed 32238040
  123. Lofterød T, Frydenberg H, Flote V, Eggen AE, McTiernan A, Mortensen ES, Akslen LA, Reitan JB, Wilsgaard T, Thune I (2020)
    Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study
    Breast Cancer Res Treat, 182 (1), 215-227
    DOI 10.1007/s10549-020-05679-2, PubMed 32436147
  124. Lokhande L, Kuci Emruli V, Kolstad A, Hutchings M, Räty R, Jerkeman M, Ek S (2020)
    Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
    BMC Cancer, 20 (1), 1202
    DOI 10.1186/s12885-020-07678-4, PubMed 33287742
  125. Løndalen A, Blakkisrud J, Revheim ME, Madsbu UE, Dahle J, Kolstad A, Stokke C (2020)
    FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
    Eur J Nucl Med Mol Imaging, 48 (6), 1902-1914
    DOI 10.1007/s00259-020-05098-x, PubMed 33196921
  126. Lorntzsen B, Jacobsen AB, GrØholt KK, Sigstad E, Osnes T (2020)
    Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment
    Anticancer Res, 40 (12), 6979-6985
    DOI 10.21873/anticanres.14722, PubMed 33288592
  127. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Due-Tønnessen P (2020)
    Adult outcome after treatment of pediatric posterior fossa ependymoma: long-term follow-up of a single consecutive institutional series of 22 patients with more than 5 years of survival
    J Neurosurg Pediatr, 26 (1), 22-26
    DOI 10.3171/2020.1.PEDS19700, PubMed 32217795
  128. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2020)
    Outcomes in adulthood after neurosurgical treatment of brain tumors in the first 3 years of life: long-term follow-up of a single consecutive institutional series of 97 patients
    Childs Nerv Syst, 37 (2), 427-433
    DOI 10.1007/s00381-020-04859-1, PubMed 32814984
  129. Lunde P, Bye A, Bergland A, Grimsmo J, Jarstad E, Nilsson BB (2020)
    Long-term follow-up with a smartphone application improves exercise capacity post cardiac rehabilitation: A randomized controlled trial
    Eur J Prev Cardiol, 27 (16), 1782-1792
    DOI 10.1177/2047487320905717, PubMed 32106713
  130. Lundereng ED, Dihle A, Steindal SA (2020)
    Nurses' experiences and perspectives on collaborative discharge planning when patients receiving palliative care for cancer are discharged home from hospitals
    J Clin Nurs, 29 (17-18), 3382-3391
    DOI 10.1111/jocn.15371, PubMed 32533726
  131. Ma TM, Lilleby O, Lilleby WA, Kishan AU (2020)
    Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
    Cancers (Basel), 12 (12)
    DOI 10.3390/cancers12123606, PubMed 33276562
  132. Maaland AF, Saidi A, Torgue J, Heyerdahl H, Stallons TAR, Kolstad A, Dahle J (2020)
    Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003
    PLoS One, 15 (3), e0230526
    DOI 10.1371/journal.pone.0230526, PubMed 32187209
  133. Macpherson ME, Hov JR, Ueland T, Dahl TB, Kummen M, Otterdal K, Holm K, Berge RK, Mollnes TE, Trøseid M, Halvorsen B, Aukrust P, Fevang B, Jørgensen SF (2020)
    Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
    Front Immunol, 11, 574500
    DOI 10.3389/fimmu.2020.574500, PubMed 33042155
  134. Marijnen CAM, Peters FP, Rödel C, Bujko K, Haustermans K, Fokas E, Glynne-Jones R, Valentini V, Spindler KG, Guren MG, Maingon P, Calvo FA, Pares O, Glimelius B, Sebag-Montefiore D (2020)
    International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic
    Radiother Oncol, 148, 213-215
    DOI 10.1016/j.radonc.2020.03.039, PubMed 32342861
  135. Maziarz RT, Waller EK, Jaeger U, Fleury I, McGuirk J, Holte H, Jaglowski S, Schuster SJ, Bishop MR, Westin JR, Mielke S, Teshima T, Bachanova V, Foley SR, Borchmann P, Salles GA, Zhang J, Tiwari R, Pacaud LB, Ma Q, Tam CS (2020)
    Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma
    Blood Adv, 4 (4), 629-637
    DOI 10.1182/bloodadvances.2019001026, PubMed 32074277
  136. Mellblom AV, Kiserud CE, Rueegg CS, Ruud E, Loge JH, Fosså SD, Lie HC (2020)
    Self-reported late effects and long-term follow-up care among 1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (the NOR-CAYACS study)
    Support Care Cancer, 29 (6), 2947-2957
    DOI 10.1007/s00520-020-05790-6, PubMed 33011832
  137. Meltzer S, Bjørnetrø T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR (2020)
    Corrigendum to "Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer" [Transl Oncol 12 (8) (2019) 1038-1044]
    Transl Oncol, 13 (1), 122-124
    DOI 10.1016/j.tranon.2019.09.005, PubMed 31843135
  138. Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2020)
    Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
    Cancer Immunol Immunother, 69 (1), 159-161
    DOI 10.1007/s00262-019-02409-6, PubMed 31776597
  139. Milano MT, Dinh PC, Yang H, Zaid MA, Fossa SD, Feldman DR, Monahan PO, Travis LB, Fung C (2020)
    Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors
    JNCI Cancer Spectr, 4 (3), pkaa017
    DOI 10.1093/jncics/pkaa017, PubMed 32455335
  140. Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland ØS, Larsen RH (2020)
    Calibration of sodium iodide detectors and reentrant ionization chambers for 212Pb activity in different geometries by HPGe activity determined samples
    Appl Radiat Isot, 166, 109362
    DOI 10.1016/j.apradiso.2020.109362, PubMed 32979756
  141. Nilsen LB, Digernes I, Grøvik E, Saxhaug C, Latysheva A, Geier O, Breivik B, Sætre DO, Jacobsen KD, Helland Å, Emblem KE (2020)
    Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
    Neurooncol Adv, 2 (1), vdaa028
    DOI 10.1093/noajnl/vdaa028, PubMed 32642687
  142. Nilssen Y, Brustugun OT, Eriksen MT, Haug ES, Naume B, Møller B (2020)
    Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016
    BMC Cancer, 20 (1), 488
    DOI 10.1186/s12885-020-06979-y, PubMed 32473650
  143. Nilsson K, Klevebro F, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Hjortland GO, Bartella I, Schröder W, Bruns C, Nilsson M (2020)
    Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial: Standard Versus Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
    Ann Surg, 272 (5), 684-689
    DOI 10.1097/SLA.0000000000004340, PubMed 32833767
  144. Nilsson R, Dahl AA, Bernklev T, Kersten H, Haug ES (2020)
    Work status and work ability after radical prostatectomy or active surveillance for prostate cancer
    Scand J Urol, 54 (3), 194-200
    DOI 10.1080/21681805.2020.1750473, PubMed 32285740
  145. Nome RV, Cvancarova Småstuen M, Bjøro T, Kiserud CE, Fosså SD (2020)
    Longitudinal kidney function outcome in aging testicular cancer survivors
    Acta Oncol, 59 (4), 467-474
    DOI 10.1080/0284186X.2020.1724328, PubMed 32043400
  146. Ny L, Hernberg M, Nyakas M, Koivunen J, Oddershede L, Yoon M, Wang X, Guyot P, Geisler J (2020)
    BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis
    Acta Oncol, 59 (7), 833-844
    DOI 10.1080/0284186X.2020.1747636, PubMed 32285732
  147. Nygaard A, Halvorsrud L, Bye A, Bergland A (2020)
    It takes two to tango: carers' reflections on their participation and the participation of people with dementia in the James Lind Alliance process
    BMC Geriatr, 20 (1), 175
    DOI 10.1186/s12877-020-01570-3, PubMed 32408893
  148. Öjlert ÅK, Nebdal D, Lund-Iversen M, Åstrøm Ellefsen R, Brustugun OT, Gran JM, Halvorsen AR, Helland Å (2020)
    Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy
    Acta Oncol, 60 (2), 149-156
    DOI 10.1080/0284186X.2020.1854851, PubMed 33356733
  149. Olsen CF, Debesay J, Bergland A, Bye A, Langaas AG (2020)
    What matters when asking, "what matters to you?" - perceptions and experiences of health care providers on involving older people in transitional care
    BMC Health Serv Res, 20 (1), 317
    DOI 10.1186/s12913-020-05150-4, PubMed 32299424
  150. Olssøn I, Dahl AA (2020)
    Long-term changes in attachment patterns after psychotherapy in outpatients with Axis I and personality disorders vs. Axis I disorders only
    Personal Ment Health, 15 (2), 136-146
    DOI 10.1002/pmh.1500, PubMed 33300299
  151. Palmer DH, Valle JW, Ma YT, Faluyi O, Neoptolemos JP, Jensen Gjertsen T, Iversen B, Amund Eriksen J, Møller AS, Aksnes AK, Miller R, Dueland S (2020)
    TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial
    Br J Cancer, 122 (7), 971-977
    DOI 10.1038/s41416-020-0752-7, PubMed 32063605
  152. Palmerini E, Leithner A, Windhager R, Gosheger G, Boye K, Laitinen M, Hardes J, Traub F, Jutte P, Willegger M, Casanova J, Setola E, Righi A, Picci P, Donati DM, Ferrari S (2020)
    Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS)
    Sci Rep, 10 (1), 10853
    DOI 10.1038/s41598-020-66579-5, PubMed 32616718
  153. Panagopoulos I, Gorunova L, Johannsdottir IMR, Andersen K, Holth A, Beiske K, Heim S (2020)
    Chromosome Translocation t(14;21)(q11;q22) Activates Both OLIG1 and OLIG2 in Pediatric T-cell Lymphoblastic Malignancies and May Signify Adverse Prognosis
    Cancer Genomics Proteomics, 17 (1), 41-48
    DOI 10.21873/cgp.20166, PubMed 31882550
  154. Pierson SK, Khor JS, Ziglar J, Liu A, Floess K, NaPier E, Gorzewski AM, Tamakloe MA, Powers V, Akhter F, Haljasmaa E, Jayanthan R, Rubenstein A, Repasky M, Elenitoba-Johnson K, Ruth J, Jacobs B, Streetly M, Angenendt L, Patier JL, Ferrero S, Zinzani PL, Terriou L, Casper C, Jaffe E et al. (2020)
    ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder
    Cell Rep Med, 1 (9), 100158
    DOI 10.1016/j.xcrm.2020.100158, PubMed 33377129
  155. Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Grønlie Guren M, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Aagard Thomsen L, Møller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I (2020)
    Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study
    Int J Cancer, 148 (7), 1575-1585
    DOI 10.1002/ijc.33326, PubMed 33006395
  156. Pladsen AV, Nilsen G, Rueda OM, Aure MR, Borgan Ø, Liestøl K, Vitelli V, Frigessi A, Langerød A, Mathelier A, OSBREAC, Engebråten O, Kristensen V, Wedge DC, Van Loo P, Caldas C, Børresen-Dale AL, Russnes HG, Lingjærde OC (2020)
    DNA copy number motifs are strong and independent predictors of survival in breast cancer
    Commun Biol, 3 (1), 153
    DOI 10.1038/s42003-020-0884-6, PubMed 32242091
  157. Puzanov I, Ribas A, Robert C, Schachter J, Nyakas M, Daud A, Arance A, Carlino MS, O'Day SJ, Long GV, Margolin KA, Dummer R, Schadendorf D, Lutzky J, Ascierto PA, Tarhini A, Lin J, Mogg R, Homet Moreno B, Ibrahim N, Hamid O (2020)
    Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical Trials
    JAMA Oncol, 6 (8), 1256-1264
    DOI 10.1001/jamaoncol.2020.2288, PubMed 32672795
  158. Radaelli S, Fossati P, Stacchiotti S, Akiyama T, Asencio JM, Bandiera S, Boglione A, Boland P, Bolle S, Bruland Ø, Brunello A, Bruzzi P, Campanacci D, Cananzi F, Capanna R, Casadei R, Cordoba A, Court C, Dei Tos AP, DeLaney TF, De Paoli A, De Pas TM, Desai A, Di Brina L, Donati DM et al. (2020)
    The sacral chordoma margin
    Eur J Surg Oncol, 46 (8), 1415-1422
    DOI 10.1016/j.ejso.2020.04.028, PubMed 32402509
  159. Rahman MA, Brekke J, Arnesen V, Hannisdal MH, Navarro AG, Waha A, Herfindal L, Rygh CB, Bratland E, Brandal P, Haasz J, Oltedal L, Miletic H, Lundervold A, Lie SA, Goplen D, Chekenya M (2020)
    Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study
    Immun Inflamm Dis, 8 (3), 342-359
    DOI 10.1002/iid3.315, PubMed 32578964
  160. Rao S, Sclafani F, Eng C, Adams RA, Guren MG, Sebag-Montefiore D, Benson A, Bryant A, Peckitt C, Segelov E, Roy A, Seymour MT, Welch J, Saunders MP, Muirhead R, O'Dwyer P, Bridgewater J, Bhide S, Glynne-Jones R, Arnold D, Cunningham D (2020)
    International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
    J Clin Oncol, 38 (22), 2510-2518
    DOI 10.1200/JCO.19.03266, PubMed 32530769
  161. Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K (2020)
    Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study
    Acta Oncol, 59 (7), 733-740
    DOI 10.1080/0284186X.2020.1742377, PubMed 32208873
  162. Rekeland IG, Fosså A, Lande A, Ktoridou-Valen I, Sørland K, Holsen M, Tronstad KJ, Risa K, Alme K, Viken MK, Lie BA, Dahl O, Mella O, Fluge Ø (2020)
    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
    Front Med (Lausanne), 7, 162
    DOI 10.3389/fmed.2020.00162, PubMed 32411717
  163. Riis M (2020)
    Modern surgical treatment of breast cancer
    Ann Med Surg (Lond), 56, 95-107
    DOI 10.1016/j.amsu.2020.06.016, PubMed 32637082
  164. Riis M (2020)
    Future perspectives of surgical treatment of breast cancer
    Ann Med Surg (Lond), 59, 93-95
    DOI 10.1016/j.amsu.2020.09.021, PubMed 33005399
  165. Rodrigues JM, Hassan M, Freiburghaus C, Eskelund CW, Geisler C, Räty R, Kolstad A, Sundström C, Glimelius I, Grønbaek K, Kwiecinska A, Porwit A, Jerkeman M, Ek S (2020)
    p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma
    Br J Haematol, 191 (5), 796-805
    DOI 10.1111/bjh.17023, PubMed 32748433
  166. Rolfsen ALD, Dahl AA, Pripp AH, Dørum A (2020)
    Base rate of ovarian cancer on algorithms in patients with a pelvic mass
    Int J Gynecol Cancer, 30 (11), 1775-1779
    DOI 10.1136/ijgc-2020-001416, PubMed 32699016
  167. Ryalen PC, Stensrud MJ, Fossa S, Roysland K (2020)
    Causal inference in continuous time: an example on prostate cancer therapy
    Biostatistics, 21 (1), 172-185
  168. Ryg U, Lilleby W, Hole KH, Lund-Iversen M, Switlyk MD (2020)
    Local Recurrence of Prostate Cancer to the Intersphincteric Space: A Case Report
    Urology, 140, 18-21
    DOI 10.1016/j.urology.2020.03.009, PubMed 32199872
  169. Sandmæl JA, Bye A, Solheim TS, Balstad TR, Thorsen L, Skovlund E, Kaasa S, Lund JÅ, Oldervoll L (2020)
    Physical rehabilitation in patients with head and neck cancer: Impact on health-related quality of life and suitability of a post-treatment program
    Laryngoscope Investig Otolaryngol, 5 (2), 330-338
    DOI 10.1002/lio2.368, PubMed 32337365
  170. Schou-Bredal I, Bonsaksen T, Ekeberg Ø, Skogstad L, Grimholt TK, Lerdal A, Heir T (2020)
    Sexual Assault and the Association With Health, Quality of Life, and Self-Efficacy in the General Norwegian Population
    J Interpers Violence, 0886260520926307
    DOI 10.1177/0886260520926307, PubMed 32515259
  171. Schou-Bredal I, Ekeberg Ø, Kåresen R (2020)
    Variability and stability of coping styles among breast cancer survivors: A prospective study
    Psychooncology, 30 (3), 369-377
    DOI 10.1002/pon.5587, PubMed 33167066
  172. Skalleberg J, Småstuen MC, Oldenburg J, Osnes T, Fosså SD, Bunne M (2020)
    The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up
    Laryngoscope, 130 (9), E515-E521
    DOI 10.1002/lary.28543, PubMed 32065408
  173. Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2020)
    Surgical treatment of breast cancer in Norway 2003-2018
    Tidsskr Nor Laegeforen, 140 (15)
    DOI 10.4045/tidsskr.20.0090, PubMed 33118768
  174. Smeby J, Kryeziu K, Berg KCG, Eilertsen IA, Eide PW, Johannessen B, Guren MG, Nesbakken A, Bruun J, Lothe RA, Sveen A (2020)
    Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity
    EBioMedicine, 59, 102923
    DOI 10.1016/j.ebiom.2020.102923, PubMed 32799124
  175. Smedman TM, Line PD, Hagness M, Syversveen T, Grut H, Dueland S (2020)
    Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)
    BJS Open, 4 (3), 467-477
    DOI 10.1002/bjs5.50278, PubMed 32333527
  176. Sokolova M, Yang K, Hansen SH, Louwe MC, Kummen M, Hov JER, Sjaastad I, Berge RK, Halvorsen B, Aukrust P, Yndestad A, Ranheim T (2020)
    NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet
    Sci Rep, 10 (1), 21006
    DOI 10.1038/s41598-020-76497-1, PubMed 33273482
  177. Sondén ECB, Sebuødegård S, Korvald C, Lømo J, Schlichting E, Brandal SHB, Hofvind S (2020)
    Cosmetic breast implants and breast cancer
    Tidsskr Nor Laegeforen, 140 (3)
    DOI 10.4045/tidsskr.19.0266, PubMed 32105043
  178. Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2020)
    Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis
    Radiother Oncol, 158, 300-308
    DOI 10.1016/j.radonc.2020.10.003, PubMed 33065183
  179. Stadskleiv K, Stensvold E, Stokka K, Bechensteen AG, Brandal P (2020)
    Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications
    Clin Neuropsychol
    DOI 10.1080/13854046.2020.1794045, PubMed 32729777
  180. Stankovic B, Aamodt H, Bjørhovde HAK, Müller E, Hammarström C, Brustugun OT, Helland Å, Øynebråten I, Corthay A (2020)
    The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases
    Scand J Immunol, 92 (2), e12893
    DOI 10.1111/sji.12893, PubMed 32433774
  181. Stenberg VY, Juzeniene A, Bruland ØS, Larsen RH (2020)
    In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
    Curr Radiopharm, 13 (2), 130-141
    DOI 10.2174/1874471013666200511000532, PubMed 32389119
  182. Stenberg VY, Juzeniene A, Chen Q, Yang X, Bruland ØS, Larsen RH (2020)
    Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer
    J Labelled Comp Radiopharm, 63 (3), 129-143
    DOI 10.1002/jlcr.3825, PubMed 31919866
  183. Stensvold E, Stadskleiv K, Myklebust TÅ, Wesenberg F, Helseth E, Bechensteen AG, Brandal P (2020)
    Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors
    Acta Paediatr, 109 (9), 1875-1886
    DOI 10.1111/apa.15188, PubMed 31977119
  184. Stewart R, Fosså SD, Hotopf M, Mykletun A (2020)
    Extent of disease at first cancer presentation and previous anxiety and depressive symptoms: the HUNT study
    Br J Psychiatry, 217 (2), 427-433
    DOI 10.1192/bjp.2019.211, PubMed 31587671
  185. Thøgersen H, Møller B, Åsli LM, Bhargava S, Kvåle R, Fjellbirkeland L, Robsahm TE, Aaserud S, Babigumira R, Larsen IK (2020)
    Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population
    Acta Oncol, 59 (4), 376-383
    DOI 10.1080/0284186X.2019.1711167, PubMed 31920119
  186. Thorsen L, Haugnes HS, Fosså SD, Brydøy M, Tandstad T, Wisløff T, Gjerset GM, Edvardsen E, Larsen KO, Sandset PM, Henriksson CE, Raastad T, Negaard HFS (2020)
    Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature
    Int J Cancer, 147 (11), 3189-3198
    DOI 10.1002/ijc.33151, PubMed 32525564
  187. Trewin CB, Hjerkind KV, Johansson ALV, Strand BH, Kiserud CE, Ursin G (2020)
    Socioeconomic inequalities in stage-specific breast cancer incidence: a nationwide registry study of 1.1 million young women in Norway, 2000-2015
    Acta Oncol, 59 (11), 1284-1290
    DOI 10.1080/0284186X.2020.1753888, PubMed 32319848
  188. Trewin CB, Johansson ALV, Hjerkind KV, Strand BH, Kiserud CE, Ursin G (2020)
    Stage-specific survival has improved for young breast cancer patients since 2000: but not equally
    Breast Cancer Res Treat, 182 (2), 477-489
    DOI 10.1007/s10549-020-05698-z, PubMed 32495000
  189. Tveiten H, Aukrust P, Lehne G, Rodriguez JR, Skjønsberg OH (2020)
    Haemophagocytic lymphohistiocytosis in COVID-19 cases?
    Tidsskr Nor Laegeforen, 140 (6)
    DOI 10.4045/tidsskr.20.0240, PubMed 32321221
  190. Umu SU, Langseth H, Keller A, Meese E, Helland Å, Lyle R, Rounge TB (2020)
    A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis
    Mol Oncol, 14 (2), 235-247
    DOI 10.1002/1878-0261.12620, PubMed 31851411
  191. Valsø Å, Rustøen T, Småstuen MC, Ekeberg Ø, Skogstad L, Schou-Bredal I, Myhren H, Sunde K, Tøien K (2020)
    Effect of Nurse-Led Consultations on Post-Traumatic Stress and Sense of Coherence in Discharged ICU Patients With Clinically Relevant Post-Traumatic Stress Symptoms-A Randomized Controlled Trial
    Crit Care Med, 48 (12), e1218-e1225
    DOI 10.1097/CCM.0000000000004628, PubMed 33048906
  192. van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S, Streetly M, Wong R, Wu D, Maillard I, Brandstadter J, Munshi N, Bowne W, Elenitoba-Johnson KS, Fössa A, Lechowicz MJ, Chandrakasan S, Pierson SK, Greenway A, Nasta S, Yoshizaki K, Kurzrock R et al. (2020)
    International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
    Blood Adv, 4 (23), 6039-6050
    DOI 10.1182/bloodadvances.2020003334, PubMed 33284946
  193. van Rhee F, Rossi JF, Simpson D, Fosså A, Dispenzieri A, Kuruvilla J, Goh YT, Cho SG, Capra M, Liu T, Casper C, Cavet J, Wong RS (2020)
    Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab
    Br J Haematol, 192 (1), e28-e31
    DOI 10.1111/bjh.17177, PubMed 33128769
  194. VAN Vulpen JK, Sweegers MG, Peeters PHM, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, GalvÃo DA, Chinapaw MJ, Steindorf K, Irwin ML, Stuiver MM, Hayes S, Griffith KA, Mesters I, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M, Thorsen L, Schulz KH, Short CE, James EL et al. (2020)
    Moderators of Exercise Effects on Cancer-related Fatigue: A Meta-analysis of Individual Patient Data
    Med Sci Sports Exerc, 52 (2), 303-314
    DOI 10.1249/MSS.0000000000002154, PubMed 31524827
  195. Vandraas KF, Reinertsen KV, Kiserud CE, Lie HC (2020)
    Fear of cancer recurrence among young adult cancer survivors-exploring long-term contributing factors in a large, population-based cohort
    J Cancer Surviv
    DOI 10.1007/s11764-020-00943-2, PubMed 32989672
  196. Vatne Monsen K, Fosså SD, Dahl AA, Myklebust TÅ, Smeland S, Stensvold A (2020)
    Prostatectomy with or without post-operative radiotherapy: long-term adverse effects and quality of life
    Scand J Urol, 55 (1), 9-16
    DOI 10.1080/21681805.2020.1854343, PubMed 33349097
  197. Vistad I, Lindemann K, Bentzen AG, Dahl AA, Steen R, Kiserud C (2020)
    Preferences for follow up in long-term survivors after cervical cancer
    Acta Obstet Gynecol Scand, 99 (9), 1253-1259
    DOI 10.1111/aogs.13855, PubMed 32232835
  198. Vittrup AS, Tanderup K, Bentzen SM, Jensen NBK, Spampinato S, Fokdal LU, Lindegaard JC, Sturdza A, Schmid M, Segedin B, Jürgenliemk-Schulz IM, Bruheim K, Mahantshetty U, Haie-Meder C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Huang F, Nout RA, Villafranca E, Van Limbergen E, Pieters BR, Tan LT, Lutgens LCHW et al. (2020)
    Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study
    Int J Radiat Oncol Biol Phys, 109 (1), 161-173
    DOI 10.1016/j.ijrobp.2020.08.044, PubMed 32853710
  199. von der Lippe Gythfeldt H, Lien T, Tekpli X, Silwal-Pandit L, Borgen E, Garred Ø, Skjerven H, Schlichting E, Lundgren S, Wist E, Naume B, Kristensen V, Børresen-Dale AL, Lingjaerde OC, Engebraaten O (2020)
    Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer
    Int J Cancer, 147 (9), 2515-2525
    DOI 10.1002/ijc.33108, PubMed 32488909
  200. von Döbeln GA, Wagenius G, Holtved E, Jacobsen AB, Nilsson M, Yu J, Baeksgaard L (2020)
    Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction
    Cancer Treat Res Commun, 24, 100187
    DOI 10.1016/j.ctarc.2020.100187, PubMed 32619832
  201. Wälchli S, Sioud M (2020)
    Next Generation of Adoptive T Cell Therapy Using CRISPR/Cas9 Technology: Universal or Boosted?
    Methods Mol Biol, 2115, 407-417
    DOI 10.1007/978-1-0716-0290-4_22, PubMed 32006413
  202. Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS (2020)
    Upregulation of HLA Class I and Antiviral Tissue Responses in Hashimoto's Thyroiditis
    Thyroid, 30 (3), 432-442
    DOI 10.1089/thy.2019.0607, PubMed 31910110
  203. Weum Abrahamsen I, Grønvold BC, Inderberg EM, Mensali N, Mattsson J, Gedde-Dahl T (2020)
    Posttransplantation Lymphoproliferative Disease Treated by Retransplantation
    Case Reports Immunol, 2020, 9403123
    DOI 10.1155/2020/9403123, PubMed 32158568
  204. Winge-Main AK, Wälchli S, Inderberg EM (2020)
    T cell receptor therapy against melanoma-Immunotherapy for the future?
    Scand J Immunol, 92 (4), e12927
    DOI 10.1111/sji.12927, PubMed 32640053
  205. Wise JF, Nakken S, Steen CB, Vodák D, Trøen G, Johannessen B, Lingjærde OC, Hilden V, Blaker YN, Bai B, Aasheim LB, Pasanen A, Lorenz S, Sveen A, Lothe RA, Myklebost O, Leppä S, Meza-Zepeda LA, Beiske K, Lawrence MS, Hovig E, Myklebust JH, Smeland EB, Holte H (2020)
    Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
    Blood Adv, 4 (9), 1859-1866
    DOI 10.1182/bloodadvances.2019001325, PubMed 32374878
  206. Witt Nyström P, Bratland Å, Minn H, Grau C (2020)
    Ongoing and future clinical trials in particle therapy in the Nordic countries
    Acta Oncol, 59 (10), 1145-1150
    DOI 10.1080/0284186X.2020.1792548, PubMed 32673134
  207. Zilli T, Dirix P, Heikkilä R, Liefhooghe N, Siva S, Gomez-Iturriaga A, Everaerts W, Otte F, Shelan M, Mercier C, Achard V, Thon K, Stellamans K, Moon D, Conde-Moreno A, Papachristofilou A, Scorsetti M, Gückenberger M, Ameye F, Zapatero A, Van De Voorde L, López Campos F, Couñago F, Jaccard M, Spiessens A et al. (2020)
    The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases
    Eur Urol Focus, 7 (2), 241-244
    DOI 10.1016/j.euf.2020.12.010, PubMed 33386290

Publications 2019

  1. Abrahamsson H, Porojnicu AC, Lindstrøm JC, Dueland S, Flatmark K, Hole KH, Seierstad T, Moan J, Redalen KR, Meltzer S, Ree AH (2019)
    High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
    BMC Cancer, 19 (1), 488
    DOI 10.1186/s12885-019-5724-z, PubMed 31122213
  2. Abravan A, Eide HA, Løndalen AM, Helland Å, Malinen E (2019)
    Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer
    Mol Imaging Biol, 21 (2), 391-398
    DOI 10.1007/s11307-018-1226-7, PubMed 29916117
  3. Abu Zaid M, Dinh PC, Monahan PO, Fung C, El-Charif O, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Sesso HD, Huddart R, Mushiroda T, Kubo M, Dolan ME, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group (2019)
    Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors
    J Natl Compr Canc Netw, 17 (5), 459-468
    DOI 10.6004/jnccn.2018.7109, PubMed 31085753
  4. Agrawal V, Dinh PC, Fung C, Monahan PO, Althouse SK, Norton K, Cary C, Einhorn L, Fossa SD, Adra N, Travis LB (2019)
    Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
    JNCI Cancer Spectr, 4 (2), pkz079
    DOI 10.1093/jncics/pkz079, PubMed 32190815
  5. Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ (2019)
    Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial
    Int J Radiat Oncol Biol Phys, 106 (4), 706-714
    DOI 10.1016/j.ijrobp.2019.11.027, PubMed 31786279
  6. Alkodsi A, Cervera A, Zhang K, Louhimo R, Meriranta L, Pasanen A, Leivonen SK, Holte H, Leppä S, Lehtonen R, Hautaniemi S (2019)
    Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes
    Leukemia, 33 (11), 2662-2672
    DOI 10.1038/s41375-019-0509-6, PubMed 31186494
  7. Alrehily F, Hogg P, Twiste M, Johansen S, Tootell A (2019)
    The accuracy of Cobb angle measurement on CT scan projection radiograph images
    Radiography (Lond), 26 (2), e73-e77
    DOI 10.1016/j.radi.2019.11.001, PubMed 32052770
  8. Alrehily F, Hogg P, Twiste M, Johansen S, Tootell A (2019)
    Development and validation of a bespoke phantom to test accuracy of Cobb angle measurements
    Radiography (Lond), 26 (2), e78-e87
    DOI 10.1016/j.radi.2019.11.002, PubMed 32052769
  9. Alrehily F, Hogg P, Twiste M, Johansen S, Tootell A (2019)
    Scoliosis imaging: An analysis of radiation risk in the CT scan projection radiograph and a comparison with projection radiography and EOS
    Radiography (Lond), 25 (3), e68-e74
    DOI 10.1016/j.radi.2019.02.005, PubMed 31301794
  10. Andersson Y, Inderberg EM, Kvalheim G, Herud TM, Engebraaten O, Flatmark K, Dueland S, Fodstad Ø (2019)
    Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients
    Acta Oncol, 59 (4), 404-409
    DOI 10.1080/0284186X.2019.1704864, PubMed 31876430
  11. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, De P, Tervonen H, Walsh PM, Bucher O, Engholm G, Jackson C, McClure C, Woods RR, Saint-Jacques N, Morgan E, Ransom D, Thursfield V, Møller B, Leonfellner S, Guren MG, Bray F, Arnold M (2019)
    Changes in colorectal cancer incidence in seven high-income countries: a population-based study
    Lancet Gastroenterol Hepatol, 4 (7), 511-518
    DOI 10.1016/S2468-1253(19)30147-5, PubMed 31105047
  12. Baekelandt BMG, Fagerland MW, Hjermstad MJ, Heiberg T, Labori KJ, Buanes TA (2019)
    Survival, Complications and Patient Reported Outcomes after Pancreatic Surgery
    HPB, 21 (3), 275-282
  13. Bains SJ, Abrahamsson H, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Meltzer S, Ree AH (2019)
    Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
    Cancer Immunol Immunother, 69 (3), 355-364
    DOI 10.1007/s00262-019-02458-x, PubMed 31893287
  14. Balstad TR, Bye A, Jenssen CR, Solheim TS, Thoresen L, Sand K (2019)
    Patient interpretation of the Patient-Generated Subjective Global Assessment (PG-SGA) Short Form
    Patient Prefer Adherence, 13, 1391-1400
    DOI 10.2147/PPA.S204188, PubMed 31496666
  15. Ben-Aharon I, Goshen-Lago T, Fontana E, Smyth E, Guren M, Caballero C, Lordick F (2019)
    Social networks for young patients with cancer: the time for system agility
    Lancet Oncol, 20 (6), 765
    DOI 10.1016/S1470-2045(19)30346-8, PubMed 31162090
  16. Bennett MI, Kaasa S, Barke A, Korwisi B, Rief W, Treede RD, IASP Taskforce for the Classification of Chronic Pain (2019)
    The IASP classification of chronic pain for ICD-11: chronic cancer-related pain
    Pain, 160 (1), 38-44
    DOI 10.1097/j.pain.0000000000001363, PubMed 30586069
  17. Bergholtz H, Lien TG, Ursin G, Holmen MM, Helland Å, Sørlie T, Haakensen VD (2019)
    A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue
    J Mammary Gland Biol Neoplasia, 24 (2), 163-175
    DOI 10.1007/s10911-018-09423-x, PubMed 30613869
  18. Bernard P, Savard J, Steindorf K, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvao DA, Chinapaw MJ, Stuiver MM, Griffith KA, Mesters I, Knoop H, Goedendorp MM, Bohus M, Thorsen L, Schmidt ME, Ulrich CM, Sonke GS, van Harten W, Winters-Stone KM, Velthuis MJ, Taaffe DR et al. (2019)
    Effects and moderators of exercise on sleep in adults with cancer: Individual patient data and aggregated meta-analyses
    J Psychosom Res, 124, 109746
    DOI 10.1016/j.jpsychores.2019.109746, PubMed 31443811
  19. Berner K, Bruland ØS (2019)
    Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas
    Anticancer Res, 39 (5), 2459-2466
    DOI 10.21873/anticanres.13365, PubMed 31092440
  20. Bersvendsen HS, Haugnes HS, Dahl AA, Fagerli UM, Fluge Ø, Holte H, Seland M, Wilsgaard T, Smeland KB, Kiserud CE (2019)
    Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
    Bone Marrow Transplant, 55 (5), 891-905
    DOI 10.1038/s41409-019-0745-4, PubMed 31745250
  21. Bersvendsen HS, Haugnes HS, Fagerli UM, Fluge Ø, Holte H, Smeland KB, Wilsgaard T, Kiserud CE (2019)
    Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes
    Acta Oncol, 58 (5), 690-699
    DOI 10.1080/0284186X.2018.1558370, PubMed 30696346
  22. Biccler JL, Glimelius I, Eloranta S, Smeland KB, Brown PN, Jakobsen LH, Frederiksen H, Jerkeman M, Fosså A, Andersson TML, Holte H, Bøgsted M, El-Galaly TC, Smedby KE (2019)
    Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study
    J Clin Oncol, 37 (9), 703-713
    DOI 10.1200/JCO.18.01652, PubMed 30726176
  23. Bishop MR, Maziarz RT, Waller EK, Jäger U, Westin JR, McGuirk JP, Fleury I, Holte H, Borchmann P, Del Corral C, Tiwari R, Anak Ö, Awasthi R, Pacaud L, Romanov VV, Schuster SJ (2019)
    Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion
    Blood Adv, 3 (14), 2230-2236
    DOI 10.1182/bloodadvances.2019000151, PubMed 31332046
  24. Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszweksi KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A, EORTC Quality of Life Group and Breast Cancer Group (2019)
    An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45
    Ann Oncol, 31 (2), 283-288
    DOI 10.1016/j.annonc.2019.10.027, PubMed 31959345
  25. Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
    18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
    Clin Nucl Med, 44 (8), 605-611
    DOI 10.1097/RLU.0000000000002641, PubMed 31274605
  26. Bøhn SH, Thorsen L, Kiserud CE, Fosså SD, Lie HC, Loge JH, Wisløff T, Haugnes HS, Reinertsen KV (2019)
    Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
    Acta Oncol, 58 (5), 753-762
    DOI 10.1080/0284186X.2018.1557344, PubMed 30696351
  27. Boland JW, Allgar V, Boland EG, Bennett MI, Kaasa S, Hjermstad MJ, Johnson M (2019)
    The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care Cancer symptom study
    Eur J Clin Pharmacol, 76 (3), 393-402
    DOI 10.1007/s00228-019-02801-2, PubMed 31865411
  28. Bonsaksen T, Ekeberg Ø, Skogstad L, Heir T, Grimholt TK, Lerdal A, Schou-Bredal I (2019)
    Self-rated global health in the Norwegian general population
    Health Qual Life Outcomes, 17 (1), 188
    DOI 10.1186/s12955-019-1258-y, PubMed 31870385
  29. Bonsaksen T, Heir T, Ekeberg Ø, Grimholt TK, Lerdal A, Skogstad L, Schou-Bredal I (2019)
    Self-evaluated anxiety in the Norwegian population: prevalence and associated factors
    Arch Public Health, 77, 10
    DOI 10.1186/s13690-019-0338-0, PubMed 30923612
  30. Bowitz Lothe IM, Kleive D, Pomianowska E, Cvancarova M, Kure E, Dueland S, Gladhaug IP, Labori KJ (2019)
    Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy
    Pancreatology, 19 (2), 316-324
    DOI 10.1016/j.pan.2019.01.019, PubMed 30713128
  31. Brandstorp-Boesen J, Zätterström U, Evensen JF, Boysen M (2019)
    Value of patient-reported symptoms in the follow up of patients potentially cured of laryngeal carcinoma
    J Laryngol Otol, 133 (6), 508-514
    DOI 10.1017/S0022215119000677, PubMed 31006407
  32. Brunsell TH, Cengija V, Sveen A, Bjørnbeth BA, Røsok BI, Brudvik KW, Guren MG, Lothe RA, Abildgaard A, Nesbakken A (2019)
    Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
    Eur J Surg Oncol, 45 (12), 2340-2346
    DOI 10.1016/j.ejso.2019.07.017, PubMed 31350075
  33. Brunsell TH, Sveen A, Bjørnbeth BA, Røsok BI, Danielsen SA, Brudvik KW, Berg KCG, Johannessen B, Cengija V, Abildgaard A, Guren MG, Nesbakken A, Lothe RA (2019)
    High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
    Clin Colorectal Cancer, 19 (1), e26-e47
    DOI 10.1016/j.clcc.2019.09.003, PubMed 31982351
  34. Bucher-Johannessen C, Page CM, Haugen TB, Wojewodzic MW, Fosså SD, Grotmol T, Haugnes HS, Rounge TB (2019)
    Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
    Clin Epigenetics, 11 (1), 179
    DOI 10.1186/s13148-019-0764-4, PubMed 31796056
  35. Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D, KEYNOTE-048 Investigators (2019)
    Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
    Lancet, 394 (10212), 1915-1928
    DOI 10.1016/S0140-6736(19)32591-7, PubMed 31679945
  36. Camilio KA, Wang MY, Mauseth B, Waagene S, Kvalheim G, Rekdal Ø, Sveinbjørnsson B, Mælandsmo GM (2019)
    Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
    Breast Cancer Res, 21 (1), 9
    DOI 10.1186/s13058-018-1092-x, PubMed 30670061
  37. Dahl AA, Fosså SD, Lie HC, Loge JH, Reinertsen KV, Ruud E, Kiserud CE (2019)
    Employment Status and Work Ability in Long-Term Young Adult Cancer Survivors
    J Adolesc Young Adult Oncol, 8 (3), 304-311
    DOI 10.1089/jayao.2018.0109, PubMed 30900929
  38. Debik J, Euceda LR, Lundgren S, Gythfeldt HVL, Garred Ø, Borgen E, Engebraaten O, Bathen TF, Giskeødegård GF (2019)
    Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients
    J Proteome Res, 18 (10), 3649-3660
    DOI 10.1021/acs.jproteome.9b00316, PubMed 31483662
  39. Dolan RD, Laird BJA, Klepstad P, Kaasa S, Horgan PG, Paulsen Ø, McMillan DC (2019)
    An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer
    Medicine (Baltimore), 98 (37), e17019
    DOI 10.1097/MD.0000000000017019, PubMed 31517821
  40. Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, Behrens S, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Burwinkel B, Canzian F, Chan TL et al. (2019)
    Two truncating variants in FANCC and breast cancer risk
    Sci Rep, 9 (1), 12524
    DOI 10.1038/s41598-019-48804-y, PubMed 31467304
  41. El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, Fossa SD, Einhorn LH, Travis LB, Dolan ME (2019)
    Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms
    Clin Cancer Res, 25 (13), 4104-4116
    DOI 10.1158/1078-0432.CCR-18-3179, PubMed 30952644
  42. Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Boeckx B, Bojesen SE, Bonanni B, Børresen-Dale AL et al. (2019)
    Genome-wide association study of germline variants and breast cancer-specific mortality
    Br J Cancer, 120 (6), 647-657
    DOI 10.1038/s41416-019-0393-x, PubMed 30787463
  43. Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J (2019)
    DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)
    Acta Oncol, 58 (10), 1502-1505
    DOI 10.1080/0284186X.2019.1629012, PubMed 31282236
  44. Falstie-Jensen AM, Kjærsgaard A, Lorenzen EL, Jensen JD, Reinertsen KV, Dekkers OM, Ewertz M, Cronin-Fenton DP (2019)
    Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study
    Breast Cancer Res, 21 (1), 44
    DOI 10.1186/s13058-019-1122-3, PubMed 30902106
  45. Fauske L, Bondevik H, Ahlberg K, Bjørndal A (2019)
    Identifying bone sarcoma survivors facing psychosocial challenges. A study of trajectories following treatment
    Eur J Cancer Care (Engl), 28 (5), e13119
    DOI 10.1111/ecc.13119, PubMed 31184795
  46. Fauske L, Hompland I, Lorem G, Bondevik H, Bruland ØS (2019)
    Perspectives on treatment side effects in patients with metastatic gastrointestinal stromal tumour: a qualitative study
    Clin Sarcoma Res, 9, 6
    DOI 10.1186/s13569-019-0116-3, PubMed 31061697
  47. Faye-Schjøll HH, Schou-Bredal I (2019)
    Pessimism predicts anxiety and depression in breast cancer survivors: A 5-year follow-up study
    Psychooncology, 28 (6), 1314-1320
    DOI 10.1002/pon.5084, PubMed 30950120
  48. Fernandes ESM, Line PD, Mello FP, Andrade RO, Girão CL, Pimentel LS, César C, Suleiman TS, Waechter FL, Oliveira ATT, Torres OJM (2019)
    LIVING DONOR LIVER TRANSPLANT FOR COLORECTAL LIVER METASTASIS: THE FIRST CASE IN LATIN AMERICA
    Arq Bras Cir Dig, 32 (4), e1468
    DOI 10.1590/0102-672020180001e1468, PubMed 31859921
  49. Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, Evangelista A, Moia R, Kwee I, Dahl C, Di Rocco A, Stefoni V, Diop F, Favini C, Ghione P, Mahmoud AM, Schipani M, Kolstad A, Barbero D, Novero D, Paulli M, Zamò A, Jerkeman M, da Silva MG, Santoro A et al. (2019)
    KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
    Haematologica, 105 (6), 1604-1612
    DOI 10.3324/haematol.2018.214056, PubMed 31537689
  50. Fischer S, Tandstad T, Cohn-Cedermark G, Thibault C, Vincenzi B, Klingbiel D, Albany C, Necchi A, Terbuch A, Lorch A, Aparicio J, Heidenreich A, Hentrich M, Wheater M, Langberg CW, Ståhl O, Fankhauser CD, Hamid AA, Koutsoukos K, Shamash J, White J, Bokemeyer C, Beyer J, Gillessen S, Global Germ-Cell Cancer Group (2019)
    Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma
    J Clin Oncol, 38 (12), 1322-1331
    DOI 10.1200/JCO.19.01876, PubMed 31877087
  51. Fosså A, Smeland K, Fagerli UM, Galleberg RB, Bersvendsen HS, Holte H (2019)
    Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016
    Acta Oncol, 59 (1), 101-105
    DOI 10.1080/0284186X.2019.1652765, PubMed 31429371
  52. Fosså SD, Beyer B, Dahl AA, Aas K, Eri LM, Kvan E, Falk RS, Graefen M, Huland H, Berge V (2019)
    Improved patient-reported functional outcomes after nerve-sparing radical prostatectomy by using NeuroSAFE technique
    Scand J Urol, 53 (6), 385-391
    DOI 10.1080/21681805.2019.1693625, PubMed 31797716
  53. Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2019)
    ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
    Eur J Surg Oncol, 47 (1), 134-138
    DOI 10.1016/j.ejso.2019.04.014, PubMed 31036394
  54. Fung C, Dinh PC, Fossa SD, Travis LB (2019)
    Testicular Cancer Survivorship
    J Natl Compr Canc Netw, 17 (12), 1557-1568
    DOI 10.6004/jnccn.2019.7369, PubMed 31805527
  55. Gerdtsson A, Håkansson U, Törnblom M, Jancke G, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Andreassen KE, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2019)
    Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
    Eur Urol Oncol, 3 (3), 382-389
    DOI 10.1016/j.euo.2019.08.002, PubMed 31506250
  56. Gjerset GM, Kiserud CE, Loge JH, Fosså SD, Wisløff T, Gudbergsson SB, Oldervoll LM, Thorsen L (2019)
    Changes in fatigue, health-related quality of life and physical activity after a one-week educational program for cancer survivors
    Acta Oncol, 58 (5), 682-689
    DOI 10.1080/0284186X.2018.1562210, PubMed 30862228
  57. Gjerset GM, Tendille M, Skaali T, Kiserud CE, Dahl AA, Gudbergsson SB, Thorsen L (2019)
    Gender differences in health status and benefits of a one-week educational programme for caregivers of cancer patients
    Eur J Cancer Care (Engl), 28 (2), e12992
    DOI 10.1111/ecc.12992, PubMed 30652372
  58. Graadal Svestad J, Ramberg C, Skar B, Paulsen Hellebust T (2019)
    Intrafractional motion in stereotactic body radiotherapy of spinal metastases utilizing cone beam computed tomography image guidance
    Phys Imaging Radiat Oncol, 12, 1-6
    DOI 10.1016/j.phro.2019.10.001, PubMed 33458287
  59. Grimholt TK, Bonsaksen T, Schou-Bredal I, Heir T, Lerdal A, Skogstad L, Ekeberg Ø (2019)
    Flight Anxiety Reported from 1986 to 2015
    Aerosp Med Hum Perform, 90 (4), 384-388
    DOI 10.3357/AMHP.5125.2019, PubMed 30922426
  60. Grønberg BH, Valan CD, Halvorsen T, Sjøblom B, Jordhøy MS (2019)
    Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients
    J Cachexia Sarcopenia Muscle, 10 (6), 1347-1355
    DOI 10.1002/jcsm.12469, PubMed 31385663
  61. Grov EK, Dahl AA (2019)
    Golf as Therapy for Individuals With Mental Health or Substance Use Disorders
    J Psychosoc Nurs Ment Health Serv, 57 (10), 44-51
    DOI 10.3928/02793695-20190528-02, PubMed 31188463
  62. Gunn C, O'Brien K, Fosså K, Tonkopi E, Lanca L, Martins CT, Muller H, Friedrich-Nel H, Abdolell M, Johansen S (2019)
    A multi institutional comparison of imaging dose and technique protocols for neonatal chest radiography
    Radiography (Lond), 26 (2), e66-e72
    DOI 10.1016/j.radi.2019.10.013, PubMed 32052771
  63. Guren MG (2019)
    The global challenge of colorectal cancer
    Lancet Gastroenterol Hepatol, 4 (12), 894-895
    DOI 10.1016/S2468-1253(19)30329-2, PubMed 31648973
  64. Habberstad R, Hjermstad MJ, Brunelli C, Kaasa S, Bennett MI, Pardon K, Klepstad P (2019)
    Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses
    Support. Care Cancer, 27 (4), 1335-1343
  65. Hamfjord J, Guren TK, Dajani O, Johansen JS, Glimelius B, Sorbye H, Pfeiffer P, Lingjærde OC, Tveit KM, Kure EH, Pallisgaard N, Spindler KG (2019)
    Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
    Ann Oncol, 30 (7), 1088-1095
    DOI 10.1093/annonc/mdz139, PubMed 31046124
  66. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF (2019)
    Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry
    Int J Med Inform, 125, 102-109
    DOI 10.1016/j.ijmedinf.2019.03.004, PubMed 30914174
  67. Heir T, Bonsaksen T, Grimholt T, Ekeberg Ø, Skogstad L, Lerdal A, Schou-Bredal I (2019)
    Serious life events and post-traumatic stress disorder in the Norwegian population
    BJPsych Open, 5 (5), e82
    DOI 10.1192/bjo.2019.62, PubMed 31506124
  68. Hellesnes R, Kvammen Ø, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS (2019)
    Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
    Int J Cancer, 147 (1), 21-32
    DOI 10.1002/ijc.32704, PubMed 31597192
  69. Hestevik CH, Molin M, Debesay J, Bergland A, Bye A (2019)
    Older persons' experiences of adapting to daily life at home after hospital discharge: a qualitative metasummary
    BMC Health Serv Res, 19 (1), 224
    DOI 10.1186/s12913-019-4035-z, PubMed 30975144
  70. Hestevik CH, Molin M, Debesay J, Bergland A, Bye A (2019)
    Healthcare professionals' experiences of providing individualized nutritional care for Older People in hospital and home care: a qualitative study
    BMC Geriatr, 19 (1), 317
    DOI 10.1186/s12877-019-1339-0, PubMed 31747884
  71. Hestevik CH, Molin M, Debesay J, Bergland A, Bye A (2019)
    Hospital nurses and home care providers' experiences of participation in nutritional care among older persons and their family caregivers: a qualitative study
    J Hum Nutr Diet, 33 (2), 198-206
    DOI 10.1111/jhn.12729, PubMed 31876356
  72. Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, Ramos Albiac M, Magelssen H, Lassen-Ramshad Y, Ondrová B, Ajithkumar T, Alapetite C, Balgobind BV, Bolle S, Cameron AL, Davila Fajardo R, Dietzsch S, Dumont Lecomte D, van den Heuvel-Eibrink MM, Kortmann RD, Laprie A, Melchior P, Padovani L, Rombi B, Scarzello G et al. (2019)
    Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
    Lancet Oncol, 20 (3), e155-e166
    DOI 10.1016/S1470-2045(19)30034-8, PubMed 30842059
  73. Høghaug G, Skår R, Tran TN, Schou-Bredal I (2019)
    Nurses' experiences with newly acquired knowledge about medication management: A qualitative study
    J Nurs Manag, 27 (8), 1731-1737
    DOI 10.1111/jonm.12864, PubMed 31495022
  74. Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K (2019)
    Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?
    Ann Surg Oncol, 26 (13), 4730-4736
    DOI 10.1245/s10434-019-07813-x, PubMed 31520212
  75. Hølmebakk T, Boye K (2019)
    Author response to comment on: Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
    Br J Surg, 106 (8), 1102-1103
    DOI 10.1002/bjs.11245, PubMed 31260582
  76. Jakobsen G, Engstrøm M, Thronæs M, Løhre ET, Kaasa S, Fayers P, Hjermstad MJ, Klepstad P (2019)
    Sleep quality in hospitalized patients with advanced cancer: an observational study using self-reports of sleep and actigraphy
    Support Care Cancer, 28 (4), 2015-2023
    DOI 10.1007/s00520-019-04998-5, PubMed 31392550
  77. Jansen YJL, Rozeman EA, Mason R, Goldinger SM, Geukes Foppen MH, Hoejberg L, Schmidt H, van Thienen JV, Haanen JBAG, Tiainen L, Svane IM, Mäkelä S, Seremet T, Arance A, Dummer R, Bastholt L, Nyakas M, Straume O, Menzies AM, Long GV, Atkinson V, Blank CU, Neyns B (2019)
    Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
    Ann Oncol, 30 (7), 1154-1161
    DOI 10.1093/annonc/mdz110, PubMed 30923820
  78. Jha AK, Neupane P, Pradhan M, Sharma KS, Shrestha S, Sigdel PR, Smeland S, Bruland ØS (2019)
    Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
    J Glob Oncol, 5, 1-10
    DOI 10.1200/JGO.19.00015, PubMed 30917070
  79. Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF et al. (2019)
    Breast cancer quantitative proteome and proteogenomic landscape
    Nat Commun, 10 (1), 1600
    DOI 10.1038/s41467-019-09018-y, PubMed 30962452
  80. Josefsson SE, Beiske K, Blaker YN, Førsund MS, Holte H, Østenstad B, Kimby E, Köksal H, Wälchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH (2019)
    TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma
    Cancer Immunol Res, 7 (3), 355-362
    DOI 10.1158/2326-6066.CIR-18-0351, PubMed 30659053
  81. Kirkhus L, Harneshaug M, Šaltytė Benth J, Grønberg BH, Rostoft S, Bergh S, Hjermstad MJ, Selbæk G, Wyller TB, Kirkevold Ø, Borza T, Saltvedt I, Jordhøy MS (2019)
    Modifiable factors affecting older patients' quality of life and physical function during cancer treatment
    J Geriatr Oncol, 10 (6), 904-912
    DOI 10.1016/j.jgo.2019.08.001, PubMed 31444088
  82. Kirkhus L, Šaltytė Benth J, Grønberg BH, Hjermstad MJ, Rostoft S, Harneshaug M, Selbæk G, Wyller TB, Jordhøy MS (2019)
    Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational study
    Palliat Med, 33 (3), 312-322
    DOI 10.1177/0269216319825972, PubMed 30712456
  83. Kirkhus L, Šaltytė Benth J, Grønberg BH, Hjermstad MJ, Rostoft S, Harneshaug M, Selbæk G, Wyller TB, Slaaen M (2019)
    Reply to the letter to the editor 'Geriatric-oncology and palliative care: cautionary on using geriatric assessment as a sole basis to limit care'
    Palliat Med, 34 (2), 255-256
    DOI 10.1177/0269216319888987, PubMed 31739739
  84. Köksal H, Baken E, Warren DJ, Løset GÅ, Inderberg EM, Wälchli S (2019)
    Chimeric antigen receptor preparation from hybridoma to T-cell expression
    Antib Ther, 2 (2), 56-63
    DOI 10.1093/abt/tbz007, PubMed 33928223
  85. Köksal H, Dillard P, Josefsson SE, Maggadottir SM, Pollmann S, Fåne A, Blaker YN, Beiske K, Huse K, Kolstad A, Holte H, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2019)
    Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma
    Blood Adv, 3 (8), 1230-1243
    DOI 10.1182/bloodadvances.2018029678, PubMed 30979721
  86. Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S (2019)
    Treating osteosarcoma with CAR T cells
    Scand J Immunol, 89 (3), e12741
    DOI 10.1111/sji.12741, PubMed 30549299
  87. König M, Osnes T, Bratland Å, Jebsen P, Meling TR (2019)
    Treatment of Sinonasal Adenocarcinoma: A Population-Based Prospective Cohort Study
    J Neurol Surg B Skull Base, 81 (6), 627-637
    DOI 10.1055/s-0039-1694050, PubMed 33381366
  88. König M, Osnes T, Bratland Å, Meling TR (2019)
    Squamous Cell Carcinoma of the Paranasal Sinuses: A Single Center Experience
    J Neurol Surg B Skull Base, 81 (6), 664-672
    DOI 10.1055/s-0039-1694967, PubMed 33381371
  89. Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, Wasan H, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Pfeiffer P, Orlov S, Lonardi S, Elez E, Kim TW, Schellens JHM, Guo C, Krishnan A, Dekervel J, Morris V, Calvo Ferrandiz A et al. (2019)
    Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    N Engl J Med, 381 (17), 1632-1643
    DOI 10.1056/NEJMoa1908075, PubMed 31566309
  90. Kryeziu K, Bruun J, Guren TK, Sveen A, Lothe RA (2019)
    Combination therapies with HSP90 inhibitors against colorectal cancer
    Biochim Biophys Acta Rev Cancer, 1871 (2), 240-247
    DOI 10.1016/j.bbcan.2019.01.002, PubMed 30708039
  91. Kvael LAH, Debesay J, Bye A, Bergland A (2019)
    Health-care professionals' experiences of patient participation among older patients in intermediate care-At the intersection between profession, market and bureaucracy
    Health Expect, 22 (5), 921-930
    DOI 10.1111/hex.12896, PubMed 31127681
  92. Kvæl LAH, Debesay J, Bye A, Bergland A (2019)
    The Dramaturgical Act of Positioning Within Family Meetings: Negotiation of Patients' Participation in Intermediate Care Services
    Qual Health Res, 30 (6), 811-824
    DOI 10.1177/1049732319873054, PubMed 31526100
  93. Kvåle R, Myklebust TÅ, Fosså SD, Aas K, Ekanger C, Helle SI, Honoré A, Møller B (2019)
    Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer-specific mortality. A population-based study of 13 198 patients
    Prostate, 79 (16), 1852-1860
    DOI 10.1002/pros.23911, PubMed 31566779
  94. Kvammen Ø, Myklebust TÅ, Solberg A, Møller B, Klepp OH, Fosså SD, Tandstad T (2019)
    Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953-2015: A population-based prospective cohort study
    PLoS One, 14 (12), e0225942
    DOI 10.1371/journal.pone.0225942, PubMed 31851716
  95. Kyte JA, Fåne A, Pule M, Gaudernack G (2019)
    Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination
    Oncoimmunology, 8 (4), e1565236
    DOI 10.1080/2162402X.2019.1565236, PubMed 30906659
  96. Lagerlöf I, Holte H, Glimelius I, Björkholm M, Enblad G, Erlanson M, Fluge Ø, Fohlin H, Fosså A, Goldkuhl C, Gustavsson A, Johansson AS, Linderoth J, Nome O, Palma M, Åkesson L, Østenstad B, Raud C, Glimelius B, Molin D (2019)
    No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy
    Br J Haematol, 188 (5), 685-691
    DOI 10.1111/bjh.16232, PubMed 31612478
  97. Lai X, Geier OM, Fleischer T, Garred Ø, Borgen E, Funke SW, Kumar S, Rognes ME, Seierstad T, Børresen-Dale AL, Kristensen VN, Engebraaten O, Köhn-Luque A, Frigessi A (2019)
    Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data
    Cancer Res, 79 (16), 4293-4304
    DOI 10.1158/0008-5472.CAN-18-1804, PubMed 31118201
  98. Landmark T, Romundstad P, Butler S, Kaasa S, Borchgrevink P (2019)
    Development and course of chronic widespread pain: the role of time and pain characteristics (the HUNT pain study)
    Pain, 160 (9), 1976-1981
    DOI 10.1097/j.pain.0000000000001585, PubMed 30985619
  99. Latysheva A, Emblem KE, Brandal P, Vik-Mo EO, Pahnke J, Røysland K, Hald JK, Server A (2019)
    Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach
    Neuroradiology, 61 (5), 545-555
    DOI 10.1007/s00234-019-02173-5, PubMed 30712139
  100. Lie HC, Rueegg CS, Fosså SD, Loge JH, Ruud E, Kiserud CE (2019)
    Limited evidence of non-response bias despite modest response rate in a nationwide survey of long-term cancer survivors-results from the NOR-CAYACS study
    J Cancer Surviv, 13 (3), 353-363
    DOI 10.1007/s11764-019-00757-x, PubMed 30993649
  101. Lilleby O, Hernes E, Lilleby W (2019)
    Metastatic-directed therapy using PSMA-PET/CT at PSA relapse
    Urol Case Rep, 27, 100992
    DOI 10.1016/j.eucr.2019.100992, PubMed 31453108
  102. Lilleheie I, Debesay J, Bye A, Bergland A (2019)
    Experiences of elderly patients regarding participation in their hospital discharge: a qualitative metasummary
    BMJ Open, 9 (11), e025789
    DOI 10.1136/bmjopen-2018-025789, PubMed 31685492
  103. Lindholm EM, Ragle Aure M, Haugen MH, Kleivi Sahlberg K, Kristensen VN, Nebdal D, Børresen-Dale AL, Lingjaerde OC, Engebraaten O (2019)
    miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
    Mol Oncol, 13 (10), 2278-2296
    DOI 10.1002/1878-0261.12561, PubMed 31402562
  104. Lockmer S, Østenstad B, Hagberg H, Holte H, Wahlin BE, Wader KF, Smedby KE, Brown P, Kimby E (2019)
    Reply to M. Sorigue et al
    J Clin Oncol, 37 (9), 759-760
    DOI 10.1200/JCO.18.02362, PubMed 30735430
  105. Lockmer S, Ren W, Brodtkorb M, Østenstad B, Wahlin BE, Pan-Hammarström Q, Kimby E (2019)
    M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy
    Br J Haematol, 188 (2), 259-267
    DOI 10.1111/bjh.16159, PubMed 31423576
  106. Løhre ET, Thronæs M, Brunelli C, Kaasa S, Klepstad P (2019)
    An in-hospital clinical care pathway with integrated decision support for cancer pain management reduced pain intensity and needs for hospital stay
    Support Care Cancer, 28 (2), 671-682
    DOI 10.1007/s00520-019-04836-8, PubMed 31123870
  107. Long GV, Dummer R, Schadendorf D, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Haas T, Shilkrut M, Gasal E, Kefford R, Kirkwood JM, Hauschild A (2019)
    Reply to E. Hindié and K.R. Hess
    J Clin Oncol, 37 (15), 1356-1358
    DOI 10.1200/JCO.19.00004, PubMed 30939092
  108. Lund-Andersen C, Nakken S, Nygård S, Fromm B, Aasheim LB, Davidson B, Julsrud L, Abrahamsen TW, Kristensen AT, Dybdahl B, Larsen SG, Hovig E, Flatmark K (2019)
    Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
    Cold Spring Harb Mol Case Stud, 5 (2)
    DOI 10.1101/mcs.a003566, PubMed 30862609
  109. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2019)
    Adult outcome after neurosurgical treatment of brain tumours in the first year of life: long-term follow-up of a single consecutive institutional series of 34 patients
    Acta Neurochir (Wien), 161 (9), 1793-1798
    DOI 10.1007/s00701-019-04014-z, PubMed 31309304
  110. Lundar T, Due-Tønnessen BJ, Frič R, Krossnes B, Brandal P, Stensvold E, Due-Tønnessen P (2019)
    Neurosurgical treatment of pediatric pleomorphic xanthoastrocytomas: long-term follow-up of a single-institution, consecutive series of 12 patients
    J Neurosurg Pediatr, 23 (4), 512-516
    DOI 10.3171/2018.11.PEDS18449, PubMed 30738389
  111. Lunde P, Bye A, Bergland A, Nilsson BB (2019)
    Effects of individualized follow-up with a smartphone-application after cardiac rehabilitation: protocol of a randomized controlled trial
    BMC Sports Sci Med Rehabil, 11, 34
    DOI 10.1186/s13102-019-0148-2, PubMed 31768261
  112. Lunde P, Nilsson BB, Bergland A, Bye A (2019)
    Feasibility of a Mobile Phone App to Promote Adherence to a Heart-Healthy Lifestyle: Single-Arm Study
    JMIR Form Res, 3 (2), e12679
    DOI 10.2196/12679, PubMed 31066684
  113. Maaland AF, Heyerdahl H, O'Shea A, Eiriksdottir B, Pascal V, Andersen JT, Kolstad A, Dahle J (2019)
    Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003
    Eur J Nucl Med Mol Imaging, 46 (11), 2311-2321
    DOI 10.1007/s00259-019-04417-1, PubMed 31309259
  114. Mahmood JI, Grotmol KS, Tesli M, Moum T, Andreassen O, Tyssen R (2019)
    Life satisfaction in Norwegian medical doctors: a 15-year longitudinal study of work-related predictors
    BMC Health Serv Res, 19 (1), 729
    DOI 10.1186/s12913-019-4599-7, PubMed 31640717
  115. Meltzer S, Bakke KM, Rød KL, Negård A, Flatmark K, Solbakken AM, Kristensen AT, Fuglestad AJ, Kersten C, Dueland S, Seierstad T, Hole KH, Lyckander LG, Larsen FO, Schou JV, Patrick Brown D, Abrahamsson H, Redalen KR, Ree AH (2019)
    Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
    Clin Transl Radiat Oncol, 21, 5-10
    DOI 10.1016/j.ctro.2019.11.006, PubMed 31872084
  116. Meltzer S, Bjørnetrø T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR (2019)
    Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
    Transl Oncol, 12 (8), 1038-1044
    DOI 10.1016/j.tranon.2019.04.014, PubMed 31146167
  117. Mensali N, Dillard P, Hebeisen M, Lorenz S, Theodossiou T, Myhre MR, Fåne A, Gaudernack G, Kvalheim G, Myklebust JH, Inderberg EM, Wälchli S (2019)
    NK cells specifically TCR-dressed to kill cancer cells
    EBioMedicine, 40, 106-117
    DOI 10.1016/j.ebiom.2019.01.031, PubMed 30665853
  118. Mensali N, Grenov A, Pati NB, Dillard P, Myhre MR, Gaudernack G, Kvalheim G, Inderberg EM, Bakke O, Wälchli S (2019)
    Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
    Oncoimmunology, 8 (3), 1558663
    DOI 10.1080/2162402X.2018.1558663, PubMed 30723591
  119. Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2019)
    Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
    Cancer Immunol Immunother, 68 (8), 1235-1243
    DOI 10.1007/s00262-019-02356-2, PubMed 31214732
  120. Moan JM, Amdal CD, Malinen E, Svestad JG, Bogsrud TV, Dale E (2019)
    The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status
    Radiother Oncol, 140, 54-61
    DOI 10.1016/j.radonc.2019.05.019, PubMed 31177043
  121. Nabel CS, Sameroff S, Shilling D, Alapat D, Ruth JR, Kawano M, Sato Y, Stone K, Spetalen S, Valdivieso F, Feldman MD, Chadburn A, Fosså A, van Rhee F, Lipkin WI, Fajgenbaum DC (2019)
    Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease
    PLoS One, 14 (6), e0218660
    DOI 10.1371/journal.pone.0218660, PubMed 31242229
  122. Namløs HM, Boye K, Meza-Zepeda LA (2019)
    Cell-free DNA in blood as a noninvasive insight into the sarcoma genome
    Mol Aspects Med, 72, 100827
    DOI 10.1016/j.mam.2019.10.004, PubMed 31703948
  123. Nathan P, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R et al. (2019)
    Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)
    Eur J Cancer, 119, 168-178
    DOI 10.1016/j.ejca.2019.07.010, PubMed 31445199
  124. Nilssen Y, Brustugun OT, Tandberg Eriksen M, Gulbrandsen J, Skaaheim Haug E, Naume B, Møller B (2019)
    Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway
    Cancer Epidemiol, 61, 59-69
    DOI 10.1016/j.canep.2019.05.004, PubMed 31153048
  125. Nomden CN, Pötter R, de Leeuw AAC, Tanderup K, Lindegaard JC, Schmid MP, Fortin I, Haie-Meder C, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, Van Der Steen Banasik E, Van Limbergen E, Jürgenliemk-Schulz IM, EMBRACE Collaborative Group (2019)
    Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort
    Radiother Oncol, 134, 185-190
    DOI 10.1016/j.radonc.2019.02.007, PubMed 31005214
  126. Nome ME, Euceda LR, Jabeen S, Debik J, Bathen TF, Giskeødegård GF, Taskén KA, Maelandsmo GM, Halvorsen B, Yndestad A, Borgen E, Garred Ø, Aukrust P, Ueland T, Engebraaten O, Kristensen VN, Tekpli X (2019)
    Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers
    Int J Cancer, 146 (1), 223-235
    DOI 10.1002/ijc.32638, PubMed 31444972
  127. Nordvik Ø, Heggdal POL, Brännström JK, Hjermstad MJ, Aarstad AK, Aarstad HJ (2019)
    Quality of life in persons with hearing loss: a study of patients referred to an audiological service
    Int J Audiol, 58 (11), 696-703
    DOI 10.1080/14992027.2019.1627010, PubMed 31195860
  128. Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T (2019)
    Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
    Clin Exp Immunol, 197 (1), 74-82
    DOI 10.1111/cei.13283, PubMed 30821848
  129. Nygård S, Lingjærde OC, Caldas C, Hovig E, Børresen-Dale AL, Helland Å, Haakensen VD (2019)
    PathTracer: High-sensitivity detection of differential pathway activity in tumours
    Sci Rep, 9 (1), 16332
    DOI 10.1038/s41598-019-52529-3, PubMed 31704995
  130. Olsen JA, Brunborg C, Steinberg M, Persse D, Sterz F, Lozano M, Westfall M, van Grunsven PM, Lerner EB, Wik L (2019)
    Survival to hospital discharge with biphasic fixed 360 joules versus 200 escalating to 360 joules defibrillation strategies in out-of-hospital cardiac arrest of presumed cardiac etiology
    Resuscitation, 136, 112-118
    DOI 10.1016/j.resuscitation.2019.01.020, PubMed 30708074
  131. Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Jørgensen LH, Bjøro T (2019)
    The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway
    Eur Thyroid J, 8 (3), 159-166
    DOI 10.1159/000499018, PubMed 31259158
  132. Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M et al. (2019)
    Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
    Lancet, 394 (10216), 2271-2281
    DOI 10.1016/S0140-6736(19)33008-9, PubMed 31868632
  133. Ricchini F, Caraceni A, Zecca E, Pigni A, Centurioni F, Manzoni A, Kaasa S, Brunelli C (2019)
    Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial
    J Pain Symptom Manage, 58 (4), 587-595
    DOI 10.1016/j.jpainsymman.2019.06.016, PubMed 31233843
  134. Richartz N, Duthil E, Ford A, Naderi EH, Bhagwat S, Gilljam KM, Burman MM, Ruud E, Blomhoff HK, Skah S (2019)
    Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model
    Blood Adv, 3 (21), 3181-3190
    DOI 10.1182/bloodadvances.2019000473, PubMed 31698450
  135. Røen I, Stifoss-Hanssen H, Grande G, Kaasa S, Sand K, Knudsen AK (2019)
    Supporting carers: health care professionals in need of system improvements and education - a qualitative study
    BMC Palliat Care, 18 (1), 58
    DOI 10.1186/s12904-019-0444-3, PubMed 31311536
  136. Röhrl K, Guren MG, Astrup GL, Småstuen MC, Rustøen T (2019)
    High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study
    Eur J Oncol Nurs, 44, 101679
    DOI 10.1016/j.ejon.2019.101679, PubMed 31751848
  137. Röhrl K, Guren MG, Småstuen MC, Rustøen T (2019)
    Symptoms during chemotherapy in colorectal cancer patients
    Support Care Cancer, 27 (8), 3007-3017
    DOI 10.1007/s00520-018-4598-y, PubMed 30607676
  138. Rud E, Langberg CW, Baco E, Lauritzen P, Sandbæk G (2019)
    MRI in the Follow-up of Testicular Cancer: Less is More
    Anticancer Res, 39 (6), 2963-2968
    DOI 10.21873/anticanres.13427, PubMed 31177136
  139. Rusten E, Rekstad BL, Undseth C, Klotz D, Hernes E, Guren MG, Malinen E (2019)
    Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors
    Br J Radiol, 92 (1097), 20181006
    DOI 10.1259/bjr.20181006, PubMed 30810343
  140. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM et al. (2019)
    Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
    Eur Urol, 77 (1), 3-10
    DOI 10.1016/j.eururo.2019.03.022, PubMed 30992160
  141. Sandmael JA, Sand K, Bye A, Solheim TS, Oldervoll L, Helvik AS (2019)
    Nutritional experiences in head and neck cancer patients
    Eur J Cancer Care (Engl), 28 (6), e13168
    DOI 10.1111/ecc.13168, PubMed 31571296
  142. Schadendorf D, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R et al. (2019)
    Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)
    Eur J Cancer, 121, 144-153
    DOI 10.1016/j.ejca.2019.08.014, PubMed 31581055
  143. Schadendorf D, Hauschild A, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Lesimple T, Plummer R, Schachter J, Dasgupta K, Manson S, Koruth R, Mookerjee B, Kefford R, Dummer R, Kirkwood JM, Long GV (2019)
    Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial
    Lancet Oncol, 20 (5), 701-710
    DOI 10.1016/S1470-2045(18)30940-9, PubMed 30928620
  144. Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, Benoliel R, Cohen M, Cruccu G, Davis KD, Evers S, First M, Giamberardino MA, Hansson P, Kaasa S, Korwisi B, Kosek E, Lavand'homme P, Nicholas M, Nurmikko T, Perrot S, Raja SN, Rice ASC, Rowbotham MC, Schug S et al. (2019)
    The IASP classification of chronic pain for ICD-11: chronic neuropathic pain
    Pain, 160 (1), 53-59
    DOI 10.1097/j.pain.0000000000001365, PubMed 30586071
  145. Schou-Bredal I, Bonsaksen T, Heir T, Skogstad L, Lerdal A, Grimholt T, Ekeberg O (2019)
    Optimists report fewer physical and mental health conditions than pessimists in the general Norwegian population
    HEALTH PSYCHOL. REP., 7 (1), 9-18
  146. Shao B, Bjaanæs MM, Helland Å, Schütte C, Conrad T (2019)
    EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma
    PLoS One, 14 (1), e0204186
    DOI 10.1371/journal.pone.0204186, PubMed 30703089
  147. Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Milne RL, Schmidt MK, Pharoah PDP, Andrulis IL, Hunter DJ, Simard J, Easton DF, Zheng W, Breast Cancer Association Consortium (2019)
    Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
    Int J Epidemiol, 48 (3), 795-806
    DOI 10.1093/ije/dyy201, PubMed 30277539
  148. Sigurdardottir KR, Hjermstad MJ, Filbet M, Tricou C, McQuillan R, Costantini M, Autelitano C, Bennett MI, Haugen DF (2019)
    Pilot testing of the first version of the European Association for Palliative Care basic dataset: A mixed methods study
    Palliat Med, 33 (7), 832-849
    DOI 10.1177/0269216319844439, PubMed 31023149
  149. Simensen VC, Smeland KB, Kiserud CE, Dahl AA, Bersvendsen HS, Fluge Ø, Fagerli UM, Fosså A (2019)
    Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma
    Acta Oncol, 58 (9), 1315-1322
    DOI 10.1080/0284186X.2019.1637538, PubMed 31286808
  150. Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A et al. (2019)
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
    Head Neck, 41 (6), 1725-1737
    DOI 10.1002/hed.25609, PubMed 30636188
  151. Skaarud KJ, Veierød MB, Lergenmuller S, Bye A, Iversen PO, Tjønnfjord GE (2019)
    Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients
    Bone Marrow Transplant, 54 (12), 2102-2109
    DOI 10.1038/s41409-019-0638-6, PubMed 31455897
  152. Smeby J, Sveen A, Bergsland CH, Eilertsen IA, Danielsen SA, Eide PW, Hektoen M, Guren MG, Nesbakken A, Bruun J, Lothe RA (2019)
    Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
    ESMO Open, 4 (3), e000523
    DOI 10.1136/esmoopen-2019-000523, PubMed 31321083
  153. Smeby J, Sveen A, Eilertsen IA, Danielsen SA, Hoff AM, Eide PW, Johannessen B, Hektoen M, Skotheim RI, Guren MG, Nesbakken A, Lothe RA (2019)
    Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
    Oncogenesis, 8 (6), 35
    DOI 10.1038/s41389-019-0141-3, PubMed 31092812
  154. Smedman TM, Guren TK, Line PD, Dueland S (2019)
    Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation - a retrospective study
    Transpl Int, 32 (11), 1144-1150
    DOI 10.1111/tri.13471, PubMed 31209941
  155. Solberg S, Nilssen Y, Brustugun OT, Grimsrud TK, Haram PM, Helbekkmo N, Helland Å, Hjelde HH, Jakobsen B, Møller B, Petersen M, Strand TE, Wahl SGF, Aanerud M, Fjellbirkeland L (2019)
    Increase in curative treatment and survival of lung cancer in Norway 2001-2016
    Eur J Epidemiol, 34 (10), 951-955
    DOI 10.1007/s10654-019-00536-z, PubMed 31313073
  156. Stankovic B, Bjørhovde HAK, Skarshaug R, Aamodt H, Frafjord A, Müller E, Hammarström C, Beraki K, Bækkevold ES, Woldbæk PR, Helland Å, Brustugun OT, Øynebråten I, Corthay A (2019)
    Immune Cell Composition in Human Non-small Cell Lung Cancer
    Front Immunol, 9, 3101
    DOI 10.3389/fimmu.2018.03101, PubMed 30774636
  157. Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M (2019)
    A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
    Haematologica, 104 (10), e460-e464
    DOI 10.3324/haematol.2018.209080, PubMed 30846496
  158. Stene GB, Balstad TR, Leer ASM, Bye A, Kaasa S, Fallon M, Laird B, Maddocks M, Solheim TS (2019)
    Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia
    Cancers (Basel), 11 (12)
    DOI 10.3390/cancers11121925, PubMed 31816924
  159. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
    Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
    Pediatr Blood Cancer, 66 (10), e27910
    DOI 10.1002/pbc.27910, PubMed 31264356
  160. Stikbakke E, Richardsen E, Knutsen T, Wilsgaard T, Giovannucci EL, McTiernan A, Eggen AE, Haugnes HS, Thune I (2019)
    Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study
    Int J Cancer, 147 (1), 84-92
    DOI 10.1002/ijc.32718, PubMed 31583707
  161. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
    Acta Oncol, 58 (10), 1416-1422
    DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
  162. Storås AH, Sanda MG, Garin O, Chang P, Patil D, Crociani C, Suarez JF, Cvancarova M, Loge JH, Fosså SD (2019)
    A prospective study of patient reported urinary incontinence among American, Norwegian and Spanish men 1 year after prostatectomy
    Asian J Urol, 7 (2), 161-169
    DOI 10.1016/j.ajur.2019.08.001, PubMed 32257809
  163. Sunde B, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Rouvelas I, Wang N, Lundell L, Lagergren P, Nilsson M (2019)
    Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy069, PubMed 30084992
  164. Sunde B, Klevebro F, Johar A, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Ajengui A, Lundell L, Lagergren P, Nilsson M (2019)
    Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial)
    Br J Surg, 106 (11), 1452-1463
    DOI 10.1002/bjs.11246, PubMed 31436322
  165. Switlyk MD, Salberg UB, Geier OM, Vlatkovic L, Lilleby W, Lyng H, Seierstad T (2019)
    PTEN Expression in Prostate Cancer: Relationship With Clinicopathologic Features and Multiparametric MRI Findings
    AJR Am J Roentgenol, 212 (6), 1206-1214
    DOI 10.2214/AJR.18.20743, PubMed 30888866
  166. Switlyk MD, Skeie AT, Lund-Iversen M, Østenstad B (2019)
    Magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in neurolymphomatosis: an uncommon presentation of diffuse large B cell lymphoma
    Ann Hematol, 99 (1), 203-205
    DOI 10.1007/s00277-019-03850-4, PubMed 31768676
  167. Tekpli X, Lien T, Røssevold AH, Nebdal D, Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M, Due EU, Svartdal LG, Sveli MAT, Garred Ø, OSBREAC, Frigessi A, Sahlberg KK, Sørlie T, Russnes HG, Naume B, Kristensen VN (2019)
    An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
    Nat Commun, 10 (1), 5499
    DOI 10.1038/s41467-019-13329-5, PubMed 31796750
  168. Theodossiou TA, Ali M, Grigalavicius M, Grallert B, Dillard P, Schink KO, Olsen CE, Wälchli S, Inderberg EM, Kubin A, Peng Q, Berg K (2019)
    Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
    NPJ Breast Cancer, 5, 13
    DOI 10.1038/s41523-019-0108-8, PubMed 30993194
  169. Thorkildsen J, Taksdal I, Bjerkehagen B, Haugland HK, Børge Johannesen T, Viset T, Norum OJ, Bruland Ø, Zaikova O (2019)
    Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort
    Acta Oncol, 58 (3), 273-282
    DOI 10.1080/0284186X.2018.1554260, PubMed 30632866
  170. Thronæs M, Balstad TR, Brunelli C, Løhre ET, Klepstad P, Vagnildhaug OM, Kaasa S, Knudsen AK, Solheim TS (2019)
    Pain management index (PMI)-does it reflect cancer patients' wish for focus on pain?
    Support Care Cancer, 28 (4), 1675-1684
    DOI 10.1007/s00520-019-04981-0, PubMed 31290020
  171. Tøndel H, Solberg A, Lydersen S, Jensen CA, Kaasa S, Lund JÅ (2019)
    Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer
    Clin Transl Radiat Oncol, 15, 113-117
    DOI 10.1016/j.ctro.2019.02.003, PubMed 30834350
  172. Torper J, Ansteinsson V, Lundeby T (2019)
    Moving the four habits model into dentistry. Development of a dental consultation model: Do dentists need an additional habit?
    Eur J Dent Educ, 23 (2), 220-229
    DOI 10.1111/eje.12421, PubMed 30659766
  173. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavand'homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ (2019)
    Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)
    Pain, 160 (1), 19-27
    DOI 10.1097/j.pain.0000000000001384, PubMed 30586067
  174. Trendowski MR, El-Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC, Feldman DR, Ardeshir-Rouhani-Fard S, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Hannigan R, Strathmann F, Einhorn LH, Fossa SD, Travis LB, Dolan ME (2019)
    Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy
    Clin Cancer Res, 25 (19), 5913-5924
    DOI 10.1158/1078-0432.CCR-19-0113, PubMed 31296530
  175. Vagnildhaug OM, Brunelli C, Hjermstad MJ, Strasser F, Baracos V, Wilcock A, Nabal M, Kaasa S, Laird B, Solheim TS (2019)
    A prospective study examining cachexia predictors in patients with incurable cancer
    BMC Palliat Care, 18 (1), 46
    DOI 10.1186/s12904-019-0429-2, PubMed 31164115
  176. Verkissen MN, Hjermstad MJ, Van Belle S, Kaasa S, Deliens L, Pardon K (2019)
    Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study
    PLoS One, 14 (10), e0222988
    DOI 10.1371/journal.pone.0222988, PubMed 31596849
  177. von Dobeln GA, Klevebro F, Jacobsen AB, Johannessen HO, Nielsen NH, Johnsen G, Hatlevoll I, Glenjen NI, Friesland S, Lundell L, Yu J, Nilsson M (2019)
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
    Dis. Esophagus, 32 (2), doy078
  178. Zucca E, Rondeau S, Vanazzi A, Østenstad B, Mey UJM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson AS, de Nully Brown P, Hagberg H, Ferreri AJM, Lohri A, Novak U, Zander T, Bersvendsen H, Bargetzi M, Mingrone W, Krasniqi F, Dirnhofer S, Hayoz S, Hawle H, Vilei SB, Ghielmini M et al. (2019)
    Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
    Blood, 134 (4), 353-362
    DOI 10.1182/blood-2018-10-879643, PubMed 31101627

Publications 2018

  1. Aas K, Fosså SD, Kvåle R, Møller B, Myklebust TÅ, Vlatkovic L, Müller S, Berge V (2018)
    Is time from diagnosis to radical prostatectomy associated with oncological outcomes?
    World J Urol, 37 (8), 1571-1580
    DOI 10.1007/s00345-018-2570-6, PubMed 30483947
  2. Ahlgren GM, Flodgren P, Tammela TLJ, Kellokumpu-Lehtinen P, Borre M, Angelsen A, Iversen JR, Sverrisdottir A, Jonsson E, Sengelov L, Investigators of the Scandinavian Prostate Cancer Study Number 12 (2018)
    Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
    Eur Urol, 73 (6), 870-876
    DOI 10.1016/j.eururo.2018.01.012, PubMed 29395502
  3. Ajithkumar T, Horan G, Padovani L, Thorp N, Timmermann B, Alapetite C, Gandola L, Ramos M, Van Beek K, Christiaens M, Lassen-Ramshad Y, Magelssen H, Nilsson K, Saran F, Rombi B, Kortmann R, Janssens GO, SIOPE BTG Radiotherapy Group (2018)
    SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
    Radiother Oncol, 128 (2), 192-197
    DOI 10.1016/j.radonc.2018.04.016, PubMed 29729847
  4. Ali AS, Grönberg M, Langer SW, Ladekarl M, Hjortland GO, Vestermark LW, Österlund P, Welin S, Grønbæk H, Knigge U, Sorbye H, Janson ET (2018)
    Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
    Med Oncol, 35 (4), 47
    DOI 10.1007/s12032-018-1103-x, PubMed 29511910
  5. Åsli LM, Myklebust TÅ, Kvaløy SO, Jetne V, Møller B, Levernes SG, Johannesen TB (2018)
    Factors influencing access to palliative radiotherapy: a Norwegian population-based study
    Acta Oncol, 57 (9), 1250-1258
    DOI 10.1080/0284186X.2018.1468087, PubMed 29706109
  6. Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F, Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M (2018)
    Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis
    Cancer Treat Rev, 66, 23-44
    DOI 10.1016/j.ctrv.2018.03.005, PubMed 29673922
  7. Belfrage A, Grotmol KS, Tyssen R, Moum T, Lien L (2018)
    Factors associated with low vs increased perceived mastery of clinical work over ten years of practice: a prospective study of Norwegian doctors
    BMC Med Educ, 18 (1), 116
    DOI 10.1186/s12909-018-1236-9, PubMed 29843695
  8. Belfrage ASV, Grotmol KS, Tyssen R, Moum T, Finset A, Isaksson Rø K, Lien L (2018)
    Factors influencing doctors' counselling on patients' lifestyle habits: a cohort study
    BJGP Open, 2 (3), bjgpopen18X101607
    DOI 10.3399/bjgpopen18X101607, PubMed 30564740
  9. Benitez Majano S, Di Girolamo C, Rachet B, Maringe C, Guren MG, Glimelius B, Iversen LH, Schnell EA, Lundqvist K, Christensen J, Morris M, Coleman MP, Walters S (2018)
    Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study
    Lancet Oncol, 20 (1), 74-87
    DOI 10.1016/S1470-2045(18)30646-6, PubMed 30545752
  10. Berger O, Grønberg BH, Loge JH, Kaasa S, Sand K (2018)
    Cancer patients' knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study
    BMC Cancer, 18 (1), 381
    DOI 10.1186/s12885-018-4164-5, PubMed 29614997
  11. Berner K, Johannesen TB, Hall KS, Bruland ØS (2018)
    Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study
    J Bone Oncol, 14, 002-2
    DOI 10.1016/j.jbo.2018.11.002, PubMed 30568874
  12. Berner K, Zaikova O, Johannesen TB, Hall KS, Bruland ØS (2018)
    Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway
    J Surg Oncol, 118 (1), 246-247
    DOI 10.1002/jso.25137, PubMed 30208205
  13. Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W et al. (2018)
    Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
    J Natl Cancer Inst, 110 (6), 560-567
    DOI 10.1093/jnci/djy018, PubMed 29659933
  14. Bjørnelv GMW, Dueland S, Line PD, Joranger P, Fretland ÅA, Edwin B, Sørbye H, Aas E (2018)
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver
    Br J Surg, 106 (1), 132-141
    DOI 10.1002/bjs.10962, PubMed 30325494
  15. Bøhn SH, Fosså SD, Wisløff T, Thorsen L (2018)
    Physical activity and associations with treatment-induced adverse effects among prostate cancer patients
    Support Care Cancer, 27 (3), 1001-1011
    DOI 10.1007/s00520-018-4389-5, PubMed 30094728
  16. Boland JW, Allgar V, Boland EG, Kaasa S, Hjermstad MJ, Johnson MJ (2018)
    Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study
    Palliat Med, 33 (2), 206-212
    DOI 10.1177/0269216318811011, PubMed 30404572
  17. Bonsaksen T, Grimholt TK, Skogstad L, Lerdal A, Ekeberg Ø, Heir T, Schou-Bredal I (2018)
    Self-diagnosed depression in the Norwegian general population - associations with neuroticism, extraversion, optimism, and general self-efficacy
    BMC Public Health, 18 (1), 1076
    DOI 10.1186/s12889-018-5990-8, PubMed 30157827
  18. Bonsaksen T, Lerdal A, Heir T, Ekeberg Ø, Skogstad L, Grimholt TK, Schou-Bredal I (2018)
    General self-efficacy in the Norwegian population: Differences and similarities between sociodemographic groups
    Scand J Public Health, 47 (7), 695-704
    DOI 10.1177/1403494818756701, PubMed 29417880
  19. Borchmann P, Fosså A, Długosz-Danecka M, Böll B, Dietlein M, Kobe C, Goergen H, Engert A (2018)
    The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered
    Hemasphere, 2 (3), e52
    DOI 10.1097/HS9.0000000000000052, PubMed 31723777
  20. Borgen E, Rypdal MC, Sosa MS, Renolen A, Schlichting E, Lønning PE, Synnestvedt M, Aguirre-Ghiso JA, Naume B (2018)
    NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
    Breast Cancer Res, 20 (1), 120
    DOI 10.1186/s13058-018-1049-0, PubMed 30322396
  21. Bousquet PA, Meltzer S, Sønstevold L, Esbensen Y, Dueland S, Flatmark K, Sitter B, Bathen TF, Seierstad T, Redalen KR, Eide L, Ree AH (2018)
    Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer
    Transl Oncol, 12 (1), 76-83
    DOI 10.1016/j.tranon.2018.09.010, PubMed 30273860
  22. Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T (2018)
    Genotype and risk of tumour rupture in gastrointestinal stromal tumour
    Br J Surg, 105 (2), e169-e175
    DOI 10.1002/bjs.10743, PubMed 29341147
  23. Boysen AK, Sørensen BS, Lefevre AC, Abrantes R, Johansen JS, Jensen BV, Schou JV, Larsen FO, Nielsen D, Taflin H, Gustavson B, Wettergren Y, Sorensen BS, Ree AH, Dueland S, Pallisgaard N, Spindler KL (2018)
    Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer
    Clin Chim Acta, 487, 107-111
    DOI 10.1016/j.cca.2018.09.029, PubMed 30240586
  24. Brændengen M, Glimelius B (2018)
    Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved? An update of the "Nordic" LARC study in non-resectable cancers
    Radiother Oncol, 127 (3), 392-395
    DOI 10.1016/j.radonc.2018.05.004, PubMed 29778486
  25. Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG (2018)
    Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
    Acta Oncol, 57 (9), 1159-1164
    DOI 10.1080/0284186X.2018.1464664, PubMed 29771169
  26. Brunvoll SH, Thune I, Frydenberg H, Flote VG, Bertheussen GF, Schlichting E, Bjerve KS, Hjartåker A (2018)
    Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment
    Nutr J, 17 (1), 94
    DOI 10.1186/s12937-018-0402-6, PubMed 30333016
  27. Brustugun OT, Grønberg BH, Fjellbirkeland L, Helbekkmo N, Aanerud M, Grimsrud TK, Helland Å, Møller B, Nilssen Y, Strand TE, Solberg SK (2018)
    Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016
    Lung Cancer, 122, 138-145
    DOI 10.1016/j.lungcan.2018.06.003, PubMed 30032822
  28. Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA (2018)
    Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
    Mol Oncol, 12 (9), 1639-1655
    DOI 10.1002/1878-0261.12347, PubMed 29900672
  29. Buffart LM, Sweegers MG, May AM, Chinapaw MJ, van Vulpen JK, Newton RU, Galvão DA, Aaronson NK, Stuiver MM, Jacobsen PB, Verdonck-de Leeuw IM, Steindorf K, Irwin ML, Hayes S, Griffith KA, Lucia A, Herrero-Roman F, Mesters I, van Weert E, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M et al. (2018)
    Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis
    J Natl Cancer Inst, 110 (11), 1190-1200
    DOI 10.1093/jnci/djy161, PubMed 30299508
  30. Carlino MS, Long GV, Schadendorf D, Robert C, Ribas A, Richtig E, Nyakas M, Caglevic C, Tarhini A, Blank C, Hoeller C, Bar-Sela G, Barrow C, Wolter P, Zhou H, Emancipator K, Jensen EH, Ebbinghaus S, Ibrahim N, Daud A (2018)
    Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
    Eur J Cancer, 101, 236-243
    DOI 10.1016/j.ejca.2018.06.034, PubMed 30096704
  31. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T et al. (2018)
    Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 29 (Suppl 4), iv68-iv78
    DOI 10.1093/annonc/mdy095, PubMed 29846513
  32. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T et al. (2018)
    Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 29 (Suppl 4), iv51-iv67
    DOI 10.1093/annonc/mdy096, PubMed 29846498
  33. Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S et al. (2018)
    Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 29 (Suppl 4), iv79-iv95
    DOI 10.1093/annonc/mdy310, PubMed 30285218
  34. Claassen YHM, Bastiaannet E, Hartgrink HH, Dikken JL, de Steur WO, Slingerland M, Verhoeven RHA, van Eycken E, de Schutter H, Lindblad M, Hedberg J, Johnson E, Hjortland GO, Jensen LS, Larsson HJ, Koessler T, Chevallay M, Allum WH, van de Velde CJH (2018)
    International comparison of treatment strategy and survival in metastatic gastric cancer
    BJS Open, 3 (1), 56-61
    DOI 10.1002/bjs5.103, PubMed 30734016
  35. Claassen YHM, Dikken JL, Hartgrink HH, de Steur WO, Slingerland M, Verhoeven RHA, van Eycken E, de Schutter H, Johansson J, Rouvelas I, Johnson E, Hjortland GO, Jensen LS, Larsson HJ, Allum WH, Portielje JEA, Bastiaannet E, van de Velde CJH (2018)
    North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis
    Eur J Surg Oncol, 44 (12), 1982-1989
    DOI 10.1016/j.ejso.2018.09.014, PubMed 30343998
  36. Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Rutten HJT, Portielje JEA, Liefers GJ, Holman FA, van de Velde CJH, Bastiaannet E (2018)
    Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison
    Br J Cancer, 119 (4), 517-522
    DOI 10.1038/s41416-018-0215-6, PubMed 30057408
  37. Da Broi M, Jahr G, Beiske K, Holte H, Meling TR (2018)
    Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL
    Blood Cells Mol Dis, 73, 25-32
    DOI 10.1016/j.bcmd.2018.08.005, PubMed 30217760
  38. Dale E, Waldeland E (2018)
    Proton therapy - a reality in Norway from 2023
    Tidsskr Nor Laegeforen, 138 (13)
    DOI 10.4045/tidsskr.18.0250, PubMed 30180494
  39. Davidson B, Bjørnerem M, Holth A, Hellesylt E, Hetland Falkenthal TE, Flørenes VA (2018)
    Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma
    Gynecol Oncol, 150 (1), 136-142
    DOI 10.1016/j.ygyno.2018.05.007, PubMed 29804637
  40. Davidson B, Holth A, Wang Z, Hellsylt E, Tropé CG, Hetland Falkenthal TE, Holm R (2018)
    Expression of 14-3-3 sigma and eta proteins is unrelated to survival in metastatic high-grade serous carcinoma
    APMIS, 126 (4), 309-313
    DOI 10.1111/apm.12816, PubMed 29464778
  41. Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E (2018)
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
    Bone Marrow Transplant, 53 (5), 657-660
    DOI 10.1038/s41409-018-0091-y, PubMed 29358600
  42. Digernes I, Grøvik E, Nilsen LB, Saxhaug C, Geier O, Reitan E, Sætre DO, Breivik B, Reese T, Jacobsen KD, Helland Å, Emblem KE (2018)
    Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
    Adv Radiat Oncol, 3 (4), 559-567
    DOI 10.1016/j.adro.2018.05.005, PubMed 30370356
  43. Dillard P, Köksal H, Inderberg EM, Wälchli S (2018)
    A Spheroid Killing Assay by CAR T Cells
    J Vis Exp (142)
    DOI 10.3791/58785, PubMed 30596389
  44. Dueland S, Foss A, Solheim JM, Hagness M, Line PD (2018)
    Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma
    Br J Surg, 105 (6), 736-742
    DOI 10.1002/bjs.10769, PubMed 29532908
  45. Dueland S, Line PD, Hagness M, Foss A, Andersen MH (2018)
    Long-term quality of life after liver transplantation for non-resectable colorectal metastases confined to the liver
    BJS Open, 3 (2), 180-185
    DOI 10.1002/bjs5.50116, PubMed 30957065
  46. Eichenauer DA, André M, Johnson P, Fossa A, Casasnovas O, Engert A (2018)
    Controversies in the Treatment of Classical Hodgkin Lymphoma
    Hemasphere, 2 (5), e149
    DOI 10.1097/HS9.0000000000000149, PubMed 30887012
  47. Eide HA, Knudtsen IS, Sandhu V, Løndalen AM, Halvorsen AR, Abravan A, Kure EH, Bogsrud TV, Brustugun OT, Kyte JA, Malinen E, Helland Å (2018)
    Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
    Adv Radiat Oncol, 3 (2), 130-138
    DOI 10.1016/j.adro.2017.12.007, PubMed 29904737
  48. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
    Patients know their own health best
    Tidsskr. Nor. Laegeforen., 138 (8), 716-718
  49. Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Pedersen LB, Geisler CH, Jerkeman M, Grønbæk K (2018)
    Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma
    Haematologica, 103 (11), e541-e543
    DOI 10.3324/haematol.2018.194399, PubMed 29794145
  50. Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T et al. (2018)
    Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
    Lancet Haematol, 5 (8), e359-e367
    DOI 10.1016/S2352-3026(18)30090-5, PubMed 30078408
  51. Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, Fossa SD, Platinum Study Group (2018)
    Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score
    Clin Genitourin Cancer, 16 (4), e761-e769
    DOI 10.1016/j.clgc.2018.01.011, PubMed 29534941
  52. Filippov-Levy N, Cohen-Schussheim H, Tropé CG, Hetland Falkenthal TE, Smith Y, Davidson B, Reich R (2018)
    Expression and clinical role of long non-coding RNA in high-grade serous carcinoma
    Gynecol Oncol, 148 (3), 559-566
    DOI 10.1016/j.ygyno.2018.01.004, PubMed 29310950
  53. Fokdal L, Tanderup K, Pötter R, Sturdza A, Kirchheiner K, Chargari C, Jürgenliemk-Schulz IM, Segedin B, Tan LT, Hoskin P, Mahantshetty U, Bruheim K, Rai B, Kirisits C, Lindegaard JC, EMBRACE Collaborative Group (2018)
    Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies
    Int J Radiat Oncol Biol Phys, 103 (4), 887-894
    DOI 10.1016/j.ijrobp.2018.11.006, PubMed 30419309
  54. Fossa SD, Fung C, Dahl AA (2018)
    Late adverse outcomes after treatment of testicular cancer
    Onkologe, 24 2, S104-S109
  55. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P et al. (2018)
    Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
    JAMA Oncol, 4 (9), e180219
    DOI 10.1001/jamaoncol.2018.0219, PubMed 29800950
  56. Froehlich K, Stensheim H, Markert UR, Turowski G (2018)
    Breast carcinoma in pregnancy with spheroid-like placental metastases-a case report
    APMIS, 126 (5), 448-452
    DOI 10.1111/apm.12827, PubMed 29665170
  57. Fung C, Dinh P, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB (2018)
    Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
    Adv Urol, 2018, 8671832
    DOI 10.1155/2018/8671832, PubMed 29670654
  58. Gandara DR, von Pawel J, Mazieres J, Sullivan R, Helland Å, Han JY, Ponce Aix S, Rittmeyer A, Barlesi F, Kubo T, Park K, Goldschmidt J, Gandhi M, Yun C, Yu W, Matheny C, He P, Sandler A, Ballinger M, Fehrenbacher L (2018)
    Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
    J Thorac Oncol, 13 (12), 1906-1918
    DOI 10.1016/j.jtho.2018.08.2027, PubMed 30217492
  59. George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, Maas L, Müller C, Dahmen I, Delhomme TM, Ardin M, Leblay N, Byrnes G, Sun R, De Reynies A, McLeer-Florin A, Bosco G, Malchers F, Menon R, Altmüller J, Becker C, Nürnberg P, Achter V, Lang U, Schneider PM et al. (2018)
    Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
    Nat Commun, 9 (1), 1048
    DOI 10.1038/s41467-018-03099-x, PubMed 29535388
  60. Georgi TW, Kluge R, Kurch L, Chavdarova L, Hasenclever D, Stoevesandt D, Pelz T, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Fosså A, Balwierz W, Attarbaschi A, Ammann RA, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Baumann J, Körholz D et al. (2018)
    18F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
    J Nucl Med, 59 (10), 1524-1530
    DOI 10.2967/jnumed.117.205633, PubMed 29653979
  61. Grønberg BH, Sjøblom B, Wentzel-Larsen T, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Bye A, Jordhøy M (2018)
    A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer
    Eur J Clin Nutr, 73 (7), 1069-1076
    DOI 10.1038/s41430-018-0325-5, PubMed 30254241
  62. Grotmol KS, Lie HC, Loge JH, Aass N, Haugen DF, Stone PC, Kaasa S, Hjermstad MJ (2018)
    Patients with advanced cancer and depression report a significantly higher symptom burden than non-depressed patients
    Palliat Support Care, 17 (2), PII S1478951517001183-149
    DOI 10.1017/S1478951517001183, PubMed 29317008
  63. Grut H, Revheim ME, Line PD, Dueland S (2018)
    Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
    Nucl Med Commun, 39 (7), 621-627
    DOI 10.1097/MNM.0000000000000843, PubMed 29683930
  64. Guren MG, Aagnes B, Nygård M, Dahl O, Møller B (2018)
    Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016
    Clin Colorectal Cancer, 18 (1), e96-e103
    DOI 10.1016/j.clcc.2018.10.001, PubMed 30415990
  65. Habberstad R, Frøseth TCS, Aass N, Abramova T, Baas T, Mørkeset ST, Caraceni A, Laird B, Boland JW, Rossi R, Garcia-Alonso E, Stensheim H, Loge JH, Hjermstad MJ, Bjerkeset E, Bye A, Lund JÅ, Solheim TS, Vagnildhaug OM, Brunelli C, Damås JK, Mollnes TE, Kaasa S, Klepstad P (2018)
    The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain
    BMC Palliat Care, 17 (1), 110
    DOI 10.1186/s12904-018-0362-9, PubMed 30266081
  66. Halvorsen AR, Sandhu V, Sprauten M, Flote VG, Kure EH, Brustugun OT, Helland Å (2018)
    Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
    Acta Oncol, 57 (9), 1225-1231
    DOI 10.1080/0284186X.2018.1465585, PubMed 29683761
  67. Haugnes HS, Stenklev NC, Brydøy M, Dahl O, Wilsgaard T, Laukli E, Fosså SD (2018)
    Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
    Acta Oncol, 57 (8), 1075-1083
    DOI 10.1080/0284186X.2018.1433323, PubMed 29384420
  68. Hauschild A, Dummer R, Schadendorf D, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Haas T, Shilkrut M, Gasal E, Kefford R, Kirkwood JM, Long GV (2018)
    Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma
    J Clin Oncol, 36 (35), 3441-3449
    DOI 10.1200/JCO.18.01219, PubMed 30343620
  69. Hayman J, Hole KH, Seierstad T, Perin J, DeWeese TL, Tran PT, Lilleby W (2018)
    Local failure is a dominant mode of recurrence in locally advanced and clinical node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
    Urol Oncol, 37 (4), 289.e19-289.e26
    DOI 10.1016/j.urolonc.2018.09.016, PubMed 30446451
  70. Heinrich D, Bruland Ø, Guise TA, Suzuki H, Sartor O (2018)
    Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker
    Future Oncol, 14 (24), 2543-2556
    DOI 10.2217/fon-2018-0087, PubMed 29925281
  71. Helland A (2018)
    Groundbreaking basic research
    Tidsskr. Nor. Laegeforen., 138 (20), 1905
  72. Hesla AC, Bruland ØS, Jebsen N, Styring E, Eriksson S, Tsagozis P (2018)
    Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
    J Bone Oncol, 14, 100216
    DOI 10.1016/j.jbo.2018.100216, PubMed 30666289
  73. Hjelle LV, Gundersen POM, Hellesnes R, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Bremnes RM, Haugnes HS (2018)
    Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
    Acta Oncol, 57 (10), 1392-1400
    DOI 10.1080/0284186X.2018.1473641, PubMed 29775128
  74. Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V (2018)
    Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
    Genome Med, 10 (1), 92
    DOI 10.1186/s13073-018-0601-y, PubMed 30497530
  75. Høland M, Kolberg M, Danielsen SA, Bjerkehagen B, Eilertsen IA, Hektoen M, Mandahl N, van den Berg E, Smeland S, Mertens F, Sundby Hall K, Picci P, Sveen A, Lothe RA (2018)
    Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53
    Mod Pathol, 31 (11), 1694-1707
    DOI 10.1038/s41379-018-0074-y, PubMed 29946184
  76. Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ, Skovlund E, Lekven J, Schneede J, Tveit KM, Vatn M, Ursin G, Hoff G, NORCCAP Study Group† (2018)
    Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial
    Ann Intern Med, 168 (11), 775-782
    DOI 10.7326/M17-1441, PubMed 29710125
  77. Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K (2018)
    Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
    Br J Surg, 106 (4), 419-426
    DOI 10.1002/bjs.11027, PubMed 30507040
  78. Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K (2018)
    Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
    Ann Surg Oncol, 25 (5), 1133-1139
    DOI 10.1245/s10434-018-6353-5, PubMed 29435684
  79. Holte H, Beiske K, Boyle M, Trøen G, Blaker YN, Myklebust J, Kvaløy S, Rosenwald A, Lingjaerde OC, Rimsza LM, Smeland EB, Scott DW, Kolstad A (2018)
    The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy
    Br J Haematol, 183 (2), 225-234
    DOI 10.1111/bjh.15518, PubMed 30080252
  80. Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, Clarke N, Cohn-Cedermark G, Daugaard G, Dieckmann KP, Fizazi K, Fossa S, Germa-Lluch JR, Giannatempo P, Gietema JA, Gillessen S, Haugnes HS, Heidenreich A, Hemminki K, Huddart R, Jewett MAS, Joly F, Lauritsen J, Lorch A, Necchi A et al. (2018)
    ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
    Ann. Oncol., 29 (8), 1658-1686
  81. Ihle MA, Huss S, Jeske W, Hartmann W, Merkelbach-Bruse S, Schildhaus HU, Büttner R, Sihto H, Sundby Hall K, Eriksson M, Reichardt P, Joensuu H, Wardelmann E (2018)
    Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment
    PLoS One, 13 (2), e0193048
    DOI 10.1371/journal.pone.0193048, PubMed 29451912
  82. Jabeen S, Espinoza JA, Torland LA, Zucknick M, Kumar S, Haakensen VD, Lüders T, Engebraaten O, Børresen-Dale AL, Kyte JA, Gromov P, Naume B, Kristensen V, Gromova I, Tekpli X (2018)
    Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics
    Oncoimmunology, 8 (2), e1537691
    DOI 10.1080/2162402X.2018.1537691, PubMed 30713794
  83. Jabeen S, Zucknick M, Nome M, Dannenfelser R, Fleischer T, Kumar S, Lüders T, von der Lippe Gythfeldt H, Troyanskaya O, Kyte JA, Børresen-Dale AL, Naume B, Tekpli X, Engebraaten O, Kristensen V (2018)
    Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab
    Oncoimmunology, 7 (11), e1457598
    DOI 10.1080/2162402X.2018.1457598, PubMed 30377556
  84. Jacobsen EL, Bye A, Aass N, Fosså SD, Grotmol KS, Kaasa S, Loge JH, Moum T, Hjermstad MJ (2018)
    Correction to: Norwegian reference values for the Short-Form Health Survey 36: development over time
    Qual Life Res, 27 (5), 1213-1215
    DOI 10.1007/s11136-017-1708-0, PubMed 29168123
  85. Jahr G, Broi MD, Holte H, Beiske K, Meling TR (2018)
    Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma
    Brain Behav, 8 (3), e00928
    DOI 10.1002/brb3.928, PubMed 29541540
  86. Jahr G, Da Broi M, Holte H, Beiske K, Meling TR (2018)
    The role of surgery in intracranial PCNSL
    Neurosurg Rev, 41 (4), 1037-1044
    DOI 10.1007/s10143-018-0946-0, PubMed 29383600
  87. Jakobsen G, Engstrøm M, Fayers P, Hjermstad MJ, Kaasa S, Kloke M, Sabatowski R, Klepstad P (2018)
    Sleep quality with WHO Step III opioid use for cancer pain
    BMJ Support Palliat Care, 9 (3), 307-315
    DOI 10.1136/bmjspcare-2017-001399, PubMed 30018128
  88. Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I (2018)
    MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas
    Cancer Genomics Proteomics, 15 (6), 437-446
    DOI 10.21873/cgp.20102, PubMed 30343277
  89. Johansen S, Hauge IHR, Hogg P, England A, Lança L, Gunn C, Sanderud A (2018)
    Are Antimony-Bismuth Aprons as Efficient as Lead Rubber Aprons in Providing Shielding against Scattered Radiation?
    J Med Imaging Radiat Sci, 49 (2), 201-206
    DOI 10.1016/j.jmir.2018.02.002, PubMed 32074039
  90. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM (2018)
    Added value of F-18-FDG PET-CT in staging of Ewing sarcoma in children and young adults
    Eur. J. Hybrid Imag., 2 (1), 13
  91. Jordan K, Aapro M, Kaasa S, Ripamonti CI, Scotté F, Strasser F, Young A, Bruera E, Herrstedt J, Keefe D, Laird B, Walsh D, Douillard JY, Cervantes A (2018)
    European Society for Medical Oncology (ESMO) position paper on supportive and palliative care
    Ann Oncol, 29 (1), 36-43
    DOI 10.1093/annonc/mdx757, PubMed 29253069
  92. Kaasa S, Loge JH (2018)
    Early integration of palliative care-new evidence and old questions
    Lancet Oncol, 19 (3), 280-281
    DOI 10.1016/S1470-2045(18)30061-5, PubMed 29402702
  93. Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, Brunelli C, Caraceni A, Cervantes A, Currow DC, Deliens L, Fallon M, Gómez-Batiste X, Grotmol KS, Hannon B, Haugen DF, Higginson IJ, Hjermstad MJ, Hui D, Jordan K, Kurita GP, Larkin PJ, Miccinesi G, Nauck F, Pribakovic R et al. (2018)
    Integration of oncology and palliative care: a Lancet Oncology Commission
    Lancet Oncol, 19 (11), e588-e653
    DOI 10.1016/S1470-2045(18)30415-7, PubMed 30344075
  94. Kalanxhi E, Meltzer S, Schou JV, Larsen FO, Dueland S, Flatmark K, Jensen BV, Hole KH, Seierstad T, Redalen KR, Nielsen DL, Ree AH (2018)
    Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
    Br J Cancer, 118 (10), 1322-1328
    DOI 10.1038/s41416-018-0085-y, PubMed 29695770
  95. Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB, Platinum Study Group (2018)
    Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study
    J Clin Oncol, 36 (15), 1505-1512
    DOI 10.1200/JCO.2017.77.0735, PubMed 29617189
  96. Kiserud CE, Dahl AA, Fosså SD (2018)
    Cancer Survivorship in Adults
    Recent Results Cancer Res, 210, 123-143
    DOI 10.1007/978-3-319-64310-6_8, PubMed 28924683
  97. Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV et al. (2018)
    Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
    JAMA, 319 (9), 896-905
    DOI 10.1001/jama.2018.0587, PubMed 29509865
  98. Krogstad H, Sundt-Hansen SM, Hjermstad MJ, Hågensen LÅ, Kaasa S, Loge JH, Raj SX, Steinsbekk A, Sand K (2018)
    Usability testing of EirV3-a computer-based tool for patient-reported outcome measures in cancer
    Support Care Cancer, 27 (5), 1835-1844
    DOI 10.1007/s00520-018-4435-3, PubMed 30173402
  99. Kvæl LAH, Debesay J, Langaas A, Bye A, Bergland A (2018)
    A Concept Analysis of Patient Participation in Intermediate Care
    Patient Educ Couns, 101 (8), 1337-1350
    DOI 10.1016/j.pec.2018.03.005, PubMed 29551564
  100. Lampen MH, Uchtenhagen H, Blom K, Varnaitė R, Pakalniene J, Dailidyte L, Wälchli S, Lindquist L, Mickiene A, Michaëlsson J, Schumacher TN, Ljunggren HG, Sandberg JK, Achour A, Gredmark-Russ S (2018)
    Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection
    Immunohorizons, 2 (6), 172-184
    DOI 10.4049/immunohorizons.1800029, PubMed 31022685
  101. Landmark T, Dale O, Romundstad P, Woodhouse A, Kaasa S, Borchgrevink PC (2018)
    Development and course of chronic pain over 4 years in the general population: The HUNT pain study
    Eur J Pain, 22 (9), 1606-1616
    DOI 10.1002/ejp.1243, PubMed 29754398
  102. Langberg MK, Berglund-Nord C, Cohn-Cedermark G, Haugnes HS, Tandstad T, Langberg CW (2018)
    Imatinib may reduce chemotherapy-induced pneumonitis. A report on four cases from the SWENOTECA
    Acta Oncol, 57 (10), 1401-1406
    DOI 10.1080/0284186X.2018.1479072, PubMed 29869895
  103. Larkin J, Brown MP, Arance AM, Hauschild A, Queirolo P, Vecchio MD, Ascierto PA, Krajsová I, Schachter J, Neyns B, Garbe C, Sileni VC, Mandalà M, Gogas H, Espinosa E, Hospers G, Lorigan P, Nyakas M, Guminski A, Liszkay G, Rutkowski P, Miller W, Donica M, Makrutzki M, Blank C (2018)
    An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system
    Eur J Cancer, 107, 175-185
    DOI 10.1016/j.ejca.2018.11.018, PubMed 30580112
  104. Latysheva A, Emblem KE, Server A, Brandal P, Meling TR, Pahnke J, Hald JK (2018)
    Survival Associations Using Perfusion and Diffusion Magnetic Resonance Imaging in Patients With Histologic and Genetic Defined Diffuse Glioma World Health Organization Grades II and III
    J Comput Assist Tomogr, 42 (5), 807-815
    DOI 10.1097/RCT.0000000000000742, PubMed 29901512
  105. Line PD, Hagness M, Dueland S (2018)
    The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases
    Can J Gastroenterol Hepatol, 2018, 8547940
    DOI 10.1155/2018/8547940, PubMed 29623266
  106. Lockmer S, Østenstad B, Hagberg H, Holte H, Johansson AS, Wahlin BE, Wader KF, Steen CB, Meyer P, Maisenhølder M, Smedby KE, Brown P, Kimby E (2018)
    Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up
    J Clin Oncol, 36 (33), 3315-+
    DOI 10.1200/JCO.18.00262, PubMed 30285560
  107. Lofterød T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, Eggen AE, McTiernan A, Aziz S, Wist EA, Stensvold A, Reitan JB, Akslen LA, Thune I (2018)
    Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes
    BMC Cancer, 18 (1), 654
    DOI 10.1186/s12885-018-4568-2, PubMed 29902993
  108. Løhre ET, Hjermstad MJ, Brunelli C, Knudsen AK, Kaasa S, Klepstad P (2018)
    Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study
    Pain Ther, 7 (2), 193-203
    DOI 10.1007/s40122-018-0107-8, PubMed 30415462
  109. Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P, Donati D, Hompland I, Boye K (2018)
    Pazopanib in relapsed osteosarcoma patients: report on 15 cases
    Acta Oncol, 58 (1), 124-128
    DOI 10.1080/0284186X.2018.1503714, PubMed 30207179
  110. Lundar T, Due-Tønnessen BJ, Fric R, Egge A, Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2018)
    Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
    Acta Neurochir (Wien), 160 (6), 1207-1214
    DOI 10.1007/s00701-018-3550-8, PubMed 29680921
  111. Lunde P, Nilsson BB, Bergland A, Kværner KJ, Bye A (2018)
    The Effectiveness of Smartphone Apps for Lifestyle Improvement in Noncommunicable Diseases: Systematic Review and Meta-Analyses
    J Med Internet Res, 20 (5), e162
    DOI 10.2196/jmir.9751, PubMed 29728346
  112. Madeira T, Peixoto-Plácido C, Sousa-Santos N, Santos O, Alarcão V, Goulão B, Mendonça N, Nicola PJ, Yngve A, Bye A, Bergland A, Amaral TF, Lopes C, Gorjão Clara J (2018)
    Malnutrition among older adults living in Portuguese nursing homes: the PEN-3S study
    Public Health Nutr, 22 (3), 486-497
    DOI 10.1017/S1368980018002318, PubMed 30319081
  113. Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF (2018)
    Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
    Br J Cancer, 119 (9), 1144-1154
    DOI 10.1038/s41416-018-0211-x, PubMed 30401977
  114. Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvåg HL, Grøholt KK, Dueland S, Flatmark K, Larsen SG (2018)
    Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
    Eur J Surg Oncol, 44 (8), 1226-1232
    DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115
  115. Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Auer PL, Auvinen P, Barrdahl M, Beane Freeman LE, Beckmann MW et al. (2018)
    Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
    Am J Hum Genet, 104 (1), 21-34
    DOI 10.1016/j.ajhg.2018.11.002, PubMed 30554720
  116. Meling TR, Latysheva A, Da Broi M, Jahr G, Holte H, Beiske K, Emblem KE (2018)
    Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
    Neuroradiology, 60 (7), 703-713
    DOI 10.1007/s00234-018-2038-9, PubMed 29804159
  117. Moberg IO, Schou Bredal I, Schneider MR, Tønseth KA, Schlichting E (2018)
    Complications, risk factors, and patients-reported outcomes after skin-sparing mastectomy followed by breast reconstruction in women with BRCA mutations
    J Plast Surg Hand Surg, 52 (4), 234-239
    DOI 10.1080/2000656X.2018.1470093, PubMed 29741462
  118. Mohammed Ali A, Hogg P, Johansen S, England A (2018)
    Construction and validation of a low cost paediatric pelvis phantom
    Eur J Radiol, 108, 84-91
    DOI 10.1016/j.ejrad.2018.09.015, PubMed 30396676
  119. Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E, Braziel RM, Delabie J, Weisenburger DD, Song JY, Chan WC, Cook JR, Fu K, Greiner T, Smeland E, Holte H, Savage KJ, Glinsmann-Gibson BJ, Gascoyne RD, Staudt LM, Jaffe ES, Connors JM, Scott DW, Steidl C, Rimsza LM (2018)
    Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens
    Blood, 132 (22), 2401-2405
    DOI 10.1182/blood-2018-05-851154, PubMed 30257882
  120. Najjari Jamal D, Pötter R, Haie-Meder C, Lindegaard JC, Juergenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Wiebe E, Cooper R, Tanderup K, Kirchheiner K, EMBRACE collaborative group (2018)
    Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study
    Radiother Oncol, 127 (3), 449-455
    DOI 10.1016/j.radonc.2018.03.026, PubMed 29631933
  121. Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA (2018)
    Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor
    Mol Cancer Ther, 17 (11), 2473-2480
    DOI 10.1158/1535-7163.MCT-18-0174, PubMed 30097488
  122. Norum J, Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Undlien DE, Schlichting E, Mæhle L (2018)
    BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
    ESMO Open, 3 (3), e000328
    DOI 10.1136/esmoopen-2018-000328, PubMed 29682331
  123. Novello S, Mazières J, Oh IJ, de Castro J, Migliorino MR, Helland Å, Dziadziuszko R, Griesinger F, Kotb A, Zeaiter A, Cardona A, Balas B, Johannsdottir HK, Das-Gupta A, Wolf J (2018)
    Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
    Ann Oncol, 29 (6), 1409-1416
    DOI 10.1093/annonc/mdy121, PubMed 29668860
  124. Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ (2018)
    Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
    Cancer Immunol Res, 6 (4), 467-480
    DOI 10.1158/2326-6066.CIR-17-0207, PubMed 29459477
  125. Oltedal S, Kørner H, Aasprong OG, Hussain I, Tjensvoll K, Smaaland R, Søreide JA, Søreide K, Lothe RA, Heikkilä R, Gilje B, Nordgård O (2018)
    The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer
    Transl Oncol, 11 (2), 436-443
    DOI 10.1016/j.tranon.2018.01.015, PubMed 29475140
  126. Oltedal S, Skaland I, Maple-Grødem J, Tjensvoll K, Janssen EAM, Gilje B, Smaaland R, Heikkilä R, Nordgård O (2018)
    Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics
    BMC Gastroenterol, 18 (1), 26
    DOI 10.1186/s12876-018-0752-8, PubMed 29415677
  127. Onallah H, Catane LJ, Tropé CG, Hetland Falkenthal TE, Reich R, Davidson B (2018)
    Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma
    Virchows Arch, 473 (4), 463-470
    DOI 10.1007/s00428-018-2418-x, PubMed 30032361
  128. Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Mæhle L, Engebretsen LF, Jørgensen LH, Varhaug JE, Bjøro T (2018)
    Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study
    Eur Thyroid J, 8 (1), 31-40
    DOI 10.1159/000493977, PubMed 30800639
  129. Ottestad I, Ulven SM, Øyri LKL, Sandvei KS, Gjevestad GO, Bye A, Sheikh NA, Biong AS, Andersen LF, Holven KB (2018)
    Reduced plasma concentration of branched-chain amino acids in sarcopenic older subjects: a cross-sectional study
    Br J Nutr, 120 (4), 445-453
    DOI 10.1017/S0007114518001307, PubMed 29909813
  130. Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C (2018)
    DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
    Radiother Oncol, 127 (1), 12-19
    DOI 10.1016/j.radonc.2018.02.018, PubMed 29523409
  131. Panagopoulos I, Gorunova L, Leske H, Niehusmann P, Johannessen LE, Staurseth J, Øino N, Meling TR, Heim S, Micci F, Brandal P (2018)
    Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma
    Cancer Genomics Proteomics, 15 (5), 379-385
    DOI 10.21873/cgp.20096, PubMed 30194078
  132. Petersen MA, Aaronson NK, Arraras JI, Chie WC, Conroy T, Costantini A, Dirven L, Fayers P, Gamper EM, Giesinger JM, Habets EJJ, Hammerlid E, Helbostad J, Hjermstad MJ, Holzner B, Johnson C, Kemmler G, King MT, Kaasa S, Loge JH, Reijneveld JC, Singer S, Taphoorn MJB, Thamsborg LH, Tomaszewski KA et al. (2018)
    The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire
    Eur J Cancer, 100, 8-16
    DOI 10.1016/j.ejca.2018.04.016, PubMed 29936066
  133. Pötter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, Tan LT, Haie-Meder C, Mahantshetty U, Segedin B, Hoskin P, Bruheim K, Rai B, Huang F, Van Limbergen E, Schmid M, Nesvacil N, Sturdza A, Fokdal L, Jensen NBK, Georg D, Assenholt M, Seppenwoolde Y, Nomden C, Fortin I et al. (2018)
    The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
    Clin Transl Radiat Oncol, 9, 48-60
    DOI 10.1016/j.ctro.2018.01.001, PubMed 29594251
  134. Prasmickaite L, Tenstad EM, Pettersen S, Jabeen S, Egeland EV, Nord S, Pandya A, Haugen MH, Kristensen VN, Børresen-Dale AL, Oslo Breast Cancer Research Consortium (OSBREAC), Engebråten O, Maelandsmo GM (2018)
    Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4
    Mol Oncol, 12 (9), 1540-1558
    DOI 10.1002/1878-0261.12319, PubMed 29741811
  135. Rauert-Wunderlich H, Mottok A, Scott DW, Rimsza LM, Ott G, Klapper W, Unterhalt M, Kluin-Nelemans HC, Hermine O, Hartmann S, Thorns C, Rymkiewicz G, Holte H, Dreyling M, Hoster E, Rosenwald A (2018)
    Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network
    Br J Haematol, 184 (4), 616-624
    DOI 10.1111/bjh.15519, PubMed 30095158
  136. Røen I, Stifoss-Hanssen H, Grande G, Brenne AT, Kaasa S, Sand K, Knudsen AK (2018)
    Resilience for family carers of advanced cancer patients-how can health care providers contribute? A qualitative interview study with carers
    Palliat Med, 32 (8), 1410-1418
    DOI 10.1177/0269216318777656, PubMed 29852808
  137. Rogg L (2018)
    NO MAN'S LAND For those who did not die, who are no longer sick, nor are they healthy
    Tidsskr. Nor. Laegeforen., 138 (5), 483
  138. Rye IH, Trinh A, Saetersdal AB, Nebdal D, Lingjaerde OC, Almendro V, Polyak K, Borresen-Dale AL, Helland A, Markowetz F, Russnes HG (2018)
    Intratumor heterogeneity defines treatment-resistant HER2+breast tumors
    Mol. Oncol., 12 (11), 1838-1855
  139. Sá Dos Reis C, Pires Jorge JA, York H, Flaction L, Johansen S, Mæhle S (2018)
    A comparative study about motivations, expectations and future plans for professional development in four European radiography programs
    Radiography (Lond), 24 (4), e91-e97
    DOI 10.1016/j.radi.2018.05.007, PubMed 30292519
  140. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM et al. (2018)
    Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
    Int J Radiat Oncol Biol Phys, 101 (4), 883-888
    DOI 10.1016/j.ijrobp.2018.03.060, PubMed 29976500
  141. Schöffski P, Wozniak A, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Gelderblom H, Italiano A, Lindner LH, Hennig I, Strauss S, Zakotnik B, Anthoney A, Albiges L, Blay JY, Reichardt P, Sufliarsky J, van der Graaf WTA, Debiec-Rychter M, Sciot R, Van Cann T, Marréaud S, Raveloarivahy T, Collette S et al. (2018)
    Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'
    Ann Oncol, 29 (3), 758-765
    DOI 10.1093/annonc/mdx774, PubMed 29216400
  142. Schöffski P, Wozniak A, Leahy MG, Aamdal S, Rutkowski P, Bauer S, Richter S, Grünwald V, Debiec-Rychter M, Sciot R, Geoerger B, Marréaud S, Collette S, Nzokirantevye A, Strauss SJ (2018)
    The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'
    Eur J Cancer, 94, 156-167
    DOI 10.1016/j.ejca.2018.02.011, PubMed 29567632
  143. Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT, JULIET Investigators (2018)
    Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    N Engl J Med, 380 (1), 45-56
    DOI 10.1056/NEJMoa1804980, PubMed 30501490
  144. Seip K, Jørgensen K, Haselager MV, Albrecht M, Haugen MH, Egeland EV, Lucarelli P, Engebraaten O, Sauter T, Mælandsmo GM, Prasmickaite L (2018)
    Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment
    Cancer Lett, 439, 1-13
    DOI 10.1016/j.canlet.2018.09.023, PubMed 30240588
  145. Seravalli E, Bosman M, Lassen-Ramshad Y, Vestergaard A, Oldenburger F, Visser J, Koutsouveli E, Paraskevopoulou C, Horan G, Ajithkumar T, Timmermann B, Fuentes CS, Whitfield G, Marchant T, Padovani L, Garnier E, Gandola L, Meroni S, Hoeben BAW, Kusters M, Alapetite C, Losa S, Goudjil F, Magelssen H, Evensen ME et al. (2018)
    Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)
    Acta Oncol, 57 (9), 1240-1249
    DOI 10.1080/0284186X.2018.1465588, PubMed 29698060
  146. Serban M, Kirisits C, Pötter R, de Leeuw A, Nkiwane K, Dumas I, Nesvacil N, Swamidas J, Hudej R, Lowe G, Hellebust TP, Menon G, Oinam A, Bownes P, Oosterveld B, De Brabandere M, Koedooder K, Marthinsen ABL, Lindegaard J, Tanderup K, EMBRACE Collaborative Group (2018)
    Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy
    Radiother Oncol, 129 (3), 567-574
    DOI 10.1016/j.radonc.2018.09.002, PubMed 30243671
  147. Skaarud KJ, Hjermstad MJ, Bye A, Veierød MB, Gudmundstuen AM, Lundin KEA, Distante S, Brinch L, Tjønnfjord GE, Iversen PO (2018)
    Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial
    Clin Nutr ESPEN, 28, 59-66
    DOI 10.1016/j.clnesp.2018.08.002, PubMed 30390894
  148. Skjøtskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, Malinen E, Dale E (2018)
    Dose painting for re-irradiation of head and neck cancer
    Acta Oncol, 57 (12), 1693-1699
    DOI 10.1080/0284186X.2018.1512753, PubMed 30280623
  149. Smeby J, Sveen A, Merok MA, Danielsen SA, Eilertsen IA, Guren MG, Dienstmann R, Nesbakken A, Lothe RA (2018)
    CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer
    Ann Oncol, 29 (5), 1227-1234
    DOI 10.1093/annonc/mdy085, PubMed 29518181
  150. Smedman TM, Line PD, Guren TK, Dueland S (2018)
    Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients
    Acta Oncol, 57 (10), 1414-1418
    DOI 10.1080/0284186X.2018.1479069, PubMed 29912605
  151. Smeland KB, Loge JH, Aass HCD, Aspelin T, Bersvendsen H, Bolstad N, Fagerli UM, Falk RS, Fluge Ø, Fosså A, Holte H, Lund MB, Murbræch K, Reinertsen KV, Stenehjem JS, Kiserud CE (2018)
    Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity
    Bone Marrow Transplant, 54 (4), 607-610
    DOI 10.1038/s41409-018-0342-y, PubMed 30262906
  152. Smet S, Pötter R, Haie-Meder C, Lindegaard JC, Schulz-Juergenliemk I, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van Limbergen E, Tanderup K, Kirchheiner K, EMBRACE Collaborative Group (2018)
    Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study
    Radiother Oncol, 127 (3), 440-448
    DOI 10.1016/j.radonc.2018.03.009, PubMed 29627137
  153. Solheim O, Skalleberg J, Warncke T, Ørstavik K, Tropé C, Fosså SD (2018)
    Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor
    Acta Obstet Gynecol Scand, 98 (2), 240-249
    DOI 10.1111/aogs.13477, PubMed 30289161
  154. Solheim TS, Laird BJA, Balstad TR, Bye A, Stene G, Baracos V, Strasser F, Griffiths G, Maddocks M, Fallon M, Kaasa S, Fearon K (2018)
    Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
    BMJ Support Palliat Care, 8 (3), 258-265
    DOI 10.1136/bmjspcare-2017-001440, PubMed 29440149
  155. Steinberg MT, Olsen JA, Eriksen M, Neset A, Norseng PA, Kramer-Johansen J, Hardig BM, Wik L (2018)
    Haemodynamic outcomes during piston-based mechanical CPR with or without active decompression in a porcine model of cardiac arrest
    Scand J Trauma Resusc Emerg Med, 26 (1), 31
    DOI 10.1186/s13049-018-0496-z, PubMed 29690910
  156. Stokke C, Blakkisrud J, Løndalen A, Dahle J, Martinsen ACT, Holte H, Kolstad A (2018)
    Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients
    Eur J Nucl Med Mol Imaging, 45 (7), 1233-1241
    DOI 10.1007/s00259-018-3964-9, PubMed 29470615
  157. Stranne J, Brasso K, Brennhovd B, Johansson E, Jäderling F, Kouri M, Lilleby W, Meidahl Petersen P, Mirtti T, Pettersson A, Rannikko A, Thellenberg C, Akre O (2018)
    SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
    Scand J Urol, 52 (5-6), 313-320
    DOI 10.1080/21681805.2018.1520295, PubMed 30585526
  158. Sundby Hall K, Bruland ØS, Bjerkehagen B, Zaikova O, Engellau J, Hagberg O, Hansson L, Hagberg H, Ahlström M, Knobel H, Papworth K, Zemmler M, Goplen D, Bauer HCF, Eriksson M (2018)
    Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX)
    Eur J Cancer, 99, 78-85
    DOI 10.1016/j.ejca.2018.05.011, PubMed 29929092
  159. Sweegers MG, Altenburg TM, Brug J, May AM, van Vulpen JK, Aaronson NK, Arbane G, Bohus M, Courneya KS, Daley AJ, Galvao DA, Garrod R, Griffith KA, Van Harten WH, Hayes SC, Herrero-Román F, Kersten MJ, Lucia A, McConnachie A, van Mechelen W, Mutrie N, Newton RU, Nollet F, Potthoff K, Schmidt ME et al. (2018)
    Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data
    Br J Sports Med, 53 (13), 812
    DOI 10.1136/bjsports-2018-099191, PubMed 30181323
  160. Thomsen M, Skovlund E, Sorbye H, Bolstad N, Nustad KJ, Glimelius B, Pfeiffer P, Kure EH, Johansen JS, Tveit KM, Christoffersen T, Guren TK (2018)
    Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
    Br J Cancer, 118 (12), 1609-1616
    DOI 10.1038/s41416-018-0115-9, PubMed 29872151
  161. Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N (2018)
    Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
    J Thromb Haemost, 16 (7), 1347-1356
    DOI 10.1111/jth.14151, PubMed 29766637
  162. Tøndel H, Lund JÅ, Lydersen S, Wanderås AD, Aksnessæther B, Jensen CA, Kaasa S, Solberg A (2018)
    Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial
    Radiother Oncol, 126 (2), 229-235
    DOI 10.1016/j.radonc.2017.10.029, PubMed 29398152
  163. Tøndel H, Lund JÅ, Lydersen S, Wanderås AD, Aksnessæther BY, Jensen CA, Kaasa S, Solberg A (2018)
    Dose to penile bulb is not associated with erectile dysfunction 18 months post radiotherapy: A secondary analysis of a randomized trial
    Clin Transl Radiat Oncol, 13, 50-56
    DOI 10.1016/j.ctro.2018.09.006, PubMed 30364704
  164. Tulipan AJ, Hole KH, Vlatkovic L, Revheim ME, Reijnen JS, Willoch F, Seierstad T, Lilleby W (2018)
    Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
    Acta Radiol, 60 (8), 1028-1038
    DOI 10.1177/0284185118810977, PubMed 30379559
  165. Vade C, Næss S (2018)
    A Scandinavian Point of View: Caring for Patients With Sarcoma Across Boundaries
    Clin J Oncol Nurs, 22 (3), 357-359
    DOI 10.1188/18.CJON.357-359, PubMed 29781457
  166. Valan CD, Slagsvold JE, Halvorsen TO, Herje M, Bremnes RM, Brunsvig PF, Brustugun OT, Fløtten Ø, Levin N, Sundstrøm SH, Grønberg BH (2018)
    Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement
    Anticancer Res, 38 (2), 871-876
    DOI 10.21873/anticanres.12296, PubMed 29374714
  167. van den Berg M, van Dijk M, Byrne J, Campbell H, Berger C, Borgmann-Staudt A, Calaminus G, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, Kremer LC, Kruseova J, Kuehni CE, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Morsellino V, Spix C, Kaatsch P et al. (2018)
    Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)
    JMIR Res Protoc, 7 (9), e10824
    DOI 10.2196/10824, PubMed 30215599
  168. van der Kooi ALF, Clemens E, Broer L, Zolk O, Byrne J, Campbell H, van den Berg M, Berger C, Calaminus G, Dirksen U, Winther JF, Fosså SD, Grabow D, Haupt R, Kaiser M, Kepak T, Kremer L, Kruseova J, Modan-Moses D, Ranft A, Spix C, Kaatsch P, Laven JSE, van Dulmen-den Broeder E, Uitterlinden AG et al. (2018)
    Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol
    BMC Cancer, 18 (1), 930
    DOI 10.1186/s12885-018-4834-3, PubMed 30257669
  169. van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS et al. (2018)
    International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
    Blood, 132 (20), 2115-2124
    DOI 10.1182/blood-2018-07-862334, PubMed 30181172
  170. Våtsveen TK, Myhre MR, Steen CB, Wälchli S, Lingjærde OC, Bai B, Dillard P, Theodossiou TA, Holien T, Sundan A, Inderberg EM, Smeland EB, Myklebust JH, Oksvold MP (2018)
    Artesunate shows potent anti-tumor activity in B-cell lymphoma
    J Hematol Oncol, 11 (1), 23
    DOI 10.1186/s13045-018-0561-0, PubMed 29458389
  171. Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE (2018)
    Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
    J Am Acad Dermatol, 79 (1), 118-125.e1
    DOI 10.1016/j.jaad.2018.03.023, PubMed 29580861
  172. Vermeer NCA, Claassen YHM, Derks MGM, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Portielje JEA, Liefers GJ, Peeters KCMJ, van de Velde CJH, Bastiaannet E (2018)
    Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison
    Oncologist, 23 (8), 982-990
    DOI 10.1634/theoncologist.2017-0551, PubMed 29567826
  173. Vistad I, Cvancarova M, Lindviksmoen Astrup G, Rustøen T, Liavaag AH (2018)
    Symptom Experience and Self-rated Physical Functioning in Patients With Ovarian Cancer Receiving Chemotherapy: A Longitudinal Study
    Int J Gynecol Cancer, 28 (6), 1167-1175
    DOI 10.1097/IGC.0000000000001287, PubMed 29781824
  174. Vodák D, Lorenz S, Nakken S, Aasheim LB, Holte H, Bai B, Myklebost O, Meza-Zepeda LA, Hovig E (2018)
    Sample-Index Misassignment Impacts Tumour Exome Sequencing
    Sci Rep, 8 (1), 5307
    DOI 10.1038/s41598-018-23563-4, PubMed 29593270
  175. Wedde TB, Småstuen MC, Brabrand S, Fosså SD, Kaasa S, Tafjord G, Russnes KM, Hellebust TP, Lilleby W (2018)
    Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort
    Radiother Oncol, 132, 211-217
    DOI 10.1016/j.radonc.2018.10.013, PubMed 30389241
  176. Weller D, Menon U, Zalounina Falborg A, Jensen H, Barisic A, Knudsen AK, Bergin RJ, Brewster DH, Cairnduff V, Gavin AT, Grunfeld E, Harland E, Lambe M, Law RJ, Lin Y, Malmberg M, Turner D, Neal RD, White V, Harrison S, Reguilon I, ICBP Module 4 Working Group, Vedsted P (2018)
    Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP)
    BMJ Open, 8 (11), e023870
    DOI 10.1136/bmjopen-2018-023870, PubMed 30482749
  177. Westrøm S, Bønsdorff TB, Bruland ØS, Larsen RH (2018)
    Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer
    Transl Oncol, 11 (2), 259-267
    DOI 10.1016/j.tranon.2017.12.011, PubMed 29413758
  178. Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland ØS, Bønsdorff TB, Larsen RH (2018)
    Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice
    J Labelled Comp Radiopharm, 61 (6), 472-486
    DOI 10.1002/jlcr.3610, PubMed 29380410
  179. Yachnin J, Gilje B, Thon K, Johansson H, Brandberg Y, Panaretakis T, Ullén A (2018)
    Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab)
    Eur J Cancer, 97, 33-40
    DOI 10.1016/j.ejca.2018.03.007, PubMed 29685343
  180. Zaid MA, Gathirua-Mwangi WG, Fung C, Monahan PO, El-Charif O, Williams AM, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse SK, Ardeshir-Rouhani-Fard S, Dinh PC, Sesso HD, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group (2018)
    Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors
    J Natl Compr Canc Netw, 16 (3), 257-265
    DOI 10.6004/jnccn.2017.7046, PubMed 29523664
  181. Zaikova O, Berner K (2018)
    Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway
    J Surg Oncol, 118 (1), 248
    DOI 10.1002/jso.25135, PubMed 30208204

Publications 2017

  1. Aas K, Axcrona K, Kvåle R, Møller B, Myklebust TÅ, Axcrona U, Berge V, Fosså SD (2017)
    Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway
    Urology, 110, 140-147
    DOI 10.1016/j.urology.2017.07.048, PubMed 28823634
  2. Abravan A, Eide HA, Knudtsen IS, Løndalen AM, Helland Å, Malinen E (2017)
    Assessment of pulmonary 18F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib
    Clin Transl Radiat Oncol, 4, 57-63
    DOI 10.1016/j.ctro.2017.04.002, PubMed 29594209
  3. Abravan A, Knudtsen IS, Eide HA, Løndalen AM, Helland Å, van Luijk P, Malinen E (2017)
    A new method to assess pulmonary changes using 18F-fluoro-2-deoxyglucose positron emission tomography for lung cancer patients following radiotherapy
    Acta Oncol, 56 (11), 1597-1603
    DOI 10.1080/0284186X.2017.1349336, PubMed 28849707
  4. Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
    Improved treatment decisions in patients with esophageal cancer
    Acta Oncol, 56 (10), 1286-1294
    DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
  5. Ascierto PA, Del Vecchio M, Robert C, Mackiewicz A, Chiarion-Sileni V, Arance A, Lebbé C, Bastholt L, Hamid O, Rutkowski P, McNeil C, Garbe C, Loquai C, Dreno B, Thomas L, Grob JJ, Liszkay G, Nyakas M, Gutzmer R, Pikiel J, Grange F, Hoeller C, Ferraresi V, Smylie M, Schadendorf D et al. (2017)
    Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
    Lancet Oncol, 18 (5), 611-622
    DOI 10.1016/S1470-2045(17)30231-0, PubMed 28359784
  6. Åsli LM, Johannesen TB, Myklebust TÅ, Møller B, Eriksen MT, Guren MG (2017)
    Preoperative chemoradiotherapy for rectal cancer and impact on outcomes - A population-based study
    Radiother Oncol, 123 (3), 446-453
    DOI 10.1016/j.radonc.2017.04.012, PubMed 28483302
  7. Astrup GL, Hofsø K, Bjordal K, Guren MG, Vistad I, Cooper B, Miaskowski C, Rustøen T (2017)
    Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence
    Acta Oncol, 56 (3), 462-470
    DOI 10.1080/0284186X.2016.1273546, PubMed 28077018
  8. Astrup GL, Rustøen T, Hofsø K, Gran JM, Bjordal K (2017)
    Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy
    Head Neck, 39 (10), 2114-2126
    DOI 10.1002/hed.24875, PubMed 28766791
  9. Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E et al. (2017)
    Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
    Breast Cancer Res, 19 (1), 44
    DOI 10.1186/s13058-017-0812-y, PubMed 28356166
  10. Axcrona K, Nilsson R, Brennhovd B, Sørebø Ø, Fosså SD, Dahl AA (2017)
    Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
    BMC Urol, 17 (1), 111
    DOI 10.1186/s12894-017-0302-7, PubMed 29197360
  11. Bakke KM, Hole KH, Dueland S, Grøholt KK, Flatmark K, Ree AH, Seierstad T, Redalen KR (2017)
    Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
    Acta Oncol, 56 (6), 813-818
    DOI 10.1080/0284186X.2017.1287951, PubMed 28464745
  12. Barzenje DA, Kolstad A, Ghanima W, Holte H (2017)
    Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years
    Hematol Oncol, 36 (1), 217-223
    DOI 10.1002/hon.2415, PubMed 28393375
  13. Belfrage A, Grotmol KS, Lien L, Moum T, Wiese RV, Tyssen R (2017)
    Medical school predictors of later perceived mastery of clinical work among Norwegian doctors: a cohort study with 10-year and 20-year follow-up
    BMJ Open, 7 (9), e014462
    DOI 10.1136/bmjopen-2016-014462, PubMed 28947437
  14. Bjørklund SS, Panda A, Kumar S, Seiler M, Robinson D, Gheeya J, Yao M, Alnæs GIG, Toppmeyer D, Riis M, Naume B, Børresen-Dale AL, Kristensen VN, Ganesan S, Bhanot G (2017)
    Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
    Sci Rep, 7 (1), 5568
    DOI 10.1038/s41598-017-05537-0, PubMed 28717182
  15. Blakkisrud J, Holtedahl JE, Løndalen A, Dahle J, Bach-Gansmo T, Holte H, Nygaard S, Kolstad A, Stokke C (2017)
    Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
    J Nucl Med, 59 (4), 704-710
    DOI 10.2967/jnumed.117.195347, PubMed 28848035
  16. Bollum LK, Huse K, Oksvold MP, Bai B, Hilden VI, Forfang L, Yoon SO, Wälchli S, Smeland EB, Myklebust JH (2017)
    BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-β receptor type I ALK5
    PLoS One, 12 (5), e0177188
    DOI 10.1371/journal.pone.0177188, PubMed 28489883
  17. Boye K, Jebsen NL, Zaikova O, Knobel H, Løndalen AM, Trovik CS, Monge OR, Hall KS (2017)
    Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort
    Acta Oncol, 56 (3), 479-483
    DOI 10.1080/0284186X.2016.1278305, PubMed 28105885
  18. Broughton MN, Westgaard A, Paus E, Øijordsbakken M, Henanger KJ, Naume B, Bjøro T (2017)
    Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
    Tumour Biol, 39 (6), 1010428317707436
    DOI 10.1177/1010428317707436, PubMed 28653892
  19. Bryhn B, Tveit KM (2017)
    National intestinal screening will reduce the occurrence and mortality of intestinal cancer
    Tidsskr. Nor. Laegeforen., 137 (21), 1664
  20. Bye A, Sjøblom B, Wentzel-Larsen T, Grønberg BH, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Jordhøy M (2017)
    Muscle mass and association to quality of life in non-small cell lung cancer patients
    J Cachexia Sarcopenia Muscle, 8 (5), 759-767
    DOI 10.1002/jcsm.12206, PubMed 28493418
  21. Byskov CS, Nyvang L, Guren MG, Spindler KLG, Muren LP (2017)
    The normal tissue sparing potential of an adaptive plan selection strategy for re-irradiation of recurrent rectal cancer
    Phys. Imag. Radiat. Oncol., 3, 43-48
  22. Chen H, Ewing CM, Zheng S, Grindedaal EM, Cooney KA, Wiley K, Djurovic S, Andreassen OA, Axcrona K, Mills IG, Xu J, Maehle L, Fosså SD, Isaacs WB (2017)
    Genetic factors influencing prostate cancer risk in Norwegian men
    Prostate, 78 (3), 186-192
    DOI 10.1002/pros.23453, PubMed 29181843
  23. Dahl AA (2017)
    [Racing thoughts - a psychiatric term without meaning?]
    Tidsskr Nor Laegeforen, 137 (16)
    DOI 10.4045/tidsskr.17.0161, PubMed 28871751
  24. Dahl AA (2017)
    Racing thoughts- a psychiatric term without meaning?
    Tidsskr. Nor. Laegeforen., 137 (16), 1226
  25. Dannenfelser R, Nome M, Tahiri A, Ursini-Siegel J, Vollan HKM, Haakensen VD, Helland Å, Naume B, Caldas C, Børresen-Dale AL, Kristensen VN, Troyanskaya OG (2017)
    Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity
    Oncotarget, 8 (34), 57121-57133
    DOI 10.18632/oncotarget.19078, PubMed 28915659
  26. Delord JP, Robert C, Nyakas M, McArthur GA, Kudchakar R, Mahipal A, Yamada Y, Sullivan R, Arance A, Kefford RF, Carlino MS, Hidalgo M, Gomez-Roca C, Michel D, Seroutou A, Aslanis V, Caponigro G, Stuart DD, Moutouh-de Parseval L, Demuth T, Dummer R (2017)
    Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma
    Clin Cancer Res, 23 (18), 5339-5348
    DOI 10.1158/1078-0432.CCR-16-2923, PubMed 28611198
  27. Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kim J, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox NJ, Travis LB, Platinum Study Group (2017)
    Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
    Clin Cancer Res, 23 (19), 5757-5768
    DOI 10.1158/1078-0432.CCR-16-3224, PubMed 28611204
  28. Dueland S, Guren TK, Boberg KM, Reims HM, Grzyb K, Aamdal S, Julsrud L, Line PD (2017)
    Acute liver graft rejection after ipilimumab therapy
    Ann Oncol, 28 (10), 2619-2620
    DOI 10.1093/annonc/mdx281, PubMed 28961840
  29. Dumeaux V, Fjukstad B, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Børresen-Dale AL, Bongo LA, Lund E, Hallett M (2017)
    Interactions between the tumor and the blood systemic response of breast cancer patients
    PLoS Comput Biol, 13 (9), e1005680
    DOI 10.1371/journal.pcbi.1005680, PubMed 28957325
  30. Egeland EV, Boye K, Park D, Synnestvedt M, Sauer T, Oslo Breast Cancer Consortium (OSBREAC), Naume B, Borgen E, Mælandsmo GM (2017)
    Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
    Breast Cancer Res Treat, 162 (1), 127-137
    DOI 10.1007/s10549-016-4096-1, PubMed 28058579
  31. Eide N, Faye RS, Høifødt HK, Sandvik L, Qvale GA, Faber R, Jebsen P, Kvalheim G, Fodstad Ø (2017)
    The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy
    Pathol Oncol Res, 25 (1), 255-262
    DOI 10.1007/s12253-017-0355-7, PubMed 29098521
  32. Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB, Montano-Almendras CP, Husby S, Freiburghaus C, Ek S, Pedersen A, Niemann C, Räty R, Brown P, Geisler CH, Andersen MK, Guldberg P, Jerkeman M, Grønbæk K (2017)
    TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy
    Blood, 130 (17), 1903-1910
    DOI 10.1182/blood-2017-04-779736, PubMed 28819011
  33. Euceda LR, Haukaas TH, Giskeodegard GF, Vettukattil R, Engel J, Silwal-Pandit L, Lundgren S, Borgen E, Garred O, Postma G, Buydens LMC, Borresen-Dale AL, Engebraaten O, Bathen TF (2017)
    Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy
    Metabolomics, 13 (4), 37
  34. Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS et al. (2017)
    International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease
    Blood, 129 (12), 1646-1657
    DOI 10.1182/blood-2016-10-746933, PubMed 28087540
  35. Felip E, Barlesi F, Besse B, Chu Q, Gandhi L, Kim SW, Carcereny E, Sequist LV, Brunsvig P, Chouaid C, Smit EF, Groen HJM, Kim DW, Park K, Avsar E, Szpakowski S, Akimov M, Garon EB (2017)
    Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer
    J Thorac Oncol, 13 (4), 576-584
    DOI 10.1016/j.jtho.2017.11.131, PubMed 29247830
  36. Fleischer T, Klajic J, Aure MR, Louhimo R, Pladsen AV, Ottestad L, Touleimat N, Laakso M, Halvorsen AR, Grenaker Alnæs GI, Riis ML, Helland Å, Hautaniemi S, Lønning PE, Naume B, Børresen-Dale AL, Tost J, Kristensen VN (2017)
    DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
    Oncotarget, 8 (1), 1074-1082
    DOI 10.18632/oncotarget.13718, PubMed 27911866
  37. Fleischer T, Tekpli X, Mathelier A, Wang S, Nebdal D, Dhakal HP, Sahlberg KK, Schlichting E, Oslo Breast Cancer Research Consortium (OSBREAC), Børresen-Dale AL, Borgen E, Naume B, Eskeland R, Frigessi A, Tost J, Hurtado A, Kristensen VN (2017)
    DNA methylation at enhancers identifies distinct breast cancer lineages
    Nat Commun, 8 (1), 1379
    DOI 10.1038/s41467-017-00510-x, PubMed 29123100
  38. Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Olsen KH, Giercksky KE, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2017)
    Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
    Ann Surg Oncol, 24 (7), 1916-1922
    DOI 10.1245/s10434-017-5814-6, PubMed 28224367
  39. Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group (2017)
    Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy
    J Clin Oncol, 35 (11), 1211-1222
    DOI 10.1200/JCO.2016.70.3108, PubMed 28240972
  40. Galleberg RB, Knigge U, Tiensuu Janson E, Vestermark LW, Haugvik SP, Ladekarl M, Langer SW, Grønbæk H, Österlund P, Hjortland GO, Assmus J, Tang L, Perren A, Sorbye H (2017)
    Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas
    Eur J Surg Oncol, 43 (9), 1682-1689
    DOI 10.1016/j.ejso.2017.04.010, PubMed 28522174
  41. Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM et al. (2017)
    Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects
    Radiat Res, 187 (2), 186-195
    DOI 10.1667/RR14453.1, PubMed 28118119
  42. Gingras I, Holmes E, De Azambuja E, Nguyen DH, Izquierdo M, Anne Zujewski J, Inbar M, Naume B, Tomasello G, Gralow JR, Wolff AC, Harris L, Gnant M, Moreno-Aspitia A, Piccart MJ, Azim HA (2017)
    Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial
    J Natl Cancer Inst, 109 (8)
    DOI 10.1093/jnci/djw331, PubMed 28376188
  43. Giustacchini A, Thongjuea S, Barkas N, Woll PS, Povinelli BJ, Booth CAG, Sopp P, Norfo R, Rodriguez-Meira A, Ashley N, Jamieson L, Vyas P, Anderson K, Segerstolpe Å, Qian H, Olsson-Strömberg U, Mustjoki S, Sandberg R, Jacobsen SEW, Mead AJ (2017)
    Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia
    Nat Med, 23 (6), 692-702
    DOI 10.1038/nm.4336, PubMed 28504724
  44. Gjerset GM, Loge JH, Kiserud CE, Fosså SD, Gudbergsson SB, Oldervoll LM, Wisløff T, Thorsen L (2017)
    Perceived needs for different components in a rehabilitation program among cancer survivors with chronic fatigue compared to survivors without chronic fatigue
    Acta Oncol, 56 (2), 245-253
    DOI 10.1080/0284186X.2016.1266091, PubMed 28075207
  45. Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Mæhle L, Undlien DE, Norum J, Schlichting E (2017)
    Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
    BMC Cancer, 17 (1), 438
    DOI 10.1186/s12885-017-3422-2, PubMed 28637432
  46. Grotmol KS, Lie HC, Hjermstad MJ, Aass N, Currow D, Kaasa S, Moum TÅ, Pigni A, Loge JH, European Palliative Care Research Collaborative (EPCRC) (2017)
    Depression-A Major Contributor to Poor Quality of Life in Patients With Advanced Cancer
    J Pain Symptom Manage, 54 (6), 889-897
    DOI 10.1016/j.jpainsymman.2017.04.010, PubMed 28803091
  47. Grov EK, Fosså SD, Dahl AA (2017)
    A controlled study of the influence of comorbidity on activities of daily living in elderly cancer survivors (the HUNT-3 survey)
    J Geriatr Oncol, 8 (5), 328-335
    DOI 10.1016/j.jgo.2017.05.007, PubMed 28629695
  48. Grut H, Dueland S, Line PD, Revheim ME (2017)
    The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
    Eur J Nucl Med Mol Imaging, 45 (2), 218-225
    DOI 10.1007/s00259-017-3843-9, PubMed 29026950
  49. Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, Line PD, Dueland S (2017)
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
    Br J Surg, 105 (3), 295-301
    DOI 10.1002/bjs.10651, PubMed 29168565
  50. Gunnarsdottir S, Sigurdardottir V, Kloke M, Radbruch L, Sabatowski R, Kaasa S, Klepstad P (2017)
    A multicenter study of attitudinal barriers to cancer pain management
    Support Care Cancer, 25 (11), 3595-3602
    DOI 10.1007/s00520-017-3791-8, PubMed 28653107
  51. Guren TK, Thomsen M, Kure EH, Sorbye H, Glimelius B, Pfeiffer P, Österlund P, Sigurdsson F, Lothe IMB, Dalsgaard AM, Skovlund E, Christoffersen T, Tveit KM (2017)
    Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
    Br J Cancer, 116 (10), 1271-1278
    DOI 10.1038/bjc.2017.93, PubMed 28399112
  52. Halvorsen AR, Kristensen G, Embleton A, Adusei C, Barretina-Ginesta MP, Beale P, Helland Å (2017)
    Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients
    Dis Markers, 2017, 3098542
    DOI 10.1155/2017/3098542, PubMed 28293063
  53. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2017)
    Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
    World J Surg Oncol, 15 (1), 118
    DOI 10.1186/s12957-017-1184-6, PubMed 28673296
  54. Heikkilä R, Kaasa S (2017)
    Chemotherapy in end-of-life care
    Ann Oncol, 28 (4), 684-685
    DOI 10.1093/annonc/mdx039, PubMed 28327919
  55. Helland Å, Brustugun OT, Nakken S, Halvorsen AR, Dønnem T, Bremnes R, Busund LT, Sun J, Lorenz S, Solberg SK, Jørgensen LH, Vodak D, Myklebost O, Hovig E, Meza-Zepeda LA (2017)
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
    Int J Cancer, 141 (1), 184-190
    DOI 10.1002/ijc.30726, PubMed 28387924
  56. Helland T, Henne N, Bifulco E, Naume B, Borgen E, Kristensen VN, Kvaløy JT, Lash TL, Alnæs GIG, van Schaik RH, Janssen EAM, Hustad S, Lien EA, Mellgren G, Søiland H (2017)
    Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
    Breast Cancer Res, 19 (1), 125
    DOI 10.1186/s13058-017-0916-4, PubMed 29183390
  57. Hetmann F, Kongsgaard UE, Sandvik L, Schou-Bredal I (2017)
    Post-thoracotomy pain syndrome and sensory disturbances following thoracotomy at 6- and 12-month follow-ups
    J Pain Res, 10, 663-668
    DOI 10.2147/JPR.S126639, PubMed 28356766
  58. Holm HV, Dahl AA, Klepp OH, Fosså SD (2017)
    Modern treatment of metastatic prostate cancer
    Tidsskr Nor Laegeforen, 137 (11), 803-805
    DOI 10.4045/tidsskr.16.0265, PubMed 28597635
  59. Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K (2017)
    Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort
    Acta Oncol, 56 (10), 1317-1323
    DOI 10.1080/0284186X.2017.1330555, PubMed 28557540
  60. Hui D, Mori M, Meng YC, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E (2017)
    Automatic referral to standardize palliative care access: an international Delphi survey
    Support Care Cancer, 26 (1), 175-180
    DOI 10.1007/s00520-017-3830-5, PubMed 28726065
  61. Inderberg EM, Mensali N, Oksvold MP, Fallang LE, Fåne A, Skorstad G, Stenvik GE, Progida C, Bakke O, Kvalheim G, Myklebust JH, Wälchli S (2017)
    Human c-SRC kinase (CSK) overexpression makes T cells dummy
    Cancer Immunol Immunother, 67 (4), 525-536
    DOI 10.1007/s00262-017-2105-9, PubMed 29248956
  62. Inderberg EM, Wälchli S, Myhre MR, Trachsel S, Almåsbak H, Kvalheim G, Gaudernack G (2017)
    T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
    Oncoimmunology, 6 (4), e1302631
    DOI 10.1080/2162402X.2017.1302631, PubMed 28507809
  63. Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E (2017)
    Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery
    Eur Arch Otorhinolaryngol, 274 (12), 4203-4209
    DOI 10.1007/s00405-017-4764-8, PubMed 29019001
  64. Jacobsen EL, Bye A, Aass N, Fosså SD, Grotmol KS, Kaasa S, Loge JH, Moum T, Hjermstad MJ (2017)
    Norwegian reference values for the Short-Form Health Survey 36: development over time
    Qual Life Res, 27 (5), 1201-1212
    DOI 10.1007/s11136-017-1684-4, PubMed 28808829
  65. Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Ada